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“Wir sind, was wir denken.  
Alles, was wir sind, entsteht aus unseren Gedanken. 
 Mit unseren Gedanken formen wir die Welt. 
 
We are what we think. 
 All that we are arises with our thoughts.  
With our thoughts, we make the world.” 
 
    -Buddha- 
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Abstract 
Dementia currently is and will be in the future a worldwide spread disease which predominantly affects 
elderly people. Alzheimer’s disease (AD) is the most common form of dementia. It is characterized by an 
aggregation of hyperphosphorylated tau protein tangles and Aβ plaques which derives from the 
amyloidogenic processing pathway of the Amyloid Precursor Protein (APP). To understand the pathology 
of AD it is essential to assess the proteins relevance in the intact brain. So far the physiological functions 
of APP, its homologues APLP1/2 and their cleavage fragments in the healthy organism are poorly 
understood. Using gene targeted mice I investigated the role of the APP protein-family for synaptic 
transmission and activity-dependent synaptic plasticity in the hippocampus as a cellular correlate for 
learning and memory. My studies uncovered a synergistic and age-related compensatory function of APP 
and APLP2 in LTP induction and maintenance. Moreover, I could distinguish a role of both proteins for 
brain development and an acute function at active synapses in the adult brain. An involvement during 
development was indicated by abnormal brain morphology as well as an impaired neuromuscular 
junction in triple (APP-/-APLP2-/-APLP1-/-) and most of double KO (APP-/-APLP2-/-) mice which caused 
lethality. My observations in organotypic hippocampal slice cultures point towards an important function 
of APPsα during synaptogenesis indicated by an impaired activity-dependent synaptic plasticity and 
recently reported reduced spine number. I also showed a LTP defect in a viable conditional double KO 
mouse strain in which the APP gene is targeted at E11 only in the CNS on an APLP2 deficient background. 
This might suggest a role of these proteins for an intact neuronal network formation. Additionally, the 
observed LTP defect might be reasoned by an altered excitation-inhibition balance. However, the time 
point of the APP excision on an APLP2 deficient background seems to be important since a postnatally 
induced double KO revealed only a subtle LTP impairment. Furthermore, an acute function of APP 
processing products was confirmed by mice in which APP lacks 15 amino acids C-terminally on an APLP2 
deficient background leading to an impaired synaptic plasticity. Consistently, I identified another APP full 
length cleavage product APPsα as a crucial peptide for LTP induction and maintenance since it was 
capable to restore the impaired synaptic plasticity in a gain and rescue of function experiment by 
recombinant APPsα application. Since Ca2+ is a key molecule for changes in the activity-dependent 
synaptic plasticity I investigated whether the Ca2+ dynamic is affected and thus might contribute to the 
functional LTP defect. Indeed, I showed reduced Ca2+ dynamics before and upon chemically induced LTP 
which were, however, not significantly altered when the relative increase of Ca2+ was quantified upon 
cLTP induction. An inhibition of the SERCA, which reloads Ca2+ into the ER, revealed an impaired Ca2+ 
response upon cLTP induction. This suggests that APP might contribute to proper Ca2+ dynamics in the 
intact brain through APP dependent mechanisms in the ER. Consistent with the functional LTP defect an 
expression of APPsα rescued the defect in Ca2+ dynamics. Furthermore, this peptide even enhanced LTP 
induction in acute slices from control mice. These observations suggest that APPsα might be a potential 
preventive and therapeutic target for Alzheimer’s disease. 
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Zusammenfassung 
Demenz ist derzeit und wird auch in Zukunft eine weltweit stark verbreitete Erkrankung sein, die 
vornehmlich ältere Menschen betrifft. Die Alzheimersche Erkrankung ist dabei die häufigste 
Demenzform. Sie ist durch die Ablagerung von hyperphosphoryliertem Tau Protein als tangles und Aβ 
Plaques, welche durch die amyloidogene Spaltung des Amyloid Precursor Proteins (APP) entsteht, 
charakterisiert. Zum Verständnis der Pathologie der Alzheimerschen Erkrankung ist es essentiell, die 
Relevanz des Proteins im intakten Organismus zu verstehen. Die physiologischen Funktionen von APP, 
seinen Homologen APLP1/2 und deren Spaltprodukte im gesunden Organismus sind jedoch weitgehend 
unbekannt. Die Verwendung transgener Mäuse ermöglichte mir die Rolle der APP-Familie hinsichtlich 
der synaptischen Transmission und Plastizität im Hippokampus zu untersuchen, welches ein zelluläres 
Korrelat für Lernen und Gedächtnis darstellt. Meine Studien zeigen eine synergistische und 
altersabhängige kompensatorische Funktion von APP und APLP2 für die LTP Induktion und Stabilität. Des 
Weiteren konnte ich eine Rolle beider Proteine für die Gehirnentwicklung sowie eine akute Funktion an 
aktiven Synapsen belegen. Eine Beteiligung in der Entwicklung wurde durch eine veränderte 
Hirnmorphologie in letalen dreifach- (APP-/-APLP2-/-APLP1-/-) sowie doppel-KO (APP-/-APLP2-/-) Mäusen 
impliziert. Meine Beobachtungen in organotypischen hippokampalen Schnittkulturen implizieren eine 
wichtige Funktion von APPsα während der Synaptogenese. Dies äußerte sich durch eine veränderte 
aktivitätsabhängige synaptische Plastizität und eine kürzlich gezeigte reduzierte spine Anzahl. Weiterhin 
konnte ich einen LTP Defekt in einem lebensfähigen konditionalen APP-KO zeigen, welcher bei E11 auf 
einem APLP2-/- Hintergrund aktiviert wird. Dies könnte bedeuten, dass diese Proteine an der Bildung 
intakter neuronaler Netzwerke beteiligt sind. Zusätzlich könnte der LTP Defekt durch eine gestörte 
Erregungs-Inhibitionsbalance bedingt sein. Allerdings scheint der Zeitpunkt der APP Entfernung auf 
einem APLP2-/- Hintergrund entscheidend zu sein, da ein postnatal induzierter doppel-KO nur einen 
geringfügigen LTP Defekt zur Folge hatte. Außerdem bestätigte sich eine akute Funktion der APP 
Spaltprodukte dadurch, dass der Verlust von 15 C-terminalen Aminosäuren im APP bei einem APLP2-/- 
Hintergrund eine beeinträchtigte synaptische Plastizität zur Folge hatte. Übereinstimmend identifizierte 
ich APPsα als unabdingbar für die LTP Induktion und Stabilität, da es den Defekt der synaptischen 
Plastizität in einem Rettungsexperiment durch Applikation des rekombinanten Peptides wiederherstellte. 
Da Ca2+ ein zentrales Molekül während aktivitätsabhängiger synaptischer Plastizität ist, untersuchte ich 
eine potenzielle Beeinträchtigung der Ca2+ Dynamik, die möglicherweise zum funktionellen LTP Defekt 
beträgt. Ich konnte eine reduzierte Ca2+ Dynamik vor und nach chemisch induziertem LTP belegen. 
Wurde jedoch der relative Ca2+  Anstieg nach cLTP Induktion quantifiziert, war kein signifikanter 
Unterschied messbar. Eine Inhibition der SERCA, welche das ER mit Ca2+ belädt, zeigte eine 
beeinträchtigte Ca2+ Antwort nach cLTP Induktion. Dies lässt vermuten, dass APP möglicherweise durch 
Interaktionen im ER zu einer intakten Ca2+ Dynamik im gesunden Gehirn beiträgt. Konsistent stellte eine 
APPsα Expression eine veränderte Ca2+ Dynamik vor und nach cLTP wieder her. Außerdem verstärkte das 
Peptid die LTP Induktion in Akutschnitten der Kontrollgruppe. Diese Beobachtungen bestätigen APPsα als 
potenziell präventives und therapeutisches Ziel in der Alzheimerschen Erkrankung. 
I n t r o d u c t i o n  |  13 
 
1 Introduction 
The mechanisms how thinking, memory formation and behavior adaptations are realized in the 
brain fascinate people since centuries. Experiences, positive as well as negative, thereby shape 
ones individual facets and provide the opportunity to acquire new ideas and adjust behavior. 
Memory storage upon learning involves changes in the brain which can make it persistent 
throughout life time on the one hand but permits on the other hand forgetting as well.  
How memory is established has been extensively studied in the past paralleled by resolving 
technical limitations of tissue fixation as well as visualization by histological protocols and 
microscopic techniques. To understand how learning and memory work in detail it is essential to 
investigate the processes at the cellular level. The brain is characterized by a high variety of 
different cell types. Thereby, the key players are neurons with a quantity of ~100 billion. To pass 
information from one to the other neuron they build on average synaptic contacts to 5000 - 
10000 adjacent neurons finally forming a widespread network for communication. Overall, ~15 
trillion synapses make the human brain the most complex vertebrate organ. Synapses are 
dynamic structures being characterized by their ability to adapt their function and structure in 
response to changed activity levels. This feature is termed synaptic plasticity and is regarded as 
a correlate for learning and memory at the cellular level. Still, the question remains which brain 
structures are primarily involved in converting short-term memory into a long-term persisting 
memory. Lesion studies identified the hippocampus to be directly involved in the formation of 
complex memories. Therefore, it is an appropriate structure to investigate learning and memory 
processes on the cellular and molecular base during health as well as disease. Specific disorders 
affect the ability to learn and store new memory. Some of those like fragile X mental retardation 
or Down syndrome are genetically linked and occur already from childhood on whereas others 
like dementia progress with age. Currently ~35 million elderly people worldwide suffer from 
Alzheimer’s Disease, a subtype of dementia. This disease is mainly characterized by the 
formation of aggregates of intracellular tau and extracellular Aβ protein. The latter is a cleavage 
product of the Amyloid Precursor Protein (APP) which is implicated to be involved not only in 
the disease status but also to be important for learning and memory. This study focusses on the 
physiological functions of APP and its various processing products as well as its homologue 
Amyloid Precursor-Like Protein 2 (APLP2) in synaptic plasticity. 
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1.1 Synaptic Plasticity 
The fundamental principle how an information flow between neurons is carried out relays on 
the concept of translating an electrical code into a chemical one that in turn is encoded again as 
an electrical signal. Briefly, the incoming action potential along the axon alters the ion 
distribution at the membrane thereby changing its electrical potential. The resulting Ca2+ influx 
triggers the release of a chemical transmitter from the presynapse into the synaptic cleft. 
Opposing to the presynapse the postsynapse is localized. Its membrane contains specific 
ionotropic receptors which open upon neurotransmitter binding causing again a change of 
membrane polarity termed depolarization for excitatory and hyperpolarization for inhibitory 
neurons. Importantly, the chemical excitatory glutamatergic synapse is not a static element to 
transmit information throughout the network. In fact it is a highly dynamic structure reacting 
with an increase or decrease of efficacy called synaptic plasticity. Both components of the 
synapse are adaptable. While presynaptically the neurotransmitter release is modifiable the 
postsynapse can adapt with changing the structural and functional plasticity in response to 
defined stimuli described in detail in 1.1.2 (Yang and Calakos, 2013; Bellot et al., 2014).  
In particular Donald O. Hebb significantly contributed to the nowadays understanding of 
mechanisms that underlie activity-dependent synaptic plasticity. In his famous postulate he 
proposed that the information is spread through the neuronal network with the synapses to be 
the site for modulation, leaving an imprint of memory: 
“When an axon of cell A … [excites] cell B and repeatedly or persistently takes part in firing it, 
some growth process or metabolic change takes place in one or both cells so that A’s efficiency 
as one of the cells firing B is increased.” (Hebb, 1949) 
The general concept is based on the fact that synapses of two neurons that fire simultaneously 
both enhance their strength paralleled to pre- and postsynaptic activity. On the molecular base 
this is accompanied by biochemical and structural modifications resulting in an enhanced 
communication efficacy between previously active neurons. These alterations represent the 
basis for processes of learning and memory. An intensely studied structure shown to be crucial 
for the formation of long-term memory is the hippocampus. 
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1.1.1 The Hippocampus 
Anatomically the hippocampus belongs to an evolutionary old part of the cortex, the limbic 
system. It is localized bilaterally in both cerebral hemispheres displaying a characteristic curved 
shape. The Hippocampus is indispensable for memory consolidation. This process is the transfer 
of short- into long-term memory which is stored by distinct cortical regions receiving 
hippocampal projections. The knowledge that the declarative memory formation (facts, events) 
is essentially based on the hippocampus was initially proven half a century ago in studies of the 
amnesic patient “H.M.”. After removal of both hippocampi in an epilepsy surgery, he could no 
longer form new declarative memories. His short-term and working memory functions were still 
intact as well as the acquisition of new non-declarative memories (Scoville and Milner, 1957).  
In addition, the hippocampus is essential for the cognitive map formation about the 
environment. Evidence was gained by investigating rodents with a hippocampal lesion which 
precludes spatial memory formation in the Morris water maze (Mumby et al., 1999). This 
feature makes the hippocampus suitable for investigating Alzheimer’s disease (AD) since spatial 
navigation as well as short-and long-term memory is severely affected. It is also the first brain 
region affected in AD exhibiting an extensive neuronal loss accompanied by volume reduction. 
The hippocampus is part of the hippocampal formation which is a complex structure consisting 
of fornix, fimbria, subiculum, dentate gyrus (DG) and the cornu ammonis (CA). A further 
subdivision distinguishes 4 subfields CA1, CA2, CA3 and CA4 with a characteristic pyramidal 
neuron distribution whereby traditionally only CA3 and CA1 are illustrated (Figure 1.1 A and B).  
 
Figure 1.1 The neuronal circuitry in the rodent hippocampus. 
(A) Drawing of the hippocampus and the prevalent neuronal cell types from Camillo Golgi (Golgi et al., 2001). Red 
fibers are blood vessels. (B) Scheme of a transversal slice from the hippocampus depicting the major input and 
output fibers as well as projections from the intrinsic trisynaptic circuitry (Deng et al., 2010). CA = cornu ammonis, 
EC = entorhinal cortex, LPP = lateral performant pathway, MPP = medial performant pathway. 
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DG, CA3 and CA1 are three clearly differentiated structures along the longitudinal axis. This 
enables to analyze specific synaptic contacts in between these subregions since the distribution 
of somata and the axonal projections are highly organized following the intrinsic trisynaptic 
circuitry (Figure 1.1 B). Histologically the hippocampus displays 3 characteristic layers (Figure 
1.2). In CA1 and CA3 the stratum pyramidale comprises the somata 
of pyramidal neurons already illustrated by Camillo Golgi (Figure 
1.1 A and Figure 1.2). Their basal dendrites are located in the 
stratum oriens while the apical dendrites form the stratum 
moleculare which is subdivided into the stratum radiatum and 
lacunosum-moleculare (Figure 1.2). Importantly, the inner layer 
stratum lacunosum-moleculare of the CA1 and CA3 region receives 
direct or indirect input from the entorhinal cortex (EC) which itself 
is connected to various cortical areas (Figure 1.1 B). The DG 
comprises the granular cell layer and receives the major input via 
the perforant pathway from the adjacent EC layer II. The axons of 
the granular cells pass on their information via mossy fibers onto 
the dendritic compartment of CA3 pyramidal neurons. Those send their bundled axonal 
projections as Schaffer collaterals onto the dendrites of CA1 pyramidal neurons (Figure 1.1 B). 
The main source of hippocampal output via the subiculum targets again the EC but also the 
amygdala. As a unique feature of the hippocampal formation each field is linked and thus 
permits an unidirectional information flow. The majority of neurons is excitatory (~95 %) using 
glutamate as neurotransmitter. However, a projection from the medial septum provides 
excitatory input by cholinergic and inhibitory input by GABAergic fibers to all hippocampal 
subregions acting as rhythm generator (Buzsaki, 2002; Drever et al., 2011). The interneurons 
have locally restricted target regions in the hippocampus itself and characteristically bear few or 
no spines at all (Freund and Buzsaki, 1996). In the DG those inhibitory neurons are represented 
by basket cells from which axons project directly onto the somata of granule cells. Moreover, 
axo-axonic neurons target the initial segments of excitatory pyramidal neurons and thus 
influence action potential initiation. Finally, bistratified cells project onto apical and basal 
dendrites of pyramidal neurons. All interneurons are inter-connected to ensure synchronization. 
Figure 1.2 Hippocampal layers 
in the CA3 and CA1 region. 
PyrmC: pyramidal neuron. 
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Thereby they display oscillations with variable frequencies like theta (5 Hz) and gamma (40 Hz) 
(Buzsaki, 2002; Colgin and Moser, 2010). Destruction of the septal area abolishes the 
hippocampal theta rhythm and impairs spatial memory (Winson, 1978). Additionally, these 
interneurons send their dendrites to the stratum radiatum and stratum oriens receiving input 
from surrounding excitatory neurons to modulate the network activity by feed-forward and -
backward inhibition.  
The highly organized hippocampal structure is well suited to study the mechanisms of Hebbian 
plasticity in various transgenic mouse models. For the purpose of this dissertation the 
electrophysiological investigations focused on the CA3 to CA1 Schaffer collateral pathway 
whereto the stimulation as well as recording electrodes are positioned in the stratum radiatum 
of the respective hippocampal subregions (see 2.4.3 and Figure 2.2). 
 
1.1.2 Bidirectional Plasticity: Long-term Potentiation and Long-term Depression 
At the end of the 19th century Ramon y Cajal postulated that processes of learning and memory 
are fulfilled by neurons and their specific connections. Moreover, he hypothesized that new 
neuronal pathways are formed upon learning (Cajal, 1907). These suggestions were supported 
by Donald O. Hebb (Hebb, 1949). He intended to understand how perceptual memory works 
from the systemic down to the cellular/molecular level. He combined prevailing data of 
behavior, like the acquisition of conditioned reflexes shown by Pavlov, to the neurons as sites of 
changes during memory acquisition. The Hebbian postulate states that interconnected and 
simultaneous active neurons permanently enhance their effectiveness. This process is required 
for strengthening and stabilization of synaptic connection in neuronal networks and the 
formation of associative memories. However, Hebb himself didn’t mention the nowadays well 
established importance of the hippocampus for learning and memory. It was first implicated in 
1973 when Bliss and colleagues discovered the Long-Term Potentiation (LTP) and proposed this 
process as a cellular correlate for activity-dependent modulation of synaptic efficacy. They 
reported a long lasting, hours or even days, increase of synaptic transmission in neurons of the 
dentate gyrus after in vivo tetanic stimulation of the perforant path (Bliss and Gardner-Medwin, 
1973; Bliss and Lomo, 1973; Bliss and Collingridge, 1993). To date this concept of LTP is widely 
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used to assess memory related processes at the cellular and molecular level (Pastalkova et al., 
2006; Whitlock et al., 2006; Kenney and Manahan-Vaughan, 2013).  
Since several observations could not be explained by LTP alone, it was presumed that excitatory 
synapses also undergo an activity-dependent reduction in efficacy, termed Long-Term 
Depression (LTD) (Dudek and Bear, 1992). This discovery indicates that long-term plasticity is bi-
directionally modifiable (Dudek and Bear, 1993; Heynen et al., 1996; Malenka and Bear, 2004). 
Those studies focused on CA3-CA1 Schaffer collateral pathway and identified the N-methyl-D-
aspartate receptor (NMDAR) as a major component for LTP and LTD, respectively (Collingridge 
et al., 1983; Collingridge et al., 1988). The NMDAR is an ionotropic receptor for its ligand 
glutamate and the co-agonist glycine or D-serine (Henneberger et al., 2013). Through its pore 
extracellular Na+ and Ca2+ enter the postsynapse. Although synaptic plasticity clearly depends 
on the activation of NMDARs, as pharmacological blocking studies showed (Morris, 1989), it 
doesn’t contribute to the basal synaptic transmission (Figure 1.3). This is predominately 
mediated by the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) 
which becomes permeable for monovalent cations Na+ and K+ when glutamate is bound. 
Meanwhile, the NMDARs are inactive as the ion channel pore is occluded by Mg2+ (Mayer et al., 
1984; Nowak et al., 1984). The influx of Na+ through AMPARs induces an Excitatory Postsynaptic 
Potential (EPSP). Upon stimulation the membrane depolarizes thereby expelling the Mg2+ block 
from the NMDAR channel. If simultaneously glutamate is bound, the NMDARs become 
permeable for Na+ and Ca2+. This characterizes the receptor as a coincidence detector being only 
conductive when pre- and post-synapse are co-active. These findings furthermore define the 
first of three key features of LTP (Nicoll et al., 1988). The associativity means that in a pairing 
protocol a weak and a strong synaptic input induce LTP at both synapses (Wigstrom et al., 
1986). Another characteristic is input specificity whereby merely synaptic contacts of neurons 
are modified which participate in network activity. The postsynaptic compartment is formed as 
dendritic spine, a bottleneck like shaped protrusion, being separated from the less electrically 
active dendrite. However, when the postsynaptic membrane is depolarized this is conducted 
through the spine to the dendrite. This feature is termed cooperativity showing that LTP can 
only be induced by the coincident activation of a critical number of synapses by repetitive 
stimulation. 
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Figure 1.3 Mechanism of LTP induction. 
(A) During basal synaptic transmission only a low amount of glutamate is released from the presynapse binding to 
NMDA and AMPA receptors respectively. Since the NMDAR is blocked by Mg
2+
, only AMPAR promote the influx of 
monovalent kations generating an excitatory postsynaptic potential (EPSP) in the postsynaptic compartment. (B) In 
case of postsynaptic membrane depolarization the Mg
2+
 is removed from the ion channel of the NMDAR. Thus, in 
addition more kations enter the postsynape. One of these is Ca
2+
 which functions as a potent second messenger 
triggering various biochemical cascades to promote Long-Term Potentiation (LTP) and strengthening of the synaptic 
transmission. In case of LTP the massive and rapid influx of Ca
2+
 predominately activates kinases and modulates 
gene expression to maintain the potentiation for long lasting changes. The figure is reproduced from (Galizia and 
Lledo, 2013). However synaptic plasticity is bidirectional therefore a decrease in synaptic transmission is observed 
when Long-Term Depression (LTD) is induced. The inflow of Ca
2+
 through NMDAR is thereby slow and prolonged 
activating predominately phosphatases (not shown in the scheme). 
 
At hippocampal Schaffer collateral synapses LTP and LTD primarily depend on Ca2+ influx being a 
potent second messenger. It initiates a series of intracellular biochemical signaling cascades that 
promote the strengthening or weakening of synapses (Figure 1.3). Supportive studies implicated 
that postsynaptically chelated Ca2+ abolishes LTP and LTD respectively (Lynch et al., 1983; 
Cummings et al., 1996a). 
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In terms of LTP upon a high frequency stimulation a robust but relatively short Ca2+ influx 
through NMDARs activates mainly effector kinases which display a low affinity to Ca2+ (Bliss and 
Lomo, 1973). The most prominent is the calcium / calmodulin-dependent kinase II (CaMKII) 
confirmed by studies with inhibitors and gene-targeted mice for this kinase, which all lead to an 
impairment in LTP (Malenka et al., 1989; Malinow et al., 1989; Silva et al., 1992). The NMDAR 
driven rise of intracellular Ca2+ permits CaMKII activation by autophosphorylation. Amongst 
numerous substrates it phosphorylates membrane associated AMPARs to further increase their 
conductance (Derkach et al., 1999; Lee et al., 2003; Whitlock et al., 2006; Kristensen et al., 
2011). Recent studies show an enhanced accumulation of AMPARs at the PSD when CaMKII 
phosphorylates the scaffolding protein stargazin (Opazo et al., 2010). Interestingly, the number 
of AMPARs defines the strengths of synaptic transmission in response to stimulation. This is 
executed via two individual mechanisms. First, AMPARs can reach the PSD from the periphery 
by lateral diffusion (Takahashi et al., 2003). Second, receptor containing vesicles are inserted 
extra-synaptically via exocytosis (Patterson et al., 2010). Thus a relatively fast increase in 
synaptic strength is gained (Opazo and Choquet, 2011; Huganir and Nicoll, 2013). However, 
while this early phase of LTP is not protein synthesis dependent the maintenance of a long 
lasting (hours-days) increase in synaptic efficacy requires the expression of plasticity-related 
proteins (Krug et al., 1984; Frey et al., 1988; Otani and Abraham, 1989; Abraham and Williams, 
2008; Rosenberg et al., 2014). In addition to CaMKII, one key molecule in this process is the 
atypical protein kinase C (aPKC) isoform PKMζ. During LTP it is synthesized de novo as a 
constitutively active kinase (Ling et al., 2002). Interestingly, its inhibition abolishes already 
established LTP, supporting its essential role in long-term plasticity (Sajikumar et al., 2005; 
Serrano et al., 2005; Pastalkova et al., 2006). However, its role is debated since PKMζ-KO mice 
lacked any defect in activity- dependent synaptic plasticity and memory formation (Lee et al., 
2013; Volk et al., 2013). In later stages of LTP the link to gene expression is provided by the 
activity of adenylyl cyclase (AC) which itself is stimulated by CaMKII. AC mediated cAMP 
generation triggers protein kinase A (PKA) which directly or indirectly through ERK activates the 
cAMP response element-binding protein (CREB). As a transcription factor CREB initiates the 
expression of plasticity-related genes. Amongst those, immediate early genes like c-Fos and the 
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neurotrophin BDNF are shown to be crucial (Korte et al., 1995; Tao et al., 1998; Strekalova et al., 
2003). 
As the complementary bidirectional part to LTP the LTD is induced by a low frequency 
stimulation protocol initiating a moderate and prolonged Ca2+ influx through NMDARs (Lisman, 
1989; Dudek and Bear, 1992; Cummings et al., 1996b). This in turn predominantly activates 
phosphatases which display a high affinity to Ca2+ (Mulkey et al., 1993). Main effects are thereby 
mediated through the complex of Ca2+ / calmodulin dependent phosphatase calcineurin, AKAP 
and PSD95 which internalizes AMPARs via endocytosis from the PSD (Lee et al., 1998; Beattie et 
al., 2000; Shepherd and Huganir, 2007; Jurado et al., 2010). Comparably to late phases of LTP, 
maintained LTD requires de novo protein synthesis likewise (Manahan-Vaughan et al., 2000; 
Sajikumar and Frey, 2003). 
Beside NMDAR-dependent forms further mechanisms exist to enhance or decrease synaptic 
efficacy. Throughout the hippocampus metabotropic glutamate receptor (mGluR) mediated LTP 
and LTD are common (Mukherjee and Manahan-Vaughan, 2013). Furthermore, long lasting 
changes can also be conveyed exclusively or in addition to NMDARs by voltage gated calcium 
channels (VGCCs) promoting the influx of Ca2+ (Morgan and Teyler, 1999; Moosmang et al., 
2005). Interestingly, DG-CA3 mossy fiber LTP and LTD are mediated through presynaptic 
mechanisms representing a non-Hebbian form of activity-dependent synaptic plasticity 
(Manabe, 1997; Lopez-Garcia, 1998). In that case the modulation of synaptic strength does not 
require a simultaneous pre- and postsynaptic depolarization for its induction. 
The increase of cytosolic Ca2+ through NMDAR and/or VGCC activation stimulates 
supplementary Ca2+ release from internal stores of the endoplasmatic reticulum (ER) through 
ryanodine and inositol-1, 4, 5-tris-phosphate receptors. This causes the spread of LTP or LTD to 
neighboring, co-active synapses (Nishiyama et al., 2000; Maggio and Vlachos, 2014; Segal and 
Korkotian, 2014). The clearance of Ca2+ and restoration of basal Ca2+ concentrations is executed 
by the sarco / endoplasmatic reticulum Ca2+ ATPase (SERCA) pump. Another major player for the 
regulation of Ca2+ signals are mitochondria. 
The functional increase or decrease of synaptic strength is accompanied by rapid equivalent 
structural changes of enlargement and shrinkage as well gain and loss of the dendritic spines 
(Ultanir et al., 2007; Bosch and Hayashi, 2012; Bellot et al., 2014). Modifications of the actin 
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cytoskeleton including enhanced polymerization for LTP and increased depolymerization for LTD 
are essential (Matsuzaki et al., 2004; Okamoto et al., 2004; Honkura et al., 2008).  
Although LTP primarily considers a postsynaptic phenomenon, presynaptic mechanisms are 
likely to contribute to the observed alterations in synaptic efficacy (Figure 1.3). Through 
retrograde signaling the neurotransmitter release is increased further promoting the 
postsynaptic strengthening. Retrograde messengers like nitric oxide (NO) and the brain-derived- 
neurotrophic factor (BDNF) play a crucial role (Korte et al., 1995; Park and Poo, 2013).  
 
1.1.3 Short-term and Long-term Synaptic Plasticity 
The before described changes at the synapse in response to an alteration of activity reflect its 
ability to undergo synaptic plasticity. Briefly, two forms are distinguished regarding persistence. 
Long lasting changes which include four major processes: regulation of AMPA receptors, local 
protein synthesis, modulation of actin dynamics and gene expression in the nucleus (see 1.1.2). 
However, this is preceded by short-term plasticity which modulates synaptic strength for 
seconds up to minutes and mechanistically is thought to underlie information processing.  
An action potential, generated near the cell body, propagates along the axon directed to the 
presynapse where it opens voltage-gated Ca2+ channels. A transient elevation of presynaptic 
Ca2+ through short bursts of activity is crucial to enhance the fusion probability of 
neurotransmitter bearing vesicles at the active zone and induces short-lived synaptic 
modulations (Katz and Miledi, 1968). Therefore, the analysis of short-term plasticity predicts 
presynaptic functionality. A simple protocol to test presynaptic properties is to apply two single 
stimuli spaced by a defined time interval. Depending on the length of the Inter Stimulus Interval 
(ISI) and type of stimulus used the second signal is facilitated (Paired Pulse Facilitation, PPF) or 
depressed (Paired Pulse Depression, PPD). At shorter ISIs of <20 ms PPD is observed whereas 
larger ISIs >20 ms lead to PPF. Several factors contribute to PPD (Figure 1.4 a). Importantly the 
Readily Releasable Pool (RRP) is depleted. More vesicles fuse to the membrane in response to 
the initial stimulus thus fewer vesicles are available for the second stimulus. The lack of vesicles 
in the RRP is refilled within seconds by the recycling pool (Zucker and Regehr, 2002). 
Furthermore, voltage gated Ca2+ channels are inhibited  (Catterall and Few, 2008).  
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 PPF is characterized by the residual Ca2+ hypothesis 
(Figure 1.4 b). In response to an arising action potential 
from the first stimulus the presynaptic Ca2+ level is 
elevated inducing the neurotransmitter release. The 
remaining / residual Ca2+ drives an increased release 
upon the second stimulus leading to a facilitated second 
signal (Zucker and Regehr, 2002; Regehr, 2012) (see 
Figure 2.3 D). Still additional mechanisms are proposed. 
Complementary to PPD voltage gated Ca2+ channel 
conductance is enhanced (Catterall and Few, 2008; 
Mochida et al., 2008). Likewise, the facilitation is 
additionally regulated by presynaptic Ca2+ sensor kinases 
with different Ca2+ affinities and saturation of Ca2+ 
buffering proteins leading to more unbound Ca2+ 
increasing the neurotransmitter release upon the second 
stimulus (Zucker and Regehr, 2002; Matveev et al., 2004; 
Mochida et al., 2008; Regehr, 2012). 
Upon high frequent tetanic stimulation longer persistent forms of short-term plasticity occur 
termed augmentation, lasting five to ten seconds, and Post-Tetanic Potentiation (PTP), lasting 
tens of seconds to minutes (Figure 1.4 c). However, a distinction between both phenomena is 
not always clear. Mechanistically an increased transmitter release is proposed resulting either 
from an elevated presynaptic Ca2+ influx or a modification of the release machinery (Zucker and 
Regehr, 2002; Regehr, 2012). Additionally, Ca2+ independent mechanisms such as PKC activity 
increase release probabilities by decreasing the Ca2+ cooperativity thus more free Ca2+ is 
available (Korogod et al., 2007; Lou et al., 2008). Moreover, tetanic stimulation causes fusion of 
neurotransmitter vesicles (Figure 1.4 c) before they fuse to the membrane thus increasing the 
miniature synaptic current (He et al., 2009). Short- and long-term synaptic plasticity is a feature 
of neurons that is preserved throughout lifetime in an intact brain. However, these processes 
are tightly regulated and an imbalance contributes to the establishment of neurodegenerative 
diseases. For the current understanding thereby the synapse is the first location affected.  
Figure 1.4 Presynaptic mechanisms of 
short-term plasticity. 
Schematic drawing depicts proposed 
mechanism for (a) depression, (b) 
facilitation, (c) post-tetanic potentiation 
(PTP) and augmentation. Readily releasable 
pool (RRP); residual calcium (Cares). The 
figure is reproduced from (Fioravante and 
Regehr, 2011). 
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1.2 Alzheimer’s Disease 
In 1901 the psychiatrist Alois Alzheimer examined a patient named Auguste Deter who suffered 
from disorientation, progressive memory loss, depression and finally died at an age of 55. 
Alzheimer described his observations from brain autopsy as an “unusual disease of the cerebral 
cortex” which was accompanied by a “paucity of cells in the cerebral cortex and clumps of 
filaments between nerve cells” later on named Alzheimer’s Disease (AD) (Alzheimer, 1907). In 
today’s widely used terminology he already found the two major pathological processes of tau 
(neurofibrillary tangles, NFT) and amyloid beta deposition (Aβ or senile plaques). With ~50-60 % 
of cases AD is the most common form of dementia from which currently ~35 million people 
suffer. The risk to develop this disease increases dramatically with age and life standard. 
Therefore, it is predicted that every 20 years the incidence of AD will almost double (Wimo et 
al., 2013). Since its discovery many scientific breakthroughs led to more insights of this disease. 
However, besides the knowledge that NFT and Aβ plaques are major hallmarks additionally 
molecular, genetic, epidemiological as well as immunological hypothesis have been proposed to 
contribute to AD (Heneka and O'Banion, 2007; Povova et al., 2012; Heneka et al., 2014). To date 
the cause of AD remains unidentified. Recent studies suggest that the onset already starts 10-20 
years before clinical symptoms occur (Perrin et al., 2009). The early stage of mild AD is 
characterized by difficulties in short-term memory and decline of cognitive abilities while the 
more proceeded and severe stage includes loss of long-term memory and inability of handling 
daily life (Holtzman et al., 2011). At the microscopic level this is accompanied by a high density 
NFT and Aβ plaques as well as extensive neuronal loss. NFT are intracellular agglomerations of 
the microtubule-associated, stabilizing protein tau which is hyperphosphorylated and bears 
oxidative modifications (Goedert et al., 1988; Goedert and Spillantini, 2006). Tau detaches from 
the microtubules and accumulates in the somato-dendritic compartment thereby disturbing 
cellular transport mechanisms (Spillantini and Goedert, 2013). First, entorhinal cortex layer II 
neurons are affected by NFT formation (Hyman et al., 1987). Progressive spreading and 
additional tau propagation throughout the neurons of the hippocampal formation have been 
shown (Braak and Braak, 1991; de Calignon et al., 2012). However, it was proposed that NFT 
alone contribute less to neuronal death in AD than Aβ plaques (Gomez-Isla et al., 1997). After 
Aβ was proven to be the major component of plaques a lot of effort has been made to 
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understand its origin, function and pathology (Masters and Selkoe, 2012; Spires-Jones and 
Hyman, 2014). Plaque deposition occurs early in AD and progresses with time (Beyreuther and 
Masters, 1991). However, recent studies showed that soluble Aβ oligomers are the toxic species 
rather than dense plaques of aggregated Aβ causing synaptic dysfunction and less connectivity 
finally leading to neuronal loss (Schaeffer et al., 2011). Aβ oligomers are supposed to disrupt 
mechanisms involved in synaptic plasticity most likely by influencing the NMDAR dependent 
regulation of the spine cytoskeleton (Hsieh et al., 2006a; Selkoe, 2008). Furthermore Aβ was 
shown to reduce surface expression of both AMPAR and NMDAR (Almeida et al., 2005; Snyder 
et al., 2005; Hsieh et al., 2006b). This is in line with the observation that Aβ can disrupt LTP at 
nanomolar concentrations (Selkoe, 2008; Shankar et al., 2008). However, it was also shown that 
a concentration of picomolar Aβ acts contrariwise by positively modulating synaptic plasticity in 
the healthy brain (Puzzo et al., 2008; Puzzo et al., 2011).  
Processes of activity-dependent synaptic plasticity are tightly linked to an intact Ca2+ 
homeostasis. In AD it is proposed that calcium dynamics is perturbed probably by downstream 
cascades of the NMDAR and thus contributes to the functional impairment. Aβ was shown to 
directly bind to NMDAR thereby causing hyperexcitability accompanied by increased 
intracellular Ca2+ levels (LaFerla, 2002; Popugaeva and Bezprozvanny, 2013). Indeed, it is still an 
intriguing question how other APP cleavage products like non-Aβ polypeptides additionally 
contribute to AD pathology by their reduced generation itself or modulating gene expression 
(Nhan et al., 2014). Nevertheless, independent of the role of APP and its proteolytic cleavage 
products in the disease status, their physiological functions in the healthy brain are still poorly 
understood. 
 
1.3 Amyloid Precursor Protein Family Members 
The Amyloid Precursor Protein (APP) gene is localized at the chromosome 21. Its expression 
results in a ~87 kDa protein which is found in three major isoforms (APP695, APP751, APP770) 
generated by alternative splicing and posttranslational modifications. Depending on isoforms 
electrophoretic separation gives rise to bands of 110-140 kDa. APP695 is the predominant 
isoform in neurons (Robakis et al., 1987; Yoshikai et al., 1990). APP is synthesized in the ER 
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where it is shown to form stable dimers which are in turn transported through the secretory 
pathway via the Golgi apparatus to the cell surface (Isbert et al., 2012; Tan and Evin, 2012). 
Furthermore, APP is classified as a type I transmembrane glycoprotein revealing one membrane 
spanning domain, a large extracellular N-terminus and a small intracellular C-terminus 
illustrated in Figure 1.5 (Dyrks et al., 1988). 
 
Figure 1.5 The domain structure of APP family members. 
The domain structure of APP and its homologs is displayed for human (H. sapiens), mouse (M. musculus), zebrafish 
(D. rerio), worm (C. elegans) and fruit fly (D. melanogaster). All members share a high degree of homology 
regarding the large extracellular N-terminus always composed of the heparin-binding domain (HBD), copper-
binding domain (CuBD), acidic (Ac) domain, E2 domain and the short intracellular C-terminus which includes the 
YENPTY motif. Across the different species the Aβ sequence is exclusively present in APP. The Kunitz protease 
inhibitor (KPI) domain is also found in APP and APLP2. The figure is reproduced from (Nicolas and Hassan, 2014). 
 
Its structure is widely conserved though species with APL-1 in C. elegans, APPL in Drosophila as 
well as APPa and b in zebrafish D. rerio (Nicolas and Hassan, 2014). The mammal APP is part of a 
larger gene family including the paralogues Amyloid Precursor-Like Proteins 1 and 2 (APLP1 and 
APLP2) which are prevalently expressed throughout the body (Wasco et al., 1993; Aydin et al., 
2012). APP and APLP2 are widespread found in the brain with a particular high expression and 
largely overlapping pattern in pyramidal neurons of cortex and hippocampus (Bendotti et al., 
1988; Lorent et al., 1995). The APP family members differ only slightly in their peptide domain 
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structure and are therefore highly homological displaying a similar proteolytic processing 
(Figure 1.5 and see 1.3.1). The intracellular part consists of a small C-terminus termed APP 
intracellular domain (AICD) which contains the YENPTY motif. This is shown to promote various 
functions like clathrin mediated endocytosis, modulation of Aβ generation, interference with 
Ca2+ homeostasis, interaction with multiple kinases and adapter proteins (Perez et al., 1999; 
Leissring et al., 2002; Hamid et al., 2007; Ring et al., 2007; Jacobsen and Iverfeldt, 2009). The 
extracellular part of APP is composed of the large E2 and E1 domains. The latter is further 
subdivided into Kunitz protease inhibitor domain (KPI), acidic domain (Ac), copper-binding 
domain (CuBD) and heparin-binding domain (HBD). All of them are interaction sites for multiple 
binding partners like F-spondin, LRP1, Nogo-66 receptor, Notch 2, Netrin, Alcadein, sorL1/LR11 
and extracellular matrix components (Muller and Zheng, 2012). Additionally, the E1 domain was 
shown to be crucial for the homo- and heterodimerization of APP family members (Soba et al., 
2005). Interestingly, the Aβ motive is unique for APP only, conserved in mammals and zebrafish 
while the APLPs lack this sequence.  
Although the structure of both APP and APLPs are well known the precise function remains 
mostly elusive. Extensive posttranslational modifications and the various cleavage products of 
APP and APLP processing (see 1.3.1) hampered investigations. Nevertheless, several studies 
assessed putative functions and evidenced a crucial role in the developing as well as the mature 
nervous system (Jacobsen and Iverfeldt, 2009) (see 1.3.2). Interestingly, constitutive APP-KO 
mice showed no overt LTP defect at 3-4 months but surprisingly at 12-13 months of age hinting 
towards an APP involvement in age-related processes (Dawson et al., 1999; Seabrook et al., 
1999; Ring et al., 2007). This was rescued by the constitutive expression of the neurotrophic 
APPsα fragment (Ring et al., 2007). However, to date the mechanism, for instance a putative 
receptor for this peptide which mediates that effect, remains unknown. Transgenic mouse 
models of either APP, APLP1 or APLP2 single knock-out show only subtle abnormalities (Muller 
et al., 1994; Magara et al., 1999; Ring et al., 2007), whereas combined APP/APLP2 double 
knockout (DKO) and APLP1/APLP2 DKO mice die perinatally (von Koch et al., 1997; Heber et al., 
2000). In contrast, APP/APLP1 DKO are viable suggesting an essential function of APLP2 in the 
absence of either APP or APLP1 (Heber et al., 2000). The triple KO displayed cortical dysplasia 
caused by defective neuronal migration and died with a penetrance of 100 % (Herms et al., 
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2004). However, these studies were hampered by partially redundant functions within the gene 
family. Intensive studies revealed that the lethality of DKO mice most likely based on important 
functions of APP and APLP2 at the neuromuscular junction. Double KO mice expressing solely 
APPsα rescued the mortality of APP/APLP2 DKO. Still, those mice displayed a muscular 
weakness probably caused by an abnormal neuromuscular junction morphology and a defect in 
transmitter release (Weyer et al., 2011). To bypass lethality but providing also the possibility to 
investigate a full DKO of both proteins, mice with a conditional APP/APLP2 DKO were generated 
and further analyzed regarding activity-dependent synaptic transmission in this study.  
 
1.3.1 Processing Pathways 
All members of the APP protein family undergo a comparable way of sequential cleavage by 
specific secretases since they display a high degree of homology (Figure 1.5) (Walsh et al., 2007; 
Jacobsen and Iverfeldt, 2009). Thus, only the proteolytic processing of APP will be described in 
detail. For APP two different catabolic pathways including three distinct cleavage events are 
known (Figure 1.6).  
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Figure 1.6 The proteolytic processing of APP (previous page). 
Full-length APP can be processed by α-, β- and γ-secretases respectively. Thereby, two general pathways are 
distinguished. The left panel depicts the non-amyloidogenic pathway in which APP is cleaved by the α-secretase 
precluding Aβ formation since this protease cuts within the Aβ sequence. This processing liberates the soluble APPα 
(sAPPα or APPsα) fragment at the extracellular side. The remaining membrane bound fragment is then cleaved by 
the γ-secretase giving rise to the small P3 fragment extracellular and the AICD domain intracellular. The right panel 
illustrates the amyloidogenic pathway of APP shedding. First β-secretase action results in the secretion of sAPPβ 
(APPsβ). Subsequent γ-secretase shedding of the membrane tethered fragment gives rise to the extracellular 
released Aβ and again the intracellular AICD fragment. The figure is reproduced from (Nicolas and Hassan, 2014). 
 
In a healthy organism the full length APP is predominantly (>90 %) cleaved via the non-
amyloidogenic pathway in which first the α-secretase cuts within the Aβ domain liberating the 
large APPsα ectodomain. Thus, Aβ generation is precluded. Subsequently, the membrane-
associated C83 fragment is truncated by the γ-secretase resulting in the intracellular released 
AICD peptide and extracellular secreted p3. Alternatively, a minor amount of full length APP 
(<10 %) is processed in the amyloidogenic pathway which involves a sequential cleavage by the 
β-secretase giving rise to the extracellular secreted APPsβ domain. Afterwards, the γ-secretase 
activity initiates an internal release of the AICD peptide and extracellular secretion of Aβ by 
shedding of the remaining membrane bound C99 (Jacobsen and Iverfeldt, 2009; Octave et al., 
2013). Originally, the non-amyloidogenic processing pathway was thought to be the 
physiological one since pathological Aβ generation was prevented. However, this was not 
supported experimentally since during steady state only a small fraction of full length APP (~10 
%) was membrane embedded whereas the majority was present in the golgi apparatus and the 
trans-golgi-network (TGN) (Thinakaran and Koo, 2008). Additionally cell-surface expressed APP 
reveals a relatively short half-life time of ~10 min and also β- and γ-secretase APP cleavage 
occurs under physiological conditions (Haass et al., 1992; Koo et al., 1996). 
The α-secretases ADAM10, ADAM17/TACE, ADAM9, ADAM19, being all members of a 
disintegrin and metalloproteinase (ADAM) family, were indicated in APP cleavage at the cell 
surface (Howard et al., 1996; Buxbaum et al., 1998; Koike et al., 1999; Lammich et al., 1999; 
Allinson et al., 2003). ADAMs consist of a constitutive and a regulatory component which can be 
activated by synaptic activity or protein kinase C, triggering APPsα liberation (Nitsch et al., 1992; 
Buxbaum et al., 1993; LeBlanc et al., 1998; Hoey et al., 2009; Malinverno et al., 2010). It is still 
debated whether all or only one ADAM family member mediates the α-cleavage. However, 
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several publications point towards ADAM10 to be the principal constitutive APP α-secretase. 
This was shown by an overexpression model of ADAM10 in various cell lines leading to a several 
fold APPsα increase and decreased Aβ secretion, respectively (Kojro et al., 2001; Postina et al., 
2004). Moreover, neurons of conditional ADAM10 KO mice or cells with a knock down of 
ADAM10 show an almost abolished APPsα generation (Jorissen et al., 2010; Kuhn et al., 2010). 
Consistently, cells or mice being deficient of ADAM17 or 9 failed to show a defect for APPsα 
production. Nevertheless, an overexpression led to an increase of APPsα under defined 
conditions suggesting an involvement of ADAM17 and 9 in a more regulated APP cleavage 
(Weskamp et al., 2002; Kuhn et al., 2010). 
The initial and rate-limiting cleavage step in the amyloidogenic pathway is executed by β-
secretase BACE1 (β-site APP cleaving enzyme) belonging to the class of aspartyl proteinases 
(Vassar, 2004). It is likely that APP is internalized and processed via the amyloidogenic pathway 
since BACE1 was shown to predominantly localize in the golgi apparatus, TGN, secretory vesicles 
and endosomes (Koo and Squazzo, 1994; Perez et al., 1999; Vassar et al., 1999). Moreover, an 
abolished Aβ generation in BACE1 KO mice suggests that a sequential cleavage of APP is 
necessary and that BACE1 is the only β-secretase (Cai et al., 2001).  
A widely accepted model is the competition between α- and β-secretase mediated APP 
processing (Lichtenthaler et al., 2011). In both APP processing pathways the membrane bound 
fragment is subsequently cleaved by the intramembrane localized γ-secretase. Distinct to α- and 
β-secretases the γ-secretase is a large complex composed of four major protein subunits 
including presenilin 1 or 2 (PSEN1 or PSEN2) forming the catalytic core, presenilin enhancer 
(PEN-2), anterior pharynx-defective 1 (APH-1) and nicastrin (Vetrivel et al., 2006). Mice 
overexpressing presenilins with familiar AD mutations reveal an elevated amount of Aβ 
suggesting that this highly contributes to AD in forcing plaque formation (Duff et al., 1996). 
Remarkably, APP itself was shown to modulate the cell surface delivery of Presenilin 1 (Uemura 
et al., 2011). Note that all secretases involved in APP processing additionally have various other 
substrates which should be taken into account under the aspect of being therapeutic targets in 
AD (Lee et al., 2002; Edwards et al., 2008; De Strooper et al., 2010; Lichtenthaler, 2012).  
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1.3.2 Physiological Functions of APP and its Cleavage Products 
The physiological role of the APP family members and their cleavage products has been 
intensively studied during the last two and a half decades. Numerous studies point towards an 
outstanding role of the ectodomain APPsα, liberated by α-secretase shedding, which is primarily 
associated with trophic properties. In vitro this fragment was shown to alter the growth of 
various cell lines and neurons (Pietrzik et al., 1998; Young-Pearse et al., 2008). Infusion of APPsα 
after traumatic brain injury enhanced survival of neurons as well as recovery processes 
(Thornton et al., 2006). Furthermore, a knock-in of APPsα circumvented lethality of APP/APLP2 
DKO mice (Weyer et al., 2011). Comparable observations were made for C. elegans where the 
expression of the extracellular fragment rescued the lethal phenotype of APL-1 KO (Hornsten et 
al., 2007).  
APP processing is highly comparable to that of Notch, a regulator of neuronal stem cell 
differentiation (Ables et al., 2011). Therefore, a similar function for APP is suggested (Kimberly 
et al., 2001). Several publications implicated APP in stimulating the proliferation of neuronal 
stem cells whereby it is still debated which cleavage product promotes this process. APPsα is a 
potential candidate exhibiting again rescue characteristics when the proliferation was reduced 
by an application of an α-secretase inhibitor (Demars et al., 2011; Baratchi et al., 2012). 
Moreover, APP overexpression or addition of APPsα enhances neuronal differentiation (Freude 
et al., 2011). On the contrary Hu and colleagues found an APP induced increase in proliferation 
that was not due to APPsα secretion but cystatin C release (Hu et al., 2013). These observations 
indicate that several mechanisms are involved which still need to be clarified. In vitro 
experiments suggested a role of APP and APPsα in neurite outgrowth which might 
mechanistically be promoted by cell-substrate as well as cell-cell adhesion (Gakhar-Koppole et 
al., 2008). Thereby, APP binds laminin, collagen and heparin but also forms homo- and 
heterodimers with APLP1 and APLP2 in cis- and trans-interaction (Kibbey et al., 1993; Beher et 
al., 1996; Clarris et al., 1997; Soba et al., 2005). In particular trans-dimerization of APP is 
proposed to stabilize synapses (Wang et al., 2009).  
Analysis of aged constitutive APP-KO mice revealed abnormalities in behavior, synaptic plasticity 
and neuronal morphology suggesting a key role of APP and / or its processing products for both 
synaptic morphology and functional plasticity (Zheng et al., 1995; Ring et al., 2007; Weyer et al., 
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2014). An altered synaptic function perhaps reasoned by an impaired excitation-inhibition 
balance was indicated by a paired pulse depression of GABA mediated inhibitory postsynaptic 
currents and a high susceptibility for kainite-induced seizures (Steinbach et al., 1998; Seabrook 
et al., 1999; Fitzjohn et al., 2000). Interestingly, APP-KO mice also display an age-related defect 
in learning behavior and LTP, represented in aged but not adult individuals (Dawson et al., 1999; 
Phinney et al., 1999; Seabrook et al., 1999; Ring et al., 2007). Thereby, APLP2 is suggested to 
overtake redundant functions in adult but not aged APP-KO mice (Weyer et al., 2011). A 
disturbed neuromuscular function is observed in lethal APP/APLP2 DKOs underlining the crucial 
function of APLP2 while APPsα-DM (APPsα+/+APP-/-APLP2-/-) are viable supporting the rescue 
ability of APPsα (Wang et al., 2005; Weyer et al., 2011). APP-family members are also implicated 
in regulating activity-dependent synaptic plasticity during learning and memory. These 
processes are tightly linked to NMDA receptors regulating the Ca2+ influx upon membrane 
depolarization. Several publications proposed that APP might affect intracellular Ca2+ by 
regulating the cell-surface expression of NMDAR as well as its subunit composition (Cousins et 
al., 2009; Hoe et al., 2009; Lee et al., 2010). Moreover, APP-KO mice displayed increased L-type 
Ca2+ channel levels which in turn impacts GABAergic short-term plasticity (Yang et al., 2009). LTP 
induction furthermore stimulated the APP processing which leads to APPsα secretion (Fazeli et 
al., 1994; Hoey et al., 2009). This suggests that APP and its processing under physiological 
conditions might be mandatory for the enhancement of synaptic transmission (Ishida et al., 
1997; Seabrook et al., 1999; Taylor et al., 2008).  
Since APP and Notch share comparable ways of processing, both interact with each other 
through their transmembrane domain and Notch has been shown to act as a receptor, APP 
might be a putative receptor as well (Selkoe and Kopan, 2003). Analog to Notch the γ-secretase 
processing of APP leads to an AICD fragment which was shown to translocate into the nucleus 
and modulate the gene expression in a co-complex with Fe65 (Gao and Pimplikar, 2001; 
Kimberly et al., 2001; Walsh et al., 2003).  
Proposed physiological ligands which interact with the APP ectodomain are F-spondin, Dab1, 
Nogo66 receptor, LRP and SORL1 impacting Aβ generation (Wolfe and Guenette, 2007). 
Nevertheless, a definitive ligand that activates APP as a putative receptor so far remains elusive.  
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A recent study suggests an existence of a high-affinity receptor binding those fragments by 
interaction with the E1 domain (Reinhard et al., 2013). Amongst others p75 neurotrophin 
receptor and APP itself have been proposed to function as a receptor for APPsα (Bai et al., 2008; 
Gralle et al., 2009). However, the identification to date is still lacking. Potentially the main 
physiological contribution of APP is exerted via the ectodomains APPsα or APPsβ. 
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1.4 Scope of the Study 
AD is accompanied by a progressive dysfunction of synaptic contacts between neurons, finally 
leading to a loss of first the synapse itself, followed by cell death. The hippocampus is the first 
regions affected by this process. A shift from the non amyloidogenic towards more 
amyloidogenic processing of the APP liberates additional Aβ which amongst other factors is the 
candidate to form toxic oligomers and plaques thereby initiating synaptic dysfunction. However, 
numerous studies implicate that not only Aβ accumulation but also the reduction of other 
potentially neurotrophic APP processing products might contribute to AD. Thus, it is in addition 
important to understand the physiological role of APP and its homologues APLP1 and APLP2 in 
the intact CNS. To assess the specific role of the APP protein family in processes of learning and 
memory I used different mouse models generated by gene targeted deletion of APP and / or 
APLP2 or their various cleavage products. Since APP and APLP2 display a high degree of 
homology a functional redundancy was shown. Recent studies suggest that a potential 
compensatory effect is only found in adult but not in aged transgenic mice, implicating an age 
related effect which is further assed in this study. The lethality of constitutive double knock-out 
mice (DKO) was circumvented by crossing APPfloxed/floxedAPLP2-/- mice to specific Cre-deleter lines 
to apply the conditional approach. This provided the opportunity to distinguish between a 
potential developmental or acute function of the APP protein family members. Furthermore, I 
assessed whether the α-secretase cleavage product APPsα might be capable to restore memory 
impairment in DKOs. I intensely studied the excitatory system since these neurons held the 
majority in the hippocampus. Nevertheless, inhibitory neurons contain APP and APLP2 as well 
and are essential to regulate network activity. Thus, I as well investigated mice with a 
conditional DKO restricted to GABAergic interneurons.  
Given that the mammalian hippocampus is significantly involved in memory formation and the 
first region affected in the AD I focused my research on synaptic plasticity of the CA3-CA1 
Schaffer collateral pathway. Complementary, I investigated whether deficits in Ca2+ dynamic 
mechanisms might be causative for this altered functional synaptic plasticity and if the defect 
might be rescued upon expression of solely APPsα in cultures from DKO mice representing a 
potential target for therapeutic means in AD. 
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2 Materials and Methods 
2.1 Mice Strains 
In this study a large variety of transgenic mice were investigated in order to elucidate the role of 
APP and its homologues in processes of synaptic plasticity. All of them were housed, genotyped 
and kindly provided by Prof. Dr. Ulrike Müller from the Rubrecht-Karls-University of Heidelberg. 
Table 2.1 gives an overview about the different genotypes. Thereby, two groups were 
categorized. On the one hand a constitutive APP / APLP2 knock-out strategy was applied. On the 
other hand an additional conditional knock-out strategy via Cre / loxP system was used to 
circumvent early postnatal lethality of double mutants (DM). 
Table 2.1 Genotypes of APP and APLP2 transgenic mice. 
Name Genotype 
Constitutive knock-out  
APLP2-KO APLP2-/- 
APP∆CT15-DM APP∆CT15+/+ APLP2-/- 
APPsα-DM APPsα+/+ APLP2-/- 
 
Conditional knock-out  
CaMKIIαCre cDKO CaMKIIαCreERT2 +/T APPflox/flox APLP2-/-  
NexCre cDKO NexCre+/T APPflox/flox APLP2-/-  
GADCre cDKO GAD67Cre+/T APPflox/flox APLP2-/-  
DlxCre cKO DlxCre+/T APPflox/flox  
DlxCre cDKO 
littermate control 
DlxCre+/T APPflox/flox APLP2-/-  
APPflox/flox APLP2-/- 
 
2.1.1 Constitutive Knock-out of APP and APLP2  
The basic principle for the generation of constitutive knock-out mice used in this study was the 
construction of gene targeting vectors containing the new coding sequence. In case of the 
desired APLP2-/- the gene was inactivated by deleting the promoter and the first exon of the 
APLP2 gene (von Koch et al., 1997). In case of APP∆CT15+/+ knock-in the targeting vector 
contained the coding sequence of APP exon 16 to APP695-cDNA up to amino acid 680 and a stop 
codon (APP lacked last 15 AS at the C-terminus) thus enabling to selectively replace the 
endogenous APP gene while the following expression is still realized via the endogenous 
promoter (Ring et al., 2007). Then the respective vector was inserted into murine embryonic 
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stem cells by electroporation. Positive clones which underwent homologous recombination 
were detected and transplanted into C57BL/6 blastocystes obtaining heterozygous chimeric 
mice. These mice were further intercrossed to generate homozygous individuals (APLP2-/- or 
APP∆CT15+/+). APP∆CT15+/+APLP2-/- double mutant mice (APP∆CT15-DM) were obtained by 
three consecutive intercrosses of APP∆CT15+/+ and APLP2-/- mice (similar to APPsα-DM in 
(Weyer et al., 2011). 
 
2.1.2 Conditional Knock-out of APP and APLP2 in Excitatory Forebrain Neurons 
In order to bypass postnatal lethality of constitutive APP / APLP2 double knock-out individuals a 
conditional knock-out strategy solved that issue (Heber et al., 2000; Wang et al., 2005). 
Therefore, mice were generated in which the promoter as well as exon 1 of the APP or APLP2 
gene was flanked by LoxP-sites (APPflox/flox, APLP2flox/flox) trough homologous recombination 
(Mallm et al., 2010). Mice carrying the APPflox/flox were bred with APLP2-/- mice to obtain 
individuals with conditional APP alleles on an APLP2 deficient background (APPflox/floxAPLP2-/-). 
These mice built the foundation of further investigations as they could be crossed to various 
Cre-transgenic deleter strains which enable to selectively knock-out APP at defined time points 
and in a tissue specific manner. Note that the preference was given to APPflox/floxAPLP2-/- and not 
to APPflox/floxAPLP2flox/flox since APLP2-/- alone revealed no phenotype and the recombination of 
two different floxed alleles has a high chance to be incomplete. 
In a first approach APPflox/floxAPLP2-/- were crossbred with a CaMKIIαCreERT2 strain resulting in a 
genotype of CaMKIIαCreERT2APPflox/floxAPLP2-/- (Erdmann et al., 2007). This was characterized by 
a specific Cre-ERT2 expression in excitatory forebrain neurons. Cre-ERT2 is an inducible fusion 
protein composed of Cre recombinase and a mutated part of the human estrogen receptor (ER). 
As a synthetic ligand tamoxifen bound ER and thereby induced the translocation of the fusion 
protein from the cytoplasm into the nucleus, where APP excision was preceded. 
CaMKIIαCreERT2APPflox/floxAPLP2-/- were mated with APPflox/floxAPLP2-/- obtaining 50 % 
CaMKIIαCreERT2APPflox/floxAPLP2-/- (CaMKIIαCre cDKO) and APPflox/floxAPLP2-/- (littermate control). 
In order to induce the APP ablation two strategies were followed. First, I wanted to investigate 
whether APP is required in an adult brain. Therefore, mice were i.p. injected with 1 mg of 
tamoxifen twice a day for 5 consecutive days. Second I addressed the question whether APP is 
M a t e r i a l s  a n d  M e t h o d s  |  3 7  
required during synaptogenesis. Hence, lactating mothers were treated with tamoxifen at P5 of 
the litter. Pubs ingested the drug via mother’s milk. Grown up pups were additionally i.p. 
injected with tamoxifen at adult stages. 
Since the CaMKIIα promoter was only active from P1 onwards the gene could not be targeted 
prenatally. Therefore, mice from the NexCre+/T strain (Goebbels et al., 2006) were crossed to 
APPflox/floxAPLP2-/- to receive NexCre+/TAPPflox/floxAPLP2-/- individuals which again were crossbred 
with APPflox/floxAPLP2-/- obtaining 50 % NexCre+/TAPPflox/floxAPLP2-/- (NexCre cDKO) and 50 % 
APPflox/floxAPLP2-/- (littermate control). Nex (neuronal helix-loop-helix protein 1) is a transcription 
factor shown to be involved in neuronal differentiation. From E11.5 onwards it is expressed in 
excitatory pyramidal forebrain neurons triggering the Cre-mediated APP removal. Thus, the Cre 
expression was induced much earlier covering also prenatal brain development processes 
compared to CaMKIIαCre cDKO mice. But here the knock-out was not time-controllable via 
tamoxifen application since the Nex promoter was constitutively active. 
 
2.1.3 Conditional Knock-out of APP and APLP2 in Inhibitory Interneurons 
As the hippocampus comprised only 5 % inhibitory interneurons and APP was implicated as a 
regulator of GABAergic short-term plasticity in dissociated hippocampal and striatal neurons 
(Yang et al., 2009), I also investigated if this cell-subtype contributes to functional synaptic 
plasticity in cDKOs. Thus I followed a complementary approach to excitatory pyramidal neurons.  
First the GAD67Cre+/T strain (Prof. Dr. Hannah Monyer, DKFZ, Heidelberg (Magno et al., 2011) 
was bred with APPflox/floxAPLP2-/- mice to obtain GAD67Cre+/TAPPflox/floxAPLP2-/- mice which were 
crossed to APPflox/floxAPLP2-/- receiving 50 % GAD67Cre+/TAPPflox/floxAPLP2-/- (GADCre cDKO) and 
50 % APPflox/floxAPLP2-/- (littermate control). As an enzyme GAD67 (glutamate decarboxylase) 
promotes 90 % of GABA synthesis. The promoter is expressed constitutively from E10.5 on. 
In order to obtain an APP knock-out in inhibitory neurons comparable to the NexCre cDKOs in 
excitatory neurons we crossed Dlx5/6Cre+/T mice to APPflox/floxAPLP2-/- resulting in a genotype of 
Dlx5/6Cre+/TAPPflox/floxAPLP2-/- (Stuhmer et al., 2002). These mice were then again mated with 
APPflox/floxAPLP2-/- obtaining 50 % Dlx5/6Cre+/TAPPflox/floxAPLP2-/- (DlxCre cDKO) and 50 % 
APPflox/floxAPLP2-/- (littermate control). Dlx5/6 is a transcription factor, linked to the hox gene 
cluster and is expressed from E12.5 on. It promotes the migration of interneurons by repressing 
3 8  |  M a t e r i a l s  a n d  M e t h o d s  
 
proteins that are normally expressed in almost differentiated neurons. In a second approach we 
crossed Dlx5/6Cre+/T mice to only APPflox/flox in order to obtain mice bearing APP-/- but still 
expressing APLP2. Here I wanted to investigate whether the potential compensatory function of 
APLP2 is also preserved in GABAergic neurons. 
 
2.2 Acute Hippocampal Slices 
2.2.1 ACSF 
Artificial cerebral spinal fluid (ACSF) consisted of various compounds providing suitable amounts 
of ions and glucose to ensure optimal conditions for preparation, storage and 
electrophysiological recording from the hippocampal acute slices and organotypic hippocampal 
cultures (OHCs). Concentrations were kept at ideal levels to ensure a proper function of 
neurons. The composition of the ACSF is shown in Table 2.2. In order to reach a physiological pH 
of 7.3 and to supply the tissue with a sufficient amount of oxygen the ACSF was constantly 
carbogenated (95% O2, 5% CO2). In this study for preparation and electrophysiological 
recordings an ACSF containing a high Mg2+ concentration of 2 mM was used. This prevented the 
Mg2+ block release from the NMDA-receptor which would result in a pre-potentiation in the 
acute slices due to stress events from the preparation process. Moreover, it was shown in 
previous studies that APP / APLP2 transgenic mice tend to lower excitability threshold meaning 
that LTP could be induced very easy if a low Mg2+ concentration (1 mM) was used for recordings 
which then masked potential defects among genotypes.  
Table 2.2 Composition of the high Mg
2+
 ACSF. All chemicals were obtained from Applichem. 
Substance Molarity [mM] g/1l bidest H2O 
NaCl 125 7.305 
KCl 2.5 0.186 
NaH2PO4*H2O 1.25 0.172 
MgCl2*6 H2O 2 0.406 
NaHCO3 26 2.184 
D(+)-Glucose 25 4.504 
CaCl2*H2O 2 0.294 
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2.2.2 Preparation of Acute Hippocampal Slices 
Mice were briefly anesthetized with Isofluran and rapidly decapitated. After opening the skull 
the brain was quickly removed. In order to reduce neuronal damage this procedure should not 
take longer than 1.5 min. For keeping the oxidative stress to a minimum the brain was directly 
transferred to 4 °C cold, carbogenated ACSF for 3 min. Therefore, in the following preparation 
steps always ice-cold ACSF was used as well. 
Figure 2.1 A illustrates the localization of both hippocampi in a rodent brain. For preparation the 
prefrontal cortex and the cerebellum were removed by a razor blade followed by the separation 
of both hemispheres. The hippocampi were dissected from the surrounding striatal tissue at the 
medial side by using two rounded spatula. One spatula was placed underneath the fimbria 
hippocampi whereas the second spatula loosened the connection to the subiculum. Then the 
hippocampus could gently be folded out of the cortical tissue with the second spatula. In all 
preparation steps stretching and direct touching of the hippocampus should be avoided. 
The hippocampus was cut along its longitudinal axis by a vibrating microtome (VT 1200S; Leica, 
Nussloch, Germany) into 400 µm thick transversal slices. Therefore, both hippocampi were fixed 
with glue onto the specimen plate while leaning in an upright position on an agar block. 
Thereby, the dentate gyrus faced the agar block (Figure 2.1 B). The specimen plate was rapidly 
transferred into the buffer-tray containing ice-cold and carbogenated ACSF.  
 
Figure 2.1 Localization in the rodent brain and preparation of hippocampi. 
(A) Scheme illustrates the localization of hippocampi in the rat brain. Murine hippocampi tend to be slightly larger 
compared to brain volume, but nevertheless in comparable position. (B) Dissected hippocampi were attached to the 
specimen plate while leaning at the agar block and cut into 400 µm transversal slice by a vibrating razor blade. (C) 
Plan view on cut hippocampus. Transversal slicing keeps intra-hippocampal projections between areas intact. CA = 
Cornu ammonis, DG = dentate gyrus. Adapted from (Hammond, 2001). 
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After setting the cutting borders the vibrating razor blade gently cut slice by slice in a slow (0.1 
mm/s) and tissue protecting manner. Although this way of cutting was relatively time 
consuming compared to techniques like the tissue shopper or egg slicer the neuronal damage 
and thus stress for neurons next to the slice surface was reduced to a minimum. For storage the 
slices were transferred into a custom-made submerged chamber directly after they were cut. 
There the slices were maintained and allowed to rest in carbogenated ACSF for at least 2 h at 
room temperature (RT).  
 
2.3 Organotypic Hippocampal Cultures 
Organotypic hippocampal cultures (OHCs) are a suitable tool to investigate neurons in their 
typical network and surrounding. Although the hippocampus was cut into transversal slices 
projections to the sub-regions stayed intact therefore providing the possibility to investigate 
structure and function of neurons in these networks. Furthermore, it was feasible to treat the 
cultures with drugs over a longer time range of several days by adding drugs to the medium as 
acute hippocampal slices are short-lived (Gähwiler et al., 1997). In this study the OHCs of 
C57Bl/6, APLP2-KO and APP∆CT15-DM were treated either with DMSO (Dimethyl sulfoxide, 
Roth) as control or a specific inhibitor of the α-secretase ADAM10 (GI254023X, 10 µM) 
(Andrews et al., 2000; Ludwig et al., 2005) for five consecutive days starting at DIV 14-19. 
Subsequently, synaptic plasticity was investigated at the Schaffer collateral pathway.  
 
2.3.1 Media and Solutions 
Gey’s Balanced Salt Solution pH 7.4 (GBSS) 
KCl      0.37 g  
KH2PO4     0.03 g  
MgCl2 * 6H2O     0.21 g  
MgSO4 * H2O     0.07 g  
NaCl      8 g  
NaHCO3     0.227 g  
M a t e r i a l s  a n d  M e t h o d s  |  4 1  
NaH2PO4     0.12 g  
D-Glucose    1g  
CaCl2 * 2H2O     0.22 g  
MilliQ water    fill up to 1000 ml 
 
Kynurenic acid 
Dissolve 0.946 g Kynurenic acid (Sigma) in exactly 5 ml 1 M NaOH, vortex mix, add 45 ml MilliQ 
water, filter sterile, store in 1 ml fractions at -20 °C.  
 
Preparation solution pH 7.2 
GBSS             98 ml 
Glucose (50 %)       1 ml 
Kynurenic acid       1 ml 
 
Medium for OHCs 
BME Medium    100 ml 
HBSS     50 ml 
Equine donor serum   50 ml 
L-Glutamine (200 mM)  1 ml 
Glucose (50 %)       2 ml 
 
Antimitotic drug 
Uridin (Sigma)    2.422 mg in 10 ml dH2O (1 M)  
Cytosin-β-D-Arabino- 
furanosid*Hydrochlorid   2.797 mg in 10 ml dH2O (1 M) 
5-Fluoro-2´-Deoxyuridin   2.462 mg in 10 ml H2O (1 M) 
Stock solution is prepared 1:1, filtered sterile and stored at -20 °C. 
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Fungizone 
Stock solution    250 µg Fungizone / ml 
Dilution is 1:200 = 1.25 µg Fungizone / ml medium. 
 
Penicillin/Streptomycin  
Stock solution    10000 U Penicillin / 10000 µg streptomycin per ml 
Dilution is 1:100 = 100 U Penicillin / 100 µg streptomycin per ml medium. 
 
2.3.2 Preparation of Organotypic Hippocampal Cultures 
Organotypic hippocampal slice cultures were prepared as described by Stoppini and colleagues 
(Stoppini et al., 1991). Directly after birth at P0 mice were decapitated, the skull was opened 
and removed. By using a round, sharpened spatula the dorsal part of the brain was dissected 
from the skull. All preparation steps were performed in a petri dish filled with preparation 
solution while placed on a cooling pack. Remaining cerebellum was removed and both 
hemispheres were separated. Hippocampi were then dissected from the surrounding tissue 
with the spatula and transferred with two larger spatulas onto a Teflon plate being part of the 
tissue shopper (McIllwain). Here, 400 µm thick transversal slices were cut by a razor blade and 
afterwards washed with cold preparation solution from the Teflon plate back into the petri dish, 
where they were separated and afterwards kept for 15 – 30 min at 4 °C. Meanwhile 1.1 ml of 
pre-warmed medium was filled in each of a 6 well plate. Additionally, in every well a cell culture 
inserts (Millicell®) was placed. Three slices were positioned onto one insert. The plates were 
kept at 36.5 °C, 5 % CO2 and a high humidity of 99 % in the incubator. Three days after 
preparation 15.4 µl of antimitotic drug was added to the medium in each well. 24 h later the 
medium was exchanged completely. Consecutively, 500 µl of the medium was replaced by fresh 
one once a week. From DIV 7 on the medium was supplemented with Fungizone, Penicillin and 
Streptomycin to prevent contamination.   
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2.4 Electrophysiology 
Due to its lamella structure the main projections are still well preserved in transversal acute 
hippocampal slices, therefore providing a useful model for studies of activity-dependent 
synaptic and functional plasticity. This process reflects the ability of synapses to change their 
strength and their structure upon changes in neuronal activity (see 1.1.2). 
 
2.4.1 Technical Equipment 
All electrophysiological recordings have been performed at two setups composed of almost 
identical technical equipment, partially obtained from different manufactures. To yield 
comparable results from both setups, variables like filter settings, liquid levels, flow rates, etc. 
were kept adjustable. Recordings from both setups have been compared on a regular base and 
found to be indistinguishable ensuring a legitimation to pool the data. 
For recording acute hippocampal slices or OHCs were placed in the submerged-type recording 
chamber (RC-22, Warner instruments, USA) constantly perfused with carbogenated ACSF at a 
flow rate of 1.5 ml/min adjusted with a peristaltic pump (Ismatech, Switzerland or Abimed, 
Germany). A proper flow of ACSF was ensured with PVC tubings (TYGONE, Ismatec) for standard 
recording procedures whereas silicon tubings (PharMed® Ismaprene, Ismatec) have been 
proven to be necessary if inhibitors or peptides were applied in order to prevent sticking to the 
tubing walls. The recording chamber was fixed onto vibration damped platform (Spindler & 
Hoyer, Germany and TMC, Massachusetts, USA). Additionally, a constant temperature was 
essential for stable extracellular recordings. Therefore, the chambers were mounted onto an 
aluminum heating base (PH-1, Warner Instruments) which was connected to a thermistor 
measuring the current temperature. Upstream an additional preheating element (in-line 
solution heater SC-20, Warner Instruments) was positioned. Both, chamber and in-line solution 
heater, were connected to an adjustable Dual Channel Heater Controller (TC-334B, Warner 
Instruments). In the chamber a constant temperature of 22 – 24 °C (RT) for fiber volley 
experiments and 32 ± 0.2 °C for all following recordings was adjusted. A relieved steel cannula 
connected to tubings with a larger diameter for suction than input as well as an optimally 
adjusted pump prevented pulsing of the ACSF flow and therefore supported signal stability. 
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After the acute hippocampal slice or OHC was transferred into the recording chamber the 
electrodes were positioned by visual control using a stereo microscope (SMZ 654, Nikon, Japan 
or Heerbrugg at Leica Microsystems). For placing the stimulation electrode it was fixed to a 
mechanical micromanipulator (Leitz, Germany). For positioning the recording electrode an 
electrical micromanipulator (SM-5, Luigs and Neumann or Nano-Stepper, WSE Electronics), 
moved by a motor driven remote control, was used.  
 
2.4.2 Stimulation Protocols and Extracellular Recordings  
Since presynaptically released neurotransmitters bind to postsynaptic ligand-gated ion channels 
which in turn immediately open and therefore evoke a synaptic currents, changes of these 
currents can be recorded by microelectrodes. Those processes can be monitored in single cells 
by patch clamp technique or in a cell population by field Excitatory Postsynaptic Potentials 
(fEPSPs) recordings. The latter provides advantages as cell membranes are not damaged and the 
summated response to stimuli reflects the physiological state.  
For stimulation of the Schaffer collaterals a lacquer coated, monopolar tungsten electrode (WPI, 
USA) with a resistance of 0.1 MΩ was used. The tip was freed from lacquer by a chemical 
procedure therefore allowing a highly precise current application. The electrode was fixed onto 
the mechanical micromanipulator enabling exact placing in the slice. Additionally the negative 
electrode pole was connected to a stimulus isolator (A360 or A365, WPI, USA) generating and 
applying a pattern of stimuli preprogrammed in the master pulse generator Master 8 (A.M.P.I., 
Israel). The positive pole was connected to an indifferent electrode consisting of an Ag/AgCl 
pellet (E201, WPI, USA) being in contact with the liquid in the chamber and connected to the 
amplifier’s headstage. Stimuli consisted of monophasic square pulses of 0.2 ms duration and 
ranging from 4 – 65 µA in size for baseline stimulation depending on mice strain, age, 
preparation quality, recording system (acute slice or OHC) and treatment. 
For monitoring evoked potentials the recording electrodes from borosilicate glass capillaries 
(0.58 x 1.00 x 100 mm, Biomedical Instruments, Germany) were pulled by a horizontal pipette 
puller (program 33, P-97, Sutter Instruments, USA) and afterwards filled air bubble free with 3 
M NaCl solution. Pulling settings were adjusted to yield a resistance of 2 – 10 MΩ. Following the 
recording electrode was inserted into an electrode holder (WPI, USA) which in turn was 
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Figure 2.2 Positioning of electrodes in the 
transversal acute hippocampal slice. 
The stimulation electrode was placed in the CA3 
region to stimulate the Schaffer collateral pathway. 
The recording electrode was positioned in the 
stratum radiatum of the CA1 region. Adapted from 
(Byrne and Roberts, 2009). 
 
mounted either on the amplifier’s headstage (Axoclamp-2B, Axon Instruments at Molecular 
Devices, USA) directly or indirectly by a cable.  
Placing the stimulation electrode in the stratum radiatum of CA3, thereby stimulating the 
Schaffer collateral pathway, evoked fEPSPs recorded in the stratum radiatum of hippocampal 
CA1 region by a recording electrode at a depth 
of 150 – 200 µM (Figure 2.2). For investigations 
in OHCs the recording electrode was placed 100 
– 150 µM directly in the cell body layer of CA1. 
To ensure exact positioning the slice surface, as 
zero-point, had to be determined by 
monitoring changes in electrode resistance. 
Signals were visualized and followed on an 
oscilloscope (HM507, HAMEG, Germany) and 
digitalized with a National Instruments LabView 
based software (see 2.4.3). In all recordings the 
initial negative slope of the fEPSP was 
measured (Figure 2.3 A). 
After slices adapted to 32 °C chamber temperature and confirmed to be healthy by a stabile 
basal synaptic response and hence an equal fEPSP slope size, recordings began. To keep settings 
reliable and uniform for each experiment, baseline activity of LTP recordings were always 
performed at stimulus strengths resulting in a fEPSP slope size of 40 % of the maximal slope, 
which was defined as that slope not increasing further and barely not revealing a population 
spike (Figure 2.3 B). 
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Figure 2.3 Overview about fEPSP, population spike, fiber volley and PPF 
(A) Excitatory Postsynaptic field Potential (fEPSP) including stimulus artifact and the negative slope which was 
measured before and after LTP induction. (B) fEPSP contaminated by the population spike. (C) fEPSP and fiber volley 
signal are clearly separated at room temperature. (D) Example for Paired Pulse Facilitation (PPF) at an inter-
stimulus interval (ISI) of 20 ms. Second signal is larger than the first depending on size of ISIs. Vertical scale bar = 0.5 
mV, horizontal scale bar = 5 ms. 
 
Stimulation protocols for assessment of basal synaptic transmission as wells as LTP induction 
were preassigned in the Master-8, triggering the stimulus isolator. These protocols included a 
defined frequency and voltage with which the stimulus was applied.  
Investigation of the basal synaptic transmission was performed by input-output-(IO) 
measurements. Therefore, the fEPSP slope size was correlated to given sizes of the fiber volley 
amplitude (0.1 stepwise from 0.1 – 0.8). The fiber volley represents the presynaptic part of the 
fEPSP more precisely the summated action potentials of a population of axons (Figure 2.3 C). 
The fiber volley amplitude is proportional to the number of firing axons and thus allows 
evaluation of the input strength. These recordings were performed at 22 – 24 °C to prevent 
overlapping of fiber volley and fEPSP signal. In a second approach basal synaptic transmission 
was judged by correlating the fEPSP slope size to defined stimulus intensities (stepwise 25 µA 
from 25 µA to 250 µA) at 32 °C. 
Presynaptic function and thus short-term plasticity was assessed by the Paired Pulse Facilitation 
(PPF) paradigm. PPF is believed to induce short-term plasticity due to presynaptic 
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neurotransmitter release. When two single pulses with defined inter-stimulus intervals (ISIs) 
ranging from 10, 20, 40, 80 to 160ms were applied, the second fEPSP slope is larger than the 
first (Figure 2.3 D). These recordings were done at 32 °C chamber temperature.  
Next, long-lasting effects of changes in activity-dependent synaptic plasticity upon stimulation 
were investigated by inducing Long-Term Potentiation (LTP) in acute hippocampal slices or 
OHCs. Therefore, 20 min (in case of OHCs 10 min) of stable baseline recordings at 0.1 Hz were 
followed by the LTP induction protocol and subsequent monitoring of increase in synaptic 
efficacy over 60 min for LTP, 180 min for protein synthesis dependent Late – LTP (L-LTP) and 30 
min in OHCs. LTP induction was carried out by the Theta Burst Stimulation (TBS) whereby a train 
of stimuli activated the densely packed afferent axons of the Schaffer collaterals briefly at high 
frequencies (3 trains/repetitions at 10 s intervals, each train consisting of 10 stimuli delivered at 
5 Hz, each burst composed of 4 pulses at 100 Hz, Figure 2.4). This protocol based on naturally 
occurring firing patterns in vivo and thus reflected physiological changes (Larson and Lynch, 
1986). Freely exploring rats and mice were shown to exhibit bursts of 5 Hz in hippocampal 
pyramidal neurons. These patterns were described as “theta” rhythm (Bland, 1986; Sainsbury et 
al., 1987). Until today a wide range of different LTP induction protocols ranging from weak over 
mild to strong stimulation have been established and discussed whether reflecting physiological 
events during processes of learning and memory (Albensi et al., 2007; Kumar, 2011). 
  
Figure 2.4 Theta Burst Stimulation 
Theta Burst stimulation (TBS) consists of 3 trains/repetitions at 10 s intervals, each train consisting of 10 stimuli 
delivered at 5 Hz, each burst composed of 4 pulses at 100 Hz. This high frequency protocol was used for LTP 
induction and reflects physiological firing patterns in vivo. 
 
4 8  |  M a t e r i a l s  a n d  M e t h o d s  
 
2.4.3 Data Acquisition  
fEPSP signals were recorded in the bridge mode by the Axoclamp2B differential amplifier (Axon 
Instruments Molecular Devices, USA) and thereby 200x amplified. Additionally, the signal was 
band-pass filtered with borders set at 1 – 1700 Hz (LHBF – 48x – 4HL, NPI, Germany). A 50 – 60 
Hz filter eliminated noise contaminating the results (Hum Bug, Quest Scientific, UK). This way 
processed signals were collected at 5 kHz and sent to a computer via multi – IO card (National 
Instruments, USA). For online illustration and signal acquisition a program written by M. Korte 
and V. Staiger (DAP Version 4.751) basing on the National Lab View Software (National 
Instruments, USA) was used. Basically, the negative slope of the elicited fEPSP signal was 
measured in a defined, manually set window. Furthermore, a trend display window depicted 
resulting curve of recordings over time.  
 
2.4.4 Data Analysis 
For analysis of the raw data gained from recordings again custom made programs (by M. Korte, 
V. Staiger) based on National Lab View Software were consulted.  
In order to precisely analyze data obtained from fiber volley, EPSP and LTP recordings ANA_DAB 
(version 4.755) program was used to measure the negative fEPSP slope in a defined, manually 
placed window.  
Data obtained from PPF recordings were analyzed by the program ANA_PPF (version 4.2). Here, 
the ratios of two stimuli, separated by varying ISIs, were calculated as follows: 
(
𝑠𝑙𝑜𝑝𝑒 𝑓𝐸𝑃𝑆𝑃2
𝑠𝑙𝑜𝑝𝑒 𝑓𝐸𝑃𝑆𝑃1
) ∗ 100 
Both programs generated a Microsoft Excel file (Microsoft, USA) containing all single values of 
each fEPSP slope measurement per 10 s. For experiments about basal synaptic transmission (FV, 
EPSP, PPF) three values for each condition were averaged and plotted. In case of LTP recording 
data six values were averaged representing the mean for each minute plotted in the graph. 
Since the LTP data were depicted as an increase compared to basal synaptic activity all fEPSP 
slope sizes for the 20 min baseline were averaged and set to 100 %.  
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All values obtained after TBS application, were normalized to the baseline by the equation: 
(
𝑠𝑙𝑜𝑝𝑒 𝐸𝑃𝑆𝑃𝑚𝑖𝑛𝑢𝑡𝑒
𝑠𝑙𝑜𝑝𝑒 𝐸𝑃𝑆𝑃𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒
) ∗ 100 
Parameters leading to an exclusion of single experiments were an unstable baseline (variability 
more than  10 %) or a large population spike after TBS resulting in an abnormal large and thus 
not physiological LTP. 
 
2.4.5 Pharmaca and Peptides 
In this study additional electrophysiological recordings were performed upon pre-treatment 
with a specific α – secretase inhibitor or recombinant secreted α or β peptide (recAPPsα, 
recAPPsβ) of full length APP. As all substances were diluted in ACSF for administration to the 
chamber, the volume used had to be restricted to a minimum. Previous investigations showed 
that a volume of 30 ml of ACSF is sufficient for experiments in a closed loop configuration where 
the fluid circulated during the entire experiment. In order to circumvent sticking of peptides to 
the surface silicon tubings (PharMed® Ismaprene, Ismatec) were used. Changes in the 
osmolarity, due to evaporation of liquid, was a highly critical factor influencing the recordings. 
Therefore, a custom-made system moisturized the Carbogen before it was introduced into the 
Falcon-tube containing 30 ml ACSF plus the respective substance (Table 2.3). Additionally, the 
Falcon-tube was covered with Parafilm® (Bemis, USA). 
To investigate the role of APPsα for synaptic transmission and plasticity no acute hippocampal 
slices were used since they cannot be kept alive longer than 22 h. Moreover, the acute 
treatment revealed no effect on LTP after 6 h of incubation. OHCs provided the opportunity to 
prolong the incubation time. Cultures of C57BL/6, APLP2-KO and APP∆CT15-DM pubs were 
treated with a specific ADAM10 α – secretase inhibitor GI254023X (Andrews et al., 2000; 
Hoettecke et al., 2010; Weyer et al., 2011) for five consecutive days by adding the substance to 
the media in which they were cultivated. The inhibitors stock solution concentration was 20 mM 
diluted in DMSO (Roth, Germany), final concentration for OHCs treatment and during recording 
was 10 µM (Table 2.3). DMSO treatment at same concentrations served as control.  
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The recombinant peptides used in this study were kindly provided by Prof. Dr. Ulrike Müller 
from the Rubrecht-Karls-University of Heidelberg and derived from HEK cells which were stably 
transfected with pIRES3Hyg-His-Xa-APPsα or pIRES3Hyg-His-Xa-APPsβ (Hick et al., 2015). Next, 
the question was addressed whether recombinant APPsα (10 nM in DMSO) or APPsβ (50 nM in 
DMSO) could restore the LTP defect observed in NexCre cDKOs (Table 2.3). Heat inactivated (20 
min at 95 °C) peptides served as control. Acute hippocampal slices of APLP2-KO (littermate 
control) and NexCre cDKO were pre-incubated in 30 ml gently carbogenated ACSF containing 
the respective peptide in a custom made incubation chamber for 1 h at RT. Afterwards, slices 
were transferred into the recording chamber where again 30 ml of ACSF with the respective 
peptide were circulating in a closed loop during the entire experiment. Recordings were 
performed as described before.  
Table 2.3 Inhibitor and recombinant peptides used in this study. 
Substance Target Concentration Reference 
GI254023X (inhibitor) α-secretase 10 µM (Andrews et al., 2000; 
Hoettecke et al., 2010; 
Weyer et al., 2011) 
recAPPsα unknown 10 nM (Hick et al., 2015) 
recAPPsβ unknown 50 nM (Hick et al., 2015) 
 
2.5 Primary Hippocampal Dissociated Neuronal Cultures 
2.5.1 Media and solutions 
Borate buffer pH 8.5  
Dissolve 0.31 g boric acid and 0.475 g borax in 100 ml sterile MilliQ water, adjust pH to 8.5. 
 
Poly-L-Lysine stock solution 
10 mg / ml in MilliQ water 
 
Gey’s balanced salt solution (GBSS)  
See 2.3.1 
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Serum medium 
FCS     200 µl 
DMEM (2 %)    10 ml 
 
Medium for dissociated hippocampal cultures 
Neurobasal    50 ml 
B27     1 ml 
L-Glutamin (200 mM)   125 µl 
N2 (10x)    5 ml 
 
2.5.2 Preparation of Primary Embryonic Hippocampal Cultures 
Primary embryonic cultures of hippocampal neurons were prepared at embryonic day (E) 18.5. 
Therefore, the pregnant mouse was sacrificed by cervical dislocation. Under sterile conditions 
all embryos were taken from the uterus and rapidly decapitated. The upper half of the brain 
containing cortex and hippocampus was dissected from the skull and kept in ice-cold GBSS / 
Glucose solution. Remaining tissue from the midbrain and brainstem was removed under visual 
control using a dissecting microscope (Stemi 2000, Zeiss). Hippocampi were dissected from the 
cortical tissue and digested in 1 ml Trypsin / EDTA (Sigma) for 30 min at 36.5 °C. The digestion 
was stopped by removing the Trypsin / EDTA solution and subsequent adding of 1 ml serum 
medium followed by three washing steps. The cells were dissociated further by mechanical 
separation via a Pasteur pipette. The suspension was centrifuged 5 min at 1500 rpm, the 
supernatant was removed and cells were re-suspended in 1 ml medium. Afterwards the cells 
were counted, plated at a density of 7 x 104 cells / well on poly-L-Lysine coated coverslips and 
kept in medium at 36.5 °C, 5 % CO2 and 99 % humidity. Medium was exchanged at DIV9. 
Cultures were used for experiments at DIV 12-16. 
For coating glass coverslips (Ø 13 mm, 1 mm thick, VWR) with poly-L-Lysine they were first 
incubated in 10 M NaOH for 3-5 h at 100 °C and washed 5x with MilliQ water. Next, the 
coverslips were sterilized at 225 °C for 6 h and coated with 0.5 mg / ml poly-L-Lysine (P2636, 
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Sigma) in boric acid buffer at 36.5 °C for 2-3 h. Finally, they were washed 5x with sterile water, 
dried and stored at 4 °C. 
 
2.6 Ratiometric Calcium Imaging 
2.6.1 Media and solutions 
Fura-2 Calcium Calibration Kit 
*zero to 10 mM CaEGTA, 50 µM fura-2 (11 x 1 ml)* (Invitrogen) 
 
1x Hank’s Balanced Salt Solution (HBSS) for live imaging 
HBSS 10x stock solution  50 ml 
CaCl2 * 2H2O    175 mg 
NaHCO3    147 mg 
D-Glucose    1351 mg 
MilliQ water    fill up to 500 ml 
 
Fura-2 AM stock solution 
Add 50 µl DMSO to the vial delivered with 50 µg Fura-2 AM (Invitrogen) to receive a stock 
solution of 1 mM. 
  
20 % Pluronic Acid  
Pluronic Acid    1 g 
DMSO     5 ml 
 
Glycine stimulation medium (1 mM) 
Glycine (1 M in D-PBS)  40 µl 
Strychnine (1 mM in H2Odest.)  40 µl      
1x HBSS    40 ml  
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APV medium (50 µM) 
APV (10 mM in H2Odest.)  200 µl 
Glycine (1 M in D-PBS)  40 µl 
Strychnine (1 mM in H2Odest.)  40 µl      
1x HBSS    40 ml  
 
CPA medium (10 µM) 
CPA (10 mM in DMSO)  40 µl 
Glycine (1 M in D-PBS)  40 µl 
Strychnine (1 mM in H2Odest.)  40 µl      
1x HBSS    40 ml  
 
Nifedipine medium (10 µM) 
Nifedipine (10 mM in DMSO) 40 µl 
Glycine (1 M in D-PBS)  40 µl 
Strychnine (1 mM in H2Odest.)  40 µl      
1x HBSS    40 ml  
 
2.6.2 Pharmaca and Viruses 
Table 2.4 Chemicals used for calcium imaging. 
Substance Concentration Reference 
DL-2-Amino-5-
phosphonopentanoic acid 
(APV) 
50 µM abcam 
Cyclopiazonic acid (CPA) 10 µM Tocris 
Nifedipine 10 µM Tocris 
Strychnine hydrochloride 1 µM Sigma-Aldrich 
 
 
 
5 4  |  M a t e r i a l s  a n d  M e t h o d s  
 
Table 2.5 Adeno-associated viruses (AAV) used for calcium imaging. 
Substance Stock titer Dilution Reference  
AAV9-ss-Syn-Venus-f 1.4*1010 U/µl 1 : 25 Tobias Abel (PEI, Langen) 
AAV9-ss-Syn-lck-
Venus-HA-msAPPsα 
5.63*109 U/µl 1 : 5 Tobias Abel (PEI, Langen) 
 
2.6.3 Data Acquisition 
2.6.3.1 Ratiometric Calcium Imaging in NexCre cDKO 
Ratiometric Ca2+ imaging is a feasible method to assess qualitative as well as quantitative values 
for changes in the intracellular Ca2+ concentration. Here, the fluorescent Ca2+ indicator dye Fura-
2AM is used bearing the cell-permeant acetoxymethyl ester (AM) enabling the dye to passively 
enter the neuron. After penetration intracellular esterases cleave the AM group and therefore 
trap the dye inside the cell. Fura-2 is excited with UV light at wavelengths of 340 nm and 
380 nm. The excitation peak shifts from 340 nm to 380 nm when Ca2+ binds Fura-2. The 
detection wavelength is 510 nm. The ratio of the emissions at those wavelengths was directly 
correlated to the amount of intracellular Ca2+. Ratiometric Ca2+ imaging was performed at DIV 
12-16 of hippocampal dissociated neuronal cultures prepared from APLP2-KO (littermate 
control) and NexCre cDKO. For dye-load 
2 ml of pre-warmed 1x HBSS containing 
4 mM Fura-2AM and 2.5 % Pluronic acid 
were prepared in advance. The coverslip 
was transferred into this loading 
solution in a petridish and kept at 37 °C 
for 60 min in the incubator. After 2 
washing steps with pre-warmed 1x 
HBSS, the coverslip was transferred into 
the imaging chamber which was 
constantly perfused (0.5 ml / min) with 
1x HBSS at RT. The neurons were 
allowed to adapt to the new conditions 
Figure 2.5 Imaging protocol for quantitative Calcium 
imaging 
The scheme illustrates 5 imaging time points and the drug 
application phase of 10 min. t-20 and t-10 reflect the 
untreated status of the neurons in 1xHBSS and therefore 
reflect resting Ca
2+
 concentrations. Directly after imaging t-10 
1xHBSS containing 1 mM glycine and 1 µM strychnine (and 
additionally 50 µM APV, 10 µM cyclopiazoic acid or 10 µM 
nifedipine) was washed into the chamber for 10 min. t0 
depicts the imaging time point directly after stimulation. 
Solution was switched again to 1xHBSS. Further imaging took 
place 10 min (t10) and 40 min (t40) after stimulation. 
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for 20 min. Figure 2.5 illustrates the imaging protocol including time points of drug application. 
Imaging was performed by using a fluorescence microscope (Olympus, BX61WI) with a 
LUMPlanFl 40x / 0.80 W JAPAN objective, including a CCD camera (Hamamatsu) with a binning 
of 4 x 4. For signal detection and image acquisition the 340 nm Fura and 380 nm Fura channels 
were chosen. Intensity was set to 70,9 % and the exposure time was constantly held at 130 ms 
for time lapse imaging taking 500 images in a cycle time of 326 ms and 200 cycles repetition. 
Keeping intervals relatively short ensured as less dye bleaching as possible. 
After 20 min of adaption to the chamber conditions, 2 images of spontaneous activity without 
stimulation were taken at an interval of 10 min (t-20, t-10, Figure 2.5). For stimulation and 
chemically induced LTP 1x HBSS containing Glycine (1 mM) and Strychnine (1 µM), blocking 
specifically glycine receptors, were washed into the chamber for 10 min. Afterwards 1x HBSS 
was perfused and 3 additional time points (t0, t10, t40, Figure 2.5) were imaged. In order to 
investigate how Ca2+ signals change upon treatment either 2-amino-5-phosphonopentanoic acid 
(APV, 50 µM), Nifedipine (10 µM), or Cyclopiazoic acid (CPA, 10 µM) were applied during glycine 
stimulation to inhibit selectively NDMA receptors, L-type voltage gated Ca2+ channels or the 
reuptake of Ca2+ into the endoplasmatic reticulum (ER) respectively (Table 2.4). 
 
2.6.3.2 Ratiometric Calcium Imaging with APPsα Expression via AAV 
Since results from ratiometric Ca2+ imaging indicated a defect in Ca2+ dynamics before and upon 
glycine stimulation in NexCre cDKO I assessed if this could be restored when APPsα peptide is 
again expressed. Thus, I used an adeno-associated virus (AAV) expressing a construct with the 
sequences of the APPsα peptide plus venus fluorescence protein (Figure 2.6 A) or only venus as 
control (Figure 2.6 B) under the synapsin promoter ensuring exclusive expression in neurons.  
  
 
Figure 2.6 AAV constructs 
(A) schematic AAV-syn-APPsα-venus vector, neurons 
expressing this construct under control of synapsin 
promoter reveal venus fluorescence and therefore 
also express APPsα. (B) schematic AAV-syn-venus 
vector, neurons expressing this construct under 
control of synapsin promoter reveal venus 
fluorescence but no APPsα. 
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Figure 2.7 Calibration curve of Fura-2 
[Ca
2+
]free is a function of the Kd of CaEGTA. When the 
[Ca
2+
] and [EGTA] were almost similar, the only free 
Ca
2+
 available is that which was in equilibrium with 
EGTA. Therefore the Kd of EGTA (indicator) was 
defined as the concentration at which it reaches the 
half saturated point shown in the double log plot. 
(Grynkiewicz et al., 1985; Tsien and Pozzan, 1989). 
 
Table 2.5 gives an overview about vectors, titers and concentrations which were applied. 
Previous investigations by Dr. Tobias Abel revealed a multiplicity of infection (MOI) for both 
AAVs of 2*104. As neurons were plated at a density of 7 x 104 cells / coverslip, 1.4*109 viruses 
had to be used. Hence, the AAV stock should be diluted 1 : 10 and 1 : 50 (control). But 
preliminary experiments revealed concentrations of 1 : 5 and 1 : 25 (control) resulted in higher 
transduction efficiencies. AAV stocks were stored as 5 µl aliquots at -80 °C and thawed for each 
experiment to keep virus quality equal. Dilutions were prepared with medium from each 
dissociated culture and were added back to wells for transduction. Cells were cultured without 
medium change until imaging for 7 consecutive days. 
 
2.6.4 Data Analysis 
2.6.4.1 Calibration Curve of Fura-2  
The Ca2+ Calibration buffer Kit (Invitrogen) provided a suitable tool to determine the dissociation 
constant (Kd) for the Fura-2AM fluorescent Ca
2+ indicator dye which was needed to calculate in 
vitro Ca2+ concentrations. It contained 11 Ca2+ standard buffers with increasing [CaEGTA] 
concentrations from 0 to 39 µM premixed with 
50 µM Fura-2 and a control buffer without 
Fura-2. For facilitating coverslip spacing and 
microscope focusing each buffer contained 15 
µm polystyrene microspheres. This kit based on 
a method described by Tsien and colleagues 
(Grynkiewicz et al., 1985; Tsien and Pozzan, 
1989) where the [Ca2+]free is a function of the Kd 
of CaEGTA. When the [Ca2+] and [EGTA] were 
almost similar, the only free Ca2+ available is 
that which was in equilibrium with EGTA. Thus, 
the Kd of indicator EGTA was defined as the 
concentration at which it reaches the half 
saturated point (Figure 2.7).  
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Figure 2.8 Shift of excitation peak from 
340-380nm upon calcium binding to Fura-2. 
 
2.6.4.2 Quantification of Calcium Signals  
Ca2+ release events took place in a neuron during 
spontaneous activity without or upon stimulation 
appearing as peaks, which reflect bursting activity, 
during imaging. Those peaks reflect the fact that if 
Ca2+ entered the cell via receptors and was released 
from internal stores it immediately bound to Fura-2 
which then in turn switched its excitation peak from 
340 nm to 380 nm (Figure 2.8).  
Images obtained from the imaging process of 
dissociated hippocampal cultures from C57BL/6, 
APLP2-KO (littermate control) and NexCre cDKO were analyzed by measuring fluorescence 
intensity changes for both wavelengths expressed as ratio (R).  
𝑅 =
𝐹380𝑛𝑚
𝐹340𝑛𝑚
 
Therefore, ratio images were separated to their wavelengths (380 nm and 340 nm) and opened 
with the imageJ software. Here, somata of 5 neurons were marked by ROIs (Region Of Interest) 
and grey values were calculated. An additional ROI was drawn to correct for background 
fluorescence. The following criteria had to be fulfilled for cells included in the analysis: (1) 
participation of the neuron analyzed in network-activity and thus showing Ca2+ signals obvious 
in ratio images, and (2) in case AAV constructs were expressed in the neurons they additionally 
had to be positive for venus fluorescence.  
The derived fluorescence ratios were plotted against calibrated values for known Ca2+ levels 
obtained from the Calcium Calibration buffer Kit (Rmin, Rmax, Kd, F
380
max, F
380
min) to determine in 
vitro Ca2+ concentrations. The relationship of the amount of free Ca2+ and the fluorescence 
emission intensity ratio was calculated as shown by (Grynkiewicz et al., 1985): 
[𝐶𝑎2+]𝑓𝑟𝑒𝑒 = 𝐾𝑑
𝐸𝐺𝑇𝐴 ∗ (
𝑅 − 𝑅𝑚𝑖𝑛
𝑅𝑚𝑎𝑥 − 𝑅
) ∗ (
𝐹𝑚𝑎𝑥
380𝑛𝑚
𝐹𝑚𝑖𝑛
380𝑛𝑚) 
The amplitude and frequency values of Ca2+ peaks were analyzed and plotted to assess 
differences in Ca2+ dynamics upon neuronal activity between genotypes and treatments. 
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2.6.5 Statistical Analysis 
The statistical analysis was performed by using Microsoft Excel and GraphPad Prism (GraphPad 
software, USA). Comparing two groups or experimental conditions a two-tailed student’s t-test 
(type 2) was applied. If data from more than two groups were statistically analyzed a one-way 
variance ANOVA followed by a post-hoc Bonferroni multiple comparison test was used. Values 
of p < 0.05 were considered as significant while values with p < 0.01 and p < 0.001 were stated 
as highly significant. Significances were plotted as *p < 0.05, **p < 0.01 and ***p < 0.001. All 
data shown were generated with GraphPad Prism with mean values ± standard error of the 
mean (SEM). 
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3 Results 
3.1 The Role of the APP Protein Family for Synaptic Plasticity in Excitatory 
Neurons 
APP and APLP2 are widely expressed throughout the brain, with a particular high expression in 
excitatory pyramidal cells of the cortex and hippocampus. As the latter is composed of ~95 % 
excitatory neurons I investigated whether the deletion of defined parts of APP or the entire 
protein on an APLP2 deficient background impacts basal synaptic properties. This analysis 
included the input-output strength measured by fiber volley and EPSP size or presynaptic 
functionality assed by PPF. Furthermore, I investigated whether the induction and maintenance 
of TBS-induced Long-Term Potentiation (LTP) was impaired. For a detailed analysis the final 5 
min of slope recordings were averaged and depicted as bar graphs for each genotype. A 
complementary approach was established by quantitative Ca2+ imaging. This method enabled 
me to estimate the amount intracellular Ca2+ at before and upon glycine stimulation solely or 
additional drug administration. Notably, chemically induced LTP was shown to mimic LTP 
induction comparable to TBS (Shahi et al., 1993). 
 
3.1.1 Blocking of APPsα Generation by Inhibiting the α-secretase ADAM10 
To elucidate the role of different cleavage products of APP and its homologue APLP2 for activity-
dependent synaptic plasticity two constitutive double mutants (DM) were generated. APPsα or 
APP∆CT15 knock-in (KI) mice used by Ring and colleagues were crossed to APLP2-KO individuals 
(von Koch et al., 1997; Ring et al., 2007). By this means lethality of APP / APLP2 double knock-
out mice was circumvented. Previous investigations revealed that transgenic mice only 
expressing the soluble membrane-unbound APPsα fragment on an APLP2-KO background 
(APPsα-DM, APPsα+/+APP-/-APLP2-/-) show an impaired LTP but normal basal synaptic 
transmission (Weyer et al., 2011). In APP-KO mice an age-related LTP defect was observed in 
aged but not adult animals. It was shown that APPsα-DM revealed the LTP defect in both adult 
(3-4 months) and aged (12-13 months) animals. Indicating on the one hand a redundant 
function of APLP2 and on the other hand suggesting that expression of APPsα alone is not 
sufficient to promote potentiation to littermate control levels.  
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First, I investigated the role for APPsα in processes of LTP. Therefore, the cleavage of APP as 
well as APLP2 by the metalloproteinase ADAM10, and thus APPsα and APLP2sα generation, was 
prevented by application of the specific ADAM10 α-secretase inhibitor GI254023X (Andrews et 
al., 2000; Hoettecke et al., 2010). The 6 h lasting long-term incubation of acute hippocampal 
slices revealed an unchanged LTP and was limited by a short tissue survival time (Gähwiler et al., 
1997). Hence, organotypic hippocampal cultures (OHC) of C57Bl/6 wildtype (wt), APLP2-KO and 
APP∆CT15-DM were prepared at P0 and treated either with DMSO as vehicle control or 
ADAM10 inhibitor for five consecutive days from DIV 14 onwards (see 2.4.5). Since OHCs are 
less mature compared to acute slices, they displayed a high variability and less stable 
potentiation levels. Therefore, the baseline recording was reduced to 10 min, followed by Theta 
Burst Stimulation (TBS) and subsequent recording for 30 min. 
LTP induced in wt OHCs resulted in a stable potentiation with statistically indistinguishable 
levels from t35-40 min of 136 ± 11.9 % for DMSO treatment (n = 12 / 7) and 123 ± 4.0 % (n = 18 
/ 11) for ADAM10 inhibitor treatment (p = 0.271, t-test, Figure 3.1 A and B). Short-term 
plasticity assed by the Paired Pulse Facilitation (PPF) paradigm did not differ as well (Figure 3.1 
C). Furthermore, postsynaptic functionality was not investigated due to high susceptibility of 
OHCs to increasing currents and undistinguishable fiber volley from fEPSP signal. First, OHCs 
from APLP2-KO mice were studied. After 10 min of baseline recording, LTP induction elicited a 
stable LTP of 145 ± 8.3 % (n = 11 / 9) for vehicle treated group, which was highly significant 
altered compared to APLP2-KO treated with ADAM10 inhibitor 112 ± 3.3 % (n = 10 / 7, p = 
0.002, t-test, Figure 3.1 D and E). Thus long-term treatment with GI254023X, inhibiting APPsα 
generation, prevented a sufficient LTP induction and maintenance, whereas in controls cleavage 
products of APP alone were enough to promote LTP. Again, presynaptic functionality was not 
affected (Figure 3.1 F). To complete the study and compare to results from Weyer and 
colleagues, where besides others OHCs from APPsα-DM were investigated, OHCs of APP∆CT15-
DM (APP∆CT15+/+APP-/-APLP2-/-) were analyzed as well (Weyer et al., 2011). LTP recordings 
revealed a significant difference between APP∆CT15-DM DMSO-treated OHCs with potentiation 
values of 153 ± 14.7 % (n = 7 / 5) and APP∆CT15-DM ADAM10 inhibitor-treated with 107 ± 6.5 % 
(n = 8 / 7, p = 0.017, t-test, Figure 3.1 G and H). Here, LTP was induced, although to a lesser 
extend as in controls, but again the maintenance was affected by ADAM10 inhibitor treatment 
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since fEPSP slope returned almost to baseline level. Notably, the vehicle control group showed 
LTP which was not seen in APPsα-DM treated with DMSO. In these mutants the concentration 
of APPsα, which was not membrane anchored, could have been unsufficient to promote LTP 
due to low concentration or abnormal timed release at activated synapses (Weyer et al., 2011). 
Short-term plasticity was unaltered as well (Figure 3.1 I). These results suggest that α-secretase 
ADAM10 dependent APPsα or APLP2sα production is required for LTP induction and 
maintenance. In wt probably endogenous levels of α-secretase cleavage products APPsα and 
APLP2sα are still sufficient to promote LTP comparable to controls, since APP and APLP2 
shedding might be inadequately suppressed by GI254023X.  
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Figure 3.1 LTP experiments in organotypic hippocampal slice cultures prepared at P0 (previous page). 
(A+B) OHCs of wildtype mice were either treated for 5 consecutive days with DMSO as vehicle control (black circles) 
or ADAM10 inhibitor GI254023X (light green circles). After 10 min of baseline recording LTP was induced by TBS 
(arrow). In both conditions stable potentiation levels of 136 ± 11.9 % vs. 123 ± 4.0 % for t35-40 min were statistically 
indistinguishable (p = 0.27, t-test). (C) Short-term plasticity was unaffected. (D+E) OHCs of APLP2-KO individuals 
revealed a highly significant defect in DMSO treated controls (145 ± 8.3 %, black circles) compared to those treated 
with ADAM10 inhibitor, where no pronounced LTP was observed (112 ± 3.3 %, grey circles, p = 0.002, t-test). (F) 
Presynaptic function was found to be unchanged. (G+H) A comparable observation was made for OHCs from 
APP∆CT15-DM (red circles). Here after TBS application fEPSP slope did not increase initially afterwards but several 
minutes later compared to vehicle control (black circles) and reached just a short phase of potentiation, which 
returned to baseline levels during final 5 min of recording (107 ± 6.5 % vs. 153 ± 14.7 %, p = 0.017, t-test). (I) PPF 
paradigm failed to unravel any significant defects in short-term plasticity. Insets show original traces of 
representative individual experiments. Vertical scale bar = 0.5 mV, horizontal scale bar = 5 ms. Error bars indicate ± 
SEM. n.s. = not significant. n = number no of OHCs / number of mice used. 
 
3.1.2 APPΔCT15-Double Mutant 
Since APPsα is not membrane bound in APPsα-DM and lateral diffusion might be accountable 
for unsufficient concentrations at active synapses I analyzed APP∆CT15-DM mice 
(APP∆CT15+/+APP-/-APLP2-/-). Here, a fragment of APP was expressed which lacks the last 15 
amino acids at the intracellular C-terminus. The APP intracellular domain (AICD) was shown to 
modulate gene expression in the nucleus thereby regulating phosphoinositide-mediated Ca2+ 
signaling (Leissring et al., 2002). In all following results presented APLP2-KO mice served as 
littermate control as they were shown in previous studies to be indistinguishable to wildtype 
mice in electrophysiological and morphological characteristics (Weyer et al., 2011; Zhang et al., 
2013; Weyer et al., 2014). 
LTP induction by TBS led to an overall increase in synaptic strength in both APP∆CT15-DM and 
littermate control (Figure 3.2 A). Whereby, APP∆CT15-DM already revealed a significantly 
decreased induction phase of post tetanic potentiation (PTP) compared to control. This defect 
proceeded in the maintenance phase of the LTP showing a significant reduction of average 
potentiation levels for the final 5 min of 60 min after TBS of 129 ± 6.0 % (n = 15 / 4) for 
APP∆CT15-DM compared to 160 ± 9.7 % (n = 16 / 5) for littermate control (Figure 3.2 A and B, p 
= 0.015, t-test). To assess whether this defect persists also during protein synthesis dependent 
part of Late-LTP (L-LTP), 3 h after TBS were recorded and the mean of the last 5 min was 
analyzed. Indeed, the same trend became obvious for APP∆CT15-DM with 121 ± 13.0 % (n = 4 / 
3) and littermate control 151 ± 11.9 % of potentiation (n = 3 / 3), although it was not significant 
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between genotypes (Figure 3.2 C and D, p = 0.215, t-test). To test whether the defect is 
accompanied by an altered basal synaptic transmission first the input-output strength was 
measured. The correlation of the fEPSP slope to defined stimulus intensities (Figure 3.2 E) 
revealed a larger fEPSP slope in the double mutants than in the controls which was significant at 
currents ranging from 100 µA (p = 0.046), 125 µA (p = 0.042) to 150 µA (p = 0.048, t-test). 
Comparable results were obtained by measuring the slope size at given fiber volley amplitudes 
(Figure 3.2 F). Again, the slope size was increased in relation to values from littermate controls 
over the complete measurement while this difference became only significant for a fiber volley 
amplitude of 0.2 mV (p = 0.007. t-test). As a second approach the presynaptic functionality and 
short-term plasticity were checked by the PPF. To this end two pulses with defined interstimulus 
intervals (ISI) were applied and the sizes of slope 2 / 1 were calculated revealing no significant 
difference (Figure 3.2). Overall this hints to a postsynaptic, but not presynaptic defect which 
might affect in turn the LTP.  
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Figure 3.2 LTP and L-LTP experiments of adult APP∆CT15-DM mice. 
(A) After 20 min of baseline recording, LTP was successfully induced by TBS (arrow). APP∆CT15-DM (red circles) 
revealed significantly lower posttetanic potentiation (PTP) as well as overall potentiation levels compared to 
littermate control (black circles). (B) Average of fEPSP values for the final 5 min of 60 min LTP recording were 
depicted as bar graph showing a significant difference in potentiation levels for littermate control 160 ± 9.7 % and 
APP∆CT15-DM 129 ± 6.0 % (p = 0.015, t-test). (C) Recording time was prolonged to 3 h after LTP induction to 
investigate protein synthesis dependent L-LTP. Progression of L-LTP exhibited a comparable trend as LTP recordings, 
whereas the difference between both genotypes was not significant for the mean of the final 5 min with p = 0.215, 
t-test (D). (E) Input-output strength was significantly impaired at defined stimulus intensities of 100 µA (p = 0.046), 
125 µA (p = 0.042), 150 µA (p = 0.048, t-test) and (F) at given fiber volley amplitudes of 0.2 mV (p = 0.007, t-test). 
(G) Presynaptic functions are unchanged among genotypes. Insets show original traces of representative individual 
experiments. Vertical scale bar = 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± SEM. n.s. = not significant. 
n = number no of slices / number of mice used. 
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3.1.3 Conditional APP Knock-out on APLP2 Deficient Background 
The conditional knock-out strategy enables to create time and tissue specific ablation of 
targeted genes. Here I made use of this technique to tackle the question whether a knock-out of 
both APP and APLP2 affects activity-dependent synaptic plasticity. This was so far impossible as 
a constitutive double knock-out (DKO) was lethal due to neuro-muscular weakness (Heber et al., 
2000; Ring et al., 2007). Thus APPflox/floxAPLP2-/-, when crossed to various Cre-deleter mouse 
lines, resulted in viable DKOs for both proteins. As expression levels are particularly high in 
pyramidal cells of neocortex and hippocampus we initially focused on the excitatory system.  
 
3.1.3.1 CaMKIIαCre Conditional Double Knock-out 
In the next experimental series APPflox/floxAPLP2-/- mice were crossed to an inducible CaMKIIαCre 
line providing a tool for flexible timing of APP deletion in excitatory forebrain neurons by 
tamoxifen application. I wanted to investigate the requirement of APP and APLP2 in the adult 
CNS at active synapses in processes of activity-dependent synaptic plasticity. First, adult 
CaMKIIαCre cDKO and the respective littermate controls were treated with tamoxifen to induce 
APP excision. Those animals were investigated regarding synaptic plasticity 4 weeks (1x 
tamoxifen, adult, 3 – 4 months of age) or several months (1x tamoxifen, aged, 12 – 13 months of 
age) after injection. This should uncover possible age-related and redundant effects of APP and 
APLP2 DKO. Second, a comparable approach was applied, but now P5 pubs of CaMKIIαCre cDKO 
and littermate controls received tamoxifen additionally via lactating mothers to receive a 
maximal Cre activation (for details see 2.1.2). Again, adult (2x tamoxifen, 3 – 4 months of age) 
and aged (2x tamoxifen, 12 – 13 months of age) mice were analyzed. 
In a first recording session 1x tamoxifen treated adult CaMKIIαCre cDKO and littermate controls 
were assessed by a former PhD student (see dissertation of Andrea Delekate, 2011, Figure 3.16). 
Results revealed a significant defect in average potentiation of final 5 min in LTP (p = 0.045, t-
test) and L-LTP (p = 0.041) between genotypes. Short-term plasticity was unaltered as well as 
basal synaptic transmission at given stimulus intensities. However, fEPSP slope sizes of 
CaMKIIαCre cDKO were significantly increased at defined fiber volley amplitudes (p ≤ 0.05, t-
test). 
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In order to investigate age-dependent effects next 1x tamoxifen treated aged CaMKIIαCre cDKO 
and respective littermate controls were examined. In contrast to adult individuals, older mice 
didn’t reveal any significant deficits between genotypes neither in LTP (Figure 3.3 A and B, p = 
0.099, t-test) nor in L-LTP (Figure 3.3 C and D, p = 0.499, t-test). The averaged values of 
potentiation 60 min after TBS were 133 ± 2.7 % for CaMKIIαCre cDKO (n = 22 / 5) and 143 ± 5.4 
% for littermate control (n = 23 / 5). The final 5 min of L-LTP recording led to 131 ± 4.5 % for 
CaMKIIαCre cDKO (n = 7 / 4) and 125 ± 6.0 % for littermate control (n = 9 / 3). Basal synaptic 
transmission was unaltered as well, since correlation of defined currents and set fiber volley 
amplitudes were statistically indistinguishable (Figure 3.3 E and F). Furthermore, the ratio of 
two closely applied stimuli pointed towards normal presynaptic functionality (Figure 3.3 G).  
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Figure 3.3 LTP experiments in aged 1x tamoxifen treated CaMKIIαCre cDKO mice. 
(A+B) Stable baseline recording of 20 min was followed by LTP induction via TBS (arrow) resulting in a robust and 
maintained, but not significantly altered LTP in both CaMKIIαCre cDKO (133 ± 2.7 %, purple circles) and littermate 
control mice (143 ± 5.4 %, p = 0.099, t-test, black circles). (C+D) L-LTP exhibited similar values after TBS for 
CaMKIIαCre cDKO (125 ± 6.0 %) and littermate control individuals (125 ± 6.0 125 ± 6.0 %, p = 0.499, t-test). (E+F) 
Postsynaptic functions were unchanged at given stimulus intensities and fiber volley amplitudes among genotypes. 
(G) Presynaptic functionality was unaltered as well. Insets show original traces of representative individual 
experiments. Vertical scale bar = 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± SEM. n.s. = not significant. 
n = number no of slices / number of mice used. 
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To reach as much neurons as possible for the Cre activation, CaMKIIαCre cDKO and their 
littermate controls were treated twice with tamoxifen. Once at P5 via mothers milk and a 
second time with an age of 6-8 weeks. Since the CaMKIIα promoter is expressed directly after 
birth this procedure should lead to the maximal APP ablation possible. Figure 3.4 depicts results 
from recordings of adult mice. After 20 min of stable baseline recording, an induction by TBS 
resulted in a robust PTP and maintained LTP in both CaMKIIαCre cDKO as well as littermate 
controls which were statistically indistinguishable at any time point recorded (Figure 3.4 A). A 
stable potentiation finally led to average levels for t75-80 min of 170 ± 6.9 % for littermate 
controls (n = 19 / 6) and 165 ± 8.9 % for CaMKIIαCre cDKO (n = 20 / 7, p = 0.659, t-test, Figure 
3.4 B). These findings contrasted to results obtained from basal synaptic transmission and long-
term recordings. L-LTP measurement of 3 h revealed again a strong induction and stability but 
now a significant difference in the protein synthesis dependent phase became obvious between 
genotypes (Figure 3.4 C). 5 min before recordings ended an average potentiation of 160 ± 11.0 
% was calculated for littermate controls (n = 5 / 4) and 132 ± 4.5 % for CaMKIIαCre cDKO (n = 6 / 
4, p = 0.048, t-test, Figure 3.4 D). While the correlation of fEPSP slope sizes to given stimulus 
intensities did not differ significantly (Figure 3.4 E), the correlation to defined fiber volley 
amplitudes uncovered an increased response (Figure 3.4 F). This alteration became significant 
for amplitudes of 0.1 mV (p = 0.033) and 0.3 mV (p = 0.044, t-test). Additionally, short-term 
plasticity was affected as indicated by a significant difference for ISI 160 ms in the PPF paradigm 
(p = 0.034, t-test, Figure 3.4 G). All together these findings suggest an acute role of both APP 
and APLP2 at active synapses as well as potentially in processes of synaptogenesis.  
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Figure 3.4 LTP experiments in adult 2x tamoxifen treated CaMKIIαCre cDKO mice. 
(A+B) TBS (arrow) application induced a strong and stable LTP in littermate controls of 170 ± 6.9 % (black circles) 
and in CaMKIIαCre cDKO of 165 ± 8.9 % (grey circles) for t75 – 80 min (p = 0.659, t-test), which resulted in 
overlapping curves. (C+D) Contrary results were obtained for L-LTP. Again a robust induction phase was observed in 
both genotypes which turned into a significant difference between littermate controls of 160 ± 11.0 % and 
CaMKIIαCre cDKO of 132 ± 4.5 % for t195 – 200 min in the plateau of L-LTP (p = 0.048, t-test). (E) Recording of fEPSP 
slope size at given stimulus intensities revealed no significant differences between genotypes. (F) Whereas, analysis 
of fEPSP slope at defined fiber volley amplitudes led to partially significant increase of postsynaptic function (0.1 
mV: p = 0.033, 0.3 mV: p = 0.044, t-test). (G) Presynaptic functionality was affected as well as indicated by a 
significant deficit for an ISI of 160 ms (p = 0.034, t-test). Insets show original traces of representative individual 
experiments. Vertical scale bar = 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± SEM. n.s. = not significant. 
n = number no of slices / number of mice used. 
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To complement the investigations concerning the aspect of age, CaMKIIαCre cDKO mice and 
their littermate controls were treated twice with tamoxifen as described beforehand. In this 
experimental series aged individuals (12-13 months) have been analyzed. Figure 3.5 depicts 
results obtained from these recordings. The TBS application led to a strong LTP induction. 
Compared to adult individuals (Figure 3.4 A and C) the PTP was found not to be as pronounced 
in aged mice (Figure 3.5 A and B). Nevertheless, both genotypes revealed a stable plateau for 
LTP with 142 ± 6.0 % (n = 11 / 4) for littermate controls and 132 ± 4.3 % (n = 16 / 6) in 
CaMKIIαCre cDKO mice which was statistically indistinguishable (p = 0.177, t-test, Figure 3.5 A 
and B). These findings were supported by data obtained from L-LTP measurements (Figure 3.5 C 
and D) which uncovered no significant defect as curves almost overlapped the entire recording 
time (littermate control: 130 ± 2.3 %, n = 7 / 3; CaMKIIαCre cDKO: 135 ± 6.3 %, n = 8 / 5; p = 
0.770, t-test). Postsynaptic functionality was unchanged irrespective of paradigm tested (Figure 
3.5 E and F). In contrast to this, but in line with observations made in adult transgenic mice 
(Figure 3.4 G), short-term plasticity was highly significantly altered again at larger ISI of 160 ms 
(p = 0.003) and additionally at shorter ISI of 40 ms (p = 0.007, t-test, Figure 3.5 G). 
All together the examination of APPflox/floxAPLP2-/- mice crossed to an inducible CaMKIIαCre line 
lead to a mild or not at all affected LTP as well as L-LTP. This suggests that a postnatal knock-out 
of APP on an APLP2 deficient background was not effective enough to cause a pronounced 
defect in potentiation. Aged mice receiving tamoxifen once revealed no significant deficit. This 
was sustained in adult and aged twice tamoxifen treated mice revealing only subtle effects as 
well. Possibly, the knock-out of APP during synaptogenesis might be already too late or too 
inefficient to cause a severe impairment in activity-dependent synaptic plasticity or neuronal 
network formation.  
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Figure 3.5 LTP experiments in aged 2x tamoxifen treated CaMKIIαCre cDKO mice. 
(A+B) Littermate controls (black circles) revealed an average potentiation of 142 ± 6.0 % for the final 5 min of LTP 
recording. These values were statistically indistinguishable to those obtained from CaMKIIαCre cDKO (132 ± 4.3 %, p 
= 0.177, t-test, light grey circles). (C+D) Comparable results were gained for protein synthesis dependent L-LTP. Here 
littermate control mice revealed average potentiation levels for t195-200 min of 130 ± 2.3 % and CaMKIIαCre cDKO 
135 ± 6.3 % (p = 0.770, t-test). (E+F) Input-output strength was unaltered between genotypes. (G) Whereas a highly 
significant defect was observed for CaMKIIαCre cDKO in an ISI of 160 ms (p = 0.003) and 40 ms (p = 0.007, t-test) 
compared to littermate control individuals. Insets show original traces of representative individual experiments. 
Vertical scale bar = 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± SEM. n.s. = not significant. n = number no 
of slices / number of mice used. 
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3.1.3.2 NexCre Conditional Double Knock-out 
Having established that once or twice tamoxifen treated CaMKIIαCre cDKO exhibited only mild 
or no defects at all in activity-dependent synaptic plasticity as well as hippocampus dependent 
learning tasks (Prof. Dr. David Wolfer, University of Zürich, unpublished data) I next assessed 
whether APP might be necessary during prenatal development (e.g. circuit formation or 
neuronal morphology). Therefore, APPflox/floxAPLP2-/- mice were bred with a NexCre-deleter 
strain (Goebbels et al., 2006). Again, this led to an APP ablation exclusively in excitatory 
forebrain neurons on an APLP2 deficient background. In contrast to CaMKIIαCre cDKO this 
occurred already prenatally from E11.5 onwards (for details see 2.1.2). Thus, I wanted to gain 
insight if an early deletion might result in neurodevelopmental defects that would affect 
synaptic plasticity in adult individuals (3-4 months of age). 
Therefore, again the enlargement of fEPSP slope was recorded for either 60 min following TBS in 
order to cover the protein synthesis independent part of LTP (Figure 3.6 A and B) or in case of L-
LTP for 180 min after TBS for analyzing protein synthesis dependent events (Figure 3.6 C and D). 
In both after induction a stable LTP was observed. Nevertheless, a pronounced defect of PTP as 
well as potentiation itself became obvious for NexCre cDKO mice (Figure 3.6 A). The average 
potentiation in slices from littermate controls was 161 ± 6.0 % (n = 31 / 8), whereas NexCre 
cDKOs revealed highly significant reduced levels of 127 ± 2.3 % (n = 26 / 8) for final the 5 min (p 
= 0.00001, t-test, Figure 3.6 B). Also in long-term recordings a decreased potentiation was 
observed, although it was not significant for t195 – 200 min (littermate control: 149 ± 10.6 %, n 
= 5 / 3; NexCre cDKO: 123 ± 8.3 %, n = 7 / 3, p = 0.109, t-test, Figure 3.6 C) but for t20 – 130 min 
(p = 0.011, t-test) probably due to the instable plateau of controls. To investigate if the detected 
LTP deficit was also reflected in disturbed basal synaptic properties, next pre- and postsynaptic 
functionality was explored. Figure 3.6 E and F illustrate that input-output strength was 
unaffected since fEPSP size did not differ significantly between genotypes neither at defined 
stimulus intensities nor at given fiber volley amplitudes. In order to explore if the LTP defect was 
accompanied by alterations in short-term plasticity PPF was analyzed. Indeed, NexCre cDKO 
mice exhibited a highly significant impairment at shorter ISIs of 10 ms (p = 0.004) and 20 ms (p = 
0.007, t-test) compared to littermate control slices (Figure 3.6 G). Altogether these findings 
suggest an essential role of both APP and APLP2 during early development. 
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Figure 3.6 LTP experiments in adult NexCre cDKO mice. 
(A) After TBS (arrow) application littermate controls (black circles) revealed a robust and stable potentiation of 161 
± 6.0 % for the final 5 min of LTP recording (B). In NexCre cDKO mice (blue circles) a highly significant defect in LTP 
induction as well as maintenance compared to controls was discovered (127 ± 2.3 %, p = 0.0001, t-test). (C) NexCre 
cDKO mice showed a deficit in L-LTP induction and maintenance, which was significant only from t20-130 min (p = 
0.01) but not for t195-200 min (p = 0.109, t-test, D). (E+F) Input-output strength was unaltered. (G) PPF tested at 
defined ISIs revealed a pronounced and highly significant defect in short-term plasticity at lower ISIs in NexCre cDKO 
mice compared to the littermate controls (10 ms: p = 0.004, 20 ms: p = 0.007, t-test). Insets show original traces of 
representative individual experiments. Vertical scale bar = 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± 
SEM. n.s. = not significant. n = number no of slices / number of mice used. 
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3.1.3.3 Quantitative Ca2+ Imaging in Primary Hippocampal Dissociated NexCre cDKO Cultures 
The previously investigated electrically evoked LTP is accompanied by a transient increase in 
postsynaptic calcium ions (Ca2+). This process is crucial for the induction of activity-dependent 
synaptic plasticity (Zucker, 1999). When glutamate binds to AMPA receptors (AMPAR) they 
mediate the fast excitatory transmission (see 1.1.2). Together, back propagating action 
potentials and membrane depolarization of the dendritic spines open additionally voltage gated 
Ca2+ channels (VGCCs) which in part mediate the influx of Ca2+. A wide variety of VGCCs are 
classified including high-voltage-activated L-, P/Q, N- and R-type channels and low-voltage-
activated T-type channels. L-type channels were proven to be essential for synaptic plasticity 
since through Ca2+ entry they regulate gene transcription of immediate early genes and mediate 
the activation of CREB via stimulation of CaMKII pathway (Murphy et al., 1991; Wheeler et al., 
2012). Since APP was shown to regulate the Cav1.2 L-type Ca
2+ channel and its functionality in 
GABAergic short-term plasticity I asked whether inhibition of this channel might affect the Ca2+ 
dynamics in NexCre cDKOs (Yang et al., 2009). As a further effect of simultaneous glutamate 
binding and postsynaptic membrane depolarization NMDA receptors (NMDAR) open which 
mediate the main Ca2+ influx into the dendritic spine. Ca2+ influx through NMDAR is required for 
both LTP and LTD (see 1.1.2). In the following experimental series I investigated if a chemically 
induced LTP uncovers a comparable defect as observed in electrophysiological studies of NexCre 
cDKO. The NDMAR can be activated by glycine as this is a co-agonist for glutamate binding. To 
ensure that results obtained from these experiments exclusively based on NMDAR activation, 
additionally always Strychnine was applied to specifically block endogenous glycine receptors. 
When furthermore the NMDAR inhibitor APV was administered the opening of the NMDAR 
upon glycine binding should be abolished. After Ca2+ entered the neuron it triggers subsequent 
Ca2+ release from internal stores of the endoplasmatic reticulum (ER) through IP3R and RyR. 
Reuptake of Ca2+ back into the ER by the sarco-/endoplasmic reticulum ATPase (SERCA) is 
mandatory for propagating future signals. Given that the frequent release of Ca2+ from internal 
stores is crucial to ensure the reaction upon neuronal stimulation and induction of synaptic 
plasticity I also inhibited the reload of Ca2+ into the ER by blocking the SERCA. 
As recording Ca2+ signals is a feasible and widely used method to investigate action potential 
distribution in vitro I as well established this technique (see 2.6) to examine NexCre cDKO and 
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littermate control mice regarding Ca2+ dynamics. Figure 3.7 illustrates how Ca2+ signals for a 
randomly chosen experiment from littermate controls (A, black) and NexCre cDKO (B, blue) look 
like. First, the neurons with clearly apparent somata in the field of view are shown. Ca2+ 
transients were always measured in the soma. The adjacent graphs illustrate example traces 
from a single experiment over time and for each time-point imaged following the scheme 
described in Figure 2.5. Additionally, a heat map generated by a pseudo-line scan (pink bar) 
visualizes the Ca2+ alteration.  
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Figure 3.7 Example traces for cLTP induction by glycine in littermate controls and NexCre cDKO (previous page). 
The scheme illustrates example traces obtained from one littermate control (A, black) and one NexCre cDKOs (B, 
blue) Ca
2+
 imaging experiment. The first image depicts the neurons in the field of view. Following graphs show one 
example trace of the Ca
2+
 signals recorded in the soma, separately for each time-point imaged (t-20, t-10, t0, t10, 
t40). In A and B above those graphs the pseudo-line scan (pink bar) additionally depicts these signals as a heat map 
over time. 
 
Figure 3.8, Figure 3.9 and Figure 3.10 illustrate data obtained from quantitative Ca2+ imaging. On 
the one hand, the amount of intracellular Ca2+ is depicted in nM and on the other hand the 
frequency of Ca2+ spikes / min. Following the experimental design illustrated in Figure 2.5, the 
amount of intracellular Ca2+ or the frequency of spontaneous activity were quantified. This 
includes the analysis of defined time points before (t-20, t-10) and upon (t0, t 10, t40) cLTP 
induction by glycine only, or additional drug application. For each treatment two ways of 
illustration were chosen to facilitate reviewing of the data. The first graph shows the results for 
littermate control (black) and NexCre cDKO (blue) separately. The second graph depicts every 
time-point imaged while comparing both genotypes. 
When the amount of Ca2+ during spontaneous activity without stimulation was quantified, 
littermate controls revealed stable values of 32 ± 3.1 nM for t-20 being significantly different to 
NexCre cDKO with 17 ± 3.2 nM. However, with values of 34 ± 3.8 nM (littermate control) versus 
23 ± 4.4 nM (NexCre cDKO) at t-10 (Figure 3.8 B) only a trend towards reduced Ca2+ responses 
was found. These results suggest that in NexCre cDKO already the Ca2+ signals before chemically 
induced LTP was lower than in controls. Upon glycine stimulation in both littermate controls as 
well as NexCre cDKO an increase of intracellular Ca2+ could be observed, although to a lesser 
and more instable extend in cDKOs. While in littermate controls t0 and t10 revealed comparable 
values of 80 ± 6.7 nM and 87 ± 10.0 nM, t40 showed a drop of intracellular Ca2+ amount to 53 ± 
4.2 nM Ca2+ (Figure 3.8 A). When separately analyzing imaging time-points of t0 and t10 
between genotypes for NexCre cDKO a significant defect was observed with values of 54 ± 6.7 
nM (t0) and 39 ± 4.5 nM (t10). The same trend became visible for t40, although it was not 
significant (Figure 3.8 B). Nevertheless, when the normalized amplitude of both genotypes was 
analyzed in relation to the Ca2+ concentration of spontaneous activity before cLTP induction, it 
became clear that the relative change in intracellular Ca2+ was almost the same independent of 
genotype (Figure 3.9 A). 
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Inhibiting the NMDAR by APV prevented induction of LTP in both genotypes reflected by 
preserved resting Ca2+ levels (Figure 3.8 C). When those levels were compared at all time-points 
again the significantly less spontaneous activity at t-20 in NexCre cDKOs occured (littermate 
controls: 37 ± 4.1 nM vs. NexCre cDKO: 21 ± 3.9 nM). Additionally, a significant difference was 
found for t10 as well (littermate controls: 42 ± 3.9 nM vs. NexCre cDKO: 23 ± 4.7 nM, Figure 3.8 
D). Still, when the amplitude was normalized to Ca2+ signals before cLTP induction no significant 
difference was found between genotypes (Figure 3.9 B). These observations indicate that the 
Ca2+ influx through the NMDAR is crucial for stimulating the rise of intracellular Ca2+ amongst 
others also the release from ER and thus triggering further synaptic plasticity related processes. 
Following, I investigated if blocking the reuptake of Ca2+ via SERCA back into the ER by a co-
application of CPA might influence the effect of glycine administration. Analysis revealed that in 
littermate controls the significant increase of Ca2+ upon stimulation seen in Figure 3.8 A was 
abolished although a tendency towards a rise was still obvious (Figure 3.8 E). Strikingly, the 
treatment of NexCre cDKO exhibited a highly significant increase in the cytoplasmatic Ca2+ 
amount of 80 ± 7.9 nM for t0 and 58 ± 8.2 nM for t10 following CPA application compared to the 
unstimulated state (Figure 3.8 E). The t0 value was surprisingly even higher than the one 
reached at the same time-point for solely glycine administration (Figure 3.8 A). Furthermore, 
CPA treated NexCre cDKO reached values of only glycine treated littermate controls at t0, 
indicating that the ER itself might be affected. These observations were even further supported 
when the values upon co-application of glycine and CPA were normalized to the unstimulated 
spontaneous activity of both genotypes exhibiting a significant defect (Figure 3.9 C). At later 
time-points in NexCre cDKOs the blockade of SERCA prevented the transport of Ca2+ back into 
the ER which is reflected by apparently decreasing values of 58 ± 8.2 nM for t10 and 35 ± 5.8 nM 
for t40. No stable increase of Ca2+ signals upon co-application of glycine and CPA was possible in 
NexCre cDKOs (Figure 3.8 E and D).  
Next, both genotypes were investigated regarding the potential contribution of voltage gated L-
type Ca2+ channels to the rise of intracellular Ca2+ concentration when, additionally to glycine, 
the selective L-type VGCC inhibitor Nifedipine was applied. It became clear that Nifedipine 
treatment prevented a significant increase of Ca2+ in littermate controls as well as in NexCre 
cDKOs upon cLTP induction (Figure 3.8 G and H). Still, a trend towards an increase upon glycine 
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and Nifedipine application was observable in the illustration of absolute (Figure 3.8 G and H) as 
well as relative (Figure 3.9 D) values for the Ca2+ amount which might be explained by the Ca2+ 
influx through the NMDAR. However, this was not strong enough to induce a significant 
elevation of intracellular Ca2+. These results suggest a partial contribution of voltage gated L-
type Ca2+ channels to the rise of intracellular Ca2+ upon cLTP induction in addition to the 
activation of NMDAR (Moosmang et al., 2005).  
 
R e s u l t s  |  7 9  
 
 
Figure 3.8 Quantitative Ca
2+
 imaging in NexCre cDKO revealed a severe defect in Ca
2+
 amount before and upon 
stimulation (continued from previous page). 
Imaging time-points t-20 and t-10 reflect the resting Ca
2+
 concentration. Whereas t0, t10 and t40 depict the 
quantification the Ca
2+
 amount upon glycine stimulation only or additional drug application. At the x-axis all time-
points imaged are plotted in minutes. (A) Upon glycine (Gly) application a strong and partially highly significant 
increase of cytoplasmatic Ca
2+
 concentration was observed in both genotypes. However, NexCre cDKO cultures 
(blue) exhibited minor values compared to littermate controls (black). (B) These differences became even more 
obvious when both genotypes were plotted for each imaging time-point. Here, already at basal Ca
2+
 levels a 
significant defect in NexCre cDKOs was observed at t-20 which was not as pronounced for t-10 but still found by 
trend. Furthermore, this deficit was sustained upon glycine administration at t0 and t10. Again, only a tendency was 
found at t40. (C) A co-application of glycine and APV (NMDAR inhibitor) prevented Ca
2+
 increase in both genotypes. 
(D) Again, partially significant lower resting Ca
2+
 concentration was observed in NexCre cDKO. (E) An application of 
CPA (SERCA inhibitor, no reuptake of Ca
2+
 into the ER) together with glycine prevented a significant increase of Ca
2+
 
in littermate controls while still a significant defect was observable in NexCre cDKOs. Strikingly, the values for t0 
reached even higher Ca
2+
 levels upon stimulation with both glycine and CPA than solely glycine. (F) However, this 
high mount of Ca
2+
 concentration was not stable and decreased continuously when t10 and t40 were investigated. 
(G+H) A co-treatment with glycine and Nifedipine (voltage gated L-type Ca
2+
 channel blocker, Nif) prohibited a 
significant rise of cytoplasmatic Ca
2+
 amount compared to resting Ca
2+
 levels in both littermate control and NexCre 
cDKO cultures. Significances were plotted as *p < 0.05, **p < 0.01 and ***p < 0.001. Error bars indicate ± SEM. n = 
number of experiments. Str = strychnine. 
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Figure 3.9 Relative Ca
2+
 concentration uncovered a significant increase in NexCre cDKO upon glycine and CPA co-
administration. 
Bar graphs depict Ca
2+
 amount normalized onto resting Ca
2+
 concentration (averaged t-20 and t-10) upon glycine 
solely or additional drug administration. (A) Chemically induced LTP by glycine (Gly) application led to comparable 
values reached for the amount of Ca
2+
 and was thus statistically indistinguishable for NexCre cDKO (blue) and 
littermate control (black). (B) Co-treatment with APV prevented rise of Ca
2+
 concentration in both genotypes to the 
same extend. (C) Remarkably, the co-administration of glycine and CPA led to a pronounced and significant increase 
of Ca
2+
 in NexCre cDKO cultures compared to littermate controls at t0 (p = 0.034, t-test). The normalized 
visualization highlights this more clearly than absolute values in Figure 3.8 C. However, at t10 and t40 the values 
were not significant any longer. (D) Nifedipine (Nif) treatment resulted in similar Ca
2+
 concentrations for both 
genotypes. Significances were plotted as *p < 0.05, **p < 0.01 and ***p < 0.001. Error bars indicate ± SEM. n = 
number of experiments. Str = strychnine. 
 
In addition to the quantification of intracellular Ca2+ amounts onto stimulation and inhibitor 
application, this method also enables the experimenter to investigate the frequency of 
occurring Ca2+ events. These are highly variable since the imaging time window chosen might 
sometimes cover a very active phase whereas other neurons are less active. Nevertheless, still 
convincing conclusions can be drawn from these results. 
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Comparably to the depiction of Ca2+ amounts, again first all time-points for every single 
genotype were shown, whereas the second graph illustrates a direct comparison of each time-
point between the genotypes. The application of glycine revealed a significant decrease of 5 ± 
1.1 spikes / min at t-20 and 6 ± 1.1 spikes / min at t-10 to 3 ± 0.9 spikes / min at t0, 3 ± 0.6 
spikes / min at t10 and 3 ± 0.7 spikes / min at t40 in littermate controls. This effect was not 
observed in NexCre cDKO (Figure 3.10 A) suggesting that a defect in network activity or a 
decreased number of synaptic contacts might lead to less network synchronization in the 
cultures. Nevertheless, the values obtained for each imaging time-point per genotype were 
comparable and thus statistically indistinguishable (Figure 3.10 B).  
APV treatment prevented the decrease of spikes / min upon additional glycine application thus 
reflecting again that not only the amount of cytoplasmatic Ca2+ but also the frequency is 
partially regulated by the NMDAR. Surprisingly, in NexCre cDKOs the values for t-10 and t0 were 
significantly different. This might be reasoned in a relatively high value of 7 ± 1.1 spikes / min at 
t-10 under unstimulated conditions in APV and glycine treatment experiments which was lower 
with 6 ± 1.1 spikes / min at the t-10 in solely glycine treatment experiments (Figure 3.10 A and 
C). Nevertheless, this effect was only minor and all other parameters did not reveal a significant 
defect in NexCre cDKOs (Figure 3.10 C and D).  
The application of CPA resulted in no significant decrease in the frequency upon co-treatment 
with glycine in both genotypes irrespective if separately littermate controls and NexCre cDKOs 
(Figure 3.10 E) or imaging time-points were analyzed (Figure 3.10 F). However, while in 
littermate control cultures the frequency was stable for t0, t10 and t40 upon chemically induced 
LTP the frequency of Ca2+ events in NexCre cDKOs cultures increased constantly for each of the 
three time points imaged.  
Treating the dissociated hippocampal neurons of littermate controls and NexCre cDKOs with 
Nifedipine resulted in a significant decrease of 6 ± 1.4 spikes / min at t-20 compared to t40 with 
2.5 ± 0.5 spikes / min in littermate controls while the cDKO was statistically indistinguishable 
(Figure 3.10 G). The results suggest that this difference based on a relatively high value of 6 ± 
1.4 spikes / min a t-20 whilst t-10 displayed only values of 4 ± 1.2 spikes / min. Overall, these 
results revealed a pronounced variability, indicated by a high SEM which additionally led to no 
significance when analyzing the time-points (Figure 3.10 H).  
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Taken together, in line with observation made using electrophysiological techniques 
quantitative Ca2+ imaging uncovered a defect in spontaneous Ca2+ events under unstimulated 
conditions as well as a significantly decreased Ca2+ response when activity-dependent synaptic 
plasticity was induced by glycine application. Mechanistically, this could be due to a more 
efficient reuptake of Ca2+ into the ER or an alteration in Ca2+ buffer proteins like calbindin, 
calretinin, parvalbumin and calmodulin whereby the excess of unbound Ca2+ might be 
transported into the ER. 
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Figure 3.10 Quantitative Ca
2+
 imaging in NexCre cDKO revealed a defect in frequency of spikes upon stimulation 
(continued from previous page). 
Imaging time-points t-20 and t-10 reflect the frequency in number of spikes / min at resting Ca
2+
 concentration. t0, 
t10 and t40 depict the quantification of spikes / min upon glycine stimulation only or additional drug administration. 
At the x-axis all time-points imaged are plotted in minutes. (A) Onto glycine (Gly) stimulation in littermate control 
cultures (black) the frequency of Ca
2+
 events significantly decreased while NexCre cDKOs (blue) were statistically 
indistinguishable. (B) In contrast, the comparison of both genotypes at each single imaging time-point was 
unaltered. (C) Application of APV abolished the frequency reduction in littermate controls. However, here NexCre 
cDKO cultures revealed a significant decrease of spikes / min before and directly after glycine and APV treatment. 
(D) At defined time-points genotypes were statistically indistinguishable. (E+F) Although in both genotypes a trend 
towards a lower frequency upon glycine and CPA administration was observable this was neither significant for only 
genotypes plotted nor at defined imaging time-points. (G) Glycine and Nifedipine (Nif) treatment reduced the 
frequency to significant extend in littermate control when t-20 was compared to t40. All other values were not 
significant to each other. NexCre cDKO was unaltered as well. (H) Comparing single imaging time-points exhibited 
again no significant difference. Significances were plotted as *p < 0.05, **p < 0.01 and ***p < 0.001. Error bars 
indicate ± SEM. n = number of experiments. Str = strychnine. 
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3.1.3.4 Gain of Function and Rescue Experiments in the NexCre cDKO: ex vivo Application of 
recAPPsα and recAPPsβ 
Besides the role of APP and its homologue APLP2 in embryonic development I was also 
interested in the physiological and acute function of proteolytic fragments, deriving from full 
length APP processing, which may for instance modulate dynamic properties of synapses. I 
therefore focused on APPsα which is generated by α-secretase ADAM10 cleavage of full length 
APP and released into the extracellular space upon neuronal activity (Gakhar-Koppole et al., 
2008; Hoey et al., 2009) see 1.3.1). Although the precise function of APPsα has not been 
clarified and its receptor is not identified to date, several studies showed beneficial properties 
for instance in processes related to learning and memory (Ishida et al., 1997; Meziane et al., 
1998; Ring et al., 2007; Taylor et al., 2008; Weyer et al., 2011). This brought me to design an 
experimental setting in which it was possible to investigate the effects of an ex vivo application 
of recombinant APPsα or recAPPsβ on activity-dependent synaptic plasticity (see 2.4.5). I asked 
if low amounts of recAPPsα might be sufficient to restore the LTP defect observed in NexCre 
cDKOs (Figure 3.6 and Figure 3.11) or even increase the LTP in littermate controls in which still 
endogenous APPsα could be generated (Figure 3.17). Furthermore, I performed complementary 
experiments with recAPPsβ (Figure 3.16). In order to test these suggestions slices from NexCre 
cDKOs were pre-incubated 1 h and also during the entire recordings with the respective peptide 
or boiled control (for details see 2.4.5).  
In line with my hypothesis the exogenous application of recAPPsα was sufficient to restore the 
deficits in PTP and LTP observed in naïve NexCre cDKO slices back to potentiation levels of naïve 
littermate controls (Figure 3.6 A and B compare to Figure 3.11 A and B). Thus an average 
potentiation of 143 ± 5.1 % (n = 12 / 8) for t75-80 min was reached, whereas NexCre cDKO 
treated with the boiled recAPPsα peptide revealed only 130 ± 2.3 % (n = 14 / 8, p = 0.029, t-test, 
Figure 3.11 B). These values were comparable to those obtained from untreated NexCre cDKO 
beforehand (Figure 3.6 A and B). The analysis of the input-output strength discovered that 
recAPPsα had not significant effect on fEPSP slope size when analyzed at defined stimulus 
intensities (Figure 3.11 C) being consistent with what was observed in naïve NexCre cDKO slices 
(Figure 3.6 E). However, the correlation of fEPSP slope size to given fiber volley amplitudes 
uncovered significant differences comparing the boiled-control to recAPPsα treated NexCre 
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cDKO for amplitudes of 0.2 mV (p = 0.001) and 0.3 mV (p = 0.019, t-test, Figure 3.11 D). These 
findings may suggest an additional effect of recAPPsα on postsynaptic compartment. Strikingly 
and in line with our hypothesis as well as results for rescued LTP upon recAPPsα treatment, the 
short-term plasticity was now not any longer significantly changed. The application of the intact 
peptide led to comparable values found in naïve littermate controls for the PPF paradigm. 
However, the boiled control should display a PPF comparable to naïve NexCre cDKO but that 
was not evident here (Figure 3.6 G). These observations support the idea that APPsα most likely 
functions as a mediator of activity dependent synaptic plasticity in the adult CNS. 
 
Figure 3.11 Acute application of recAPPsα rescues the LTP defect observed in NexCre cDKOs. 
(A+B) Exogenous recAPPsα application 1 h before and during entire recording resulted in a significant rescue (mean 
t75-80 min: 143 ± 5.1 %, green diamonds) of PTP as well as LTP defect observed in NexCre cDKO slices treated with 
boiled recAPPsα (mean t75-80 min: 130 ± 2.3 %, black diamonds, p = 0.029, t-test). (C) recAPPsα treated NexCre 
cDKO slices revealed a slightly, but not significantly decreased input-output strength. (D) Nevertheless, correlation 
fEPSP slope size to given fiber volley amplitudes showed a significant defect for 0.2 mV (p = 0.001) and 0.3 mV (p = 
0.019, t-test). (E) Presynaptic functionality was found to be unaffected indicating a potential rescue for recAPPsα 
treated slices to naive littermate control levels (see Figure 3.6 G). Insets show original traces of representative 
individual experiments. Vertical scale bar = 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± SEM. n.s. = not 
significant. n = number no of slices / number of mice used. 
8 6  |  R e s u l t s  
 
3.1.3.5 Gain of Function and Rescue Experiments in the NexCre cDKO for Quantitative Ca2+ 
Imaging: Adeno-associated Virus Expression of APPsα 
Based on these results which proved the beneficial function of APPsα for activity-dependent 
synaptic plasticity this raised the question whether the introduction of an APPsα containing 
vector by AAV might have comparable effects on the Ca2+ dynamics. Therefore, NexCre cDKO 
dissociated hippocampal cultures were incubated for 6 days with an AAV comprising a vector in 
which under the synapsin promoter either only the yellow fluorescent venus protein or 
additionally APPsα was encoded (for details see 2.6.3.2). Subsequent quantitative Ca2+ imaging 
was performed according to the protocol described and used before when solely glycine and 
strychnine were applied. Results for the amount of Ca2+ are depicted in Figure 3.12 and Figure 
3.13 whereas Figure 3.14 and Figure 3.15 illustrate the frequency of Ca2+ events.  
Consistent with my hypothesis again APPsα expression in cultures of NexCre cDKOs led to a 
robust and significant increase of cytoplasmatic Ca2+ when glycine was applied (Figure 3.12 A). 
Such a strong rise could not be observed in NexCre cDKO cultures expressing only venus thus 
reflecting the phenotype of NexCre observed in Figure 3.8 A and B. Analysis of the Ca2+ amount 
at defined time-points exhibited a slight increase already at resting Ca2+ concentration and a 
highly significant increase of Ca2+ amount upon glycine stimulation for t0 (48 ± 6.0 nM versus 73 
± 5.4 nM) and t40 (37 ±4.1 nM versus 55 ± 3.9 nM) while t10 (53 ± 6.0 nM versus 63 ± 5.2 nM) 
only showed a tendency (Figure 3.12 B).  
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Figure 3.12 APPsα expression in NexCre cDKO cultures restored the defect in Ca
2+
 amount compared to those 
receiving the control vector (previous page). 
Imaging time-points t-20 and t-10 reflect the resting Ca
2+
 concentration. Whereas t0, t10 and t40 depict the 
quantification the Ca
2+
 amount upon glycine stimulation. At the x-axis all time-points imaged are plotted in minutes. 
NexCre cDKO cultures were treated for 6 consecutive days with either AAV expressing venus only (light green, 
control) or additionally APPsα (dark green). (A) Upon glycine (Gly) stimulation an in part highly significant increase 
of cytoplasmatic Ca
2+
 was observed for NexCre cDKOs expressing APPsα or control vector in relation to resting Ca
2+
 
amount. Due to an increase of basal Ca
2+
 levels for t-10 in both this significance was lower or even abolished. (B) 
The rescue effect of APPsα became even clearer when the results for the Ca
2+
 levels were depicted for each time 
point separately. The obtained values uncovered a highly significant defect at t0 and t40 while t10 only showed a 
tendency towards that direction. Significances were plotted as *p < 0.05, **p < 0.01 and ***p < 0.001. Error bars 
indicate ± SEM. n = number of experiments. Str = strychnine. 
 
When plotting the data obtained from quantitative Ca2+ imaging of littermate controls (pooled 
with littermate controls expressing control construct as data was statistically indistinguishable), 
NexCre cDKO (pooled with NexCre cDKO expressing control construct as data was statistically 
indistinguishable) and NexCre cDKO expressing APPsα the previously described rescue effect 
became even more prominent (Figure 3.13). When analyzing the data regarding results of each 
genotype separately it turned out that the expression of APPsα was able to restore the Ca2+ 
amount before and upon stimulation by glycine to levels comparable to the littermate control 
(Figure 3.13 A). These findings became even more obvious when the illustration for each time-
point imaged was chosen. At t-20 the NexCre cDKO revealed a resting Ca2+ concentration of 20 ± 
2.3 nM whereas both littermate controls and NexCre cDKO expressing APPsα exhibited 
comparable values of 31 ± 2.8 nM and 32 ± 4.3 nM. This difference was significant and reflected 
the ability of solely APPsα to restore already the defect of lower basal Ca2+ amount observed 
before back to control levels (Figure 3.13 B). However, this pronounced effect could not be 
observed when the resting Ca2+ concentration was estimated 10 min later. But still a tendency 
towards this effect was found with 28 ± 3.6 nM for NexCre cDKO, 34 ± 3.3 nM for littermate 
controls and 39 ± 5.4 nM for NexCre cDKO expressing APPsα. Furthermore, when the cells were 
stimulated with glycine this resulted in a strong increase in the amplitude of the Ca2+ signal in 
littermate controls (76 ± 6.3 nM) and APPsα expressing NexCre cDKOs (73 ± 5.4 nM) while 
NexCre cDKO revealed significantly decreased levels of 51 ± 4.5 nM. These findings were 
supported as well by analyzing t10. There the NexCre cDKO exhibited a highly significant defect 
compared to littermate controls with values of 45 ± 3.8 nM versus 81 ± 9.0 nM. However, for 
this imaging time-point the expression of APPsα was not sufficient to restore the Ca2+ back to 
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control levels with reached 63 ± 5.2 nM. Nevertheless, for t40 again a full rescue of 
cytoplasmatic Ca2+ to values of littermate control (52 ± 4.1 nM) was achieved for NexCre cDKO 
expressing APPsα (55 ± 3.9 nM). This effect was highly significant compared to NexCre cDKO 
which reached values of only 36 ± 2.8 nM (Figure 3.13 B).  
 
Figure 3.13 Comparative overview of results obtained for the Ca
2+
 amount from littermate controls, NexCre cDKO 
with and without APPsα expression. 
Imaging time-points t-20 and t-10 reflect the resting Ca
2+
 concentration. Whereas t0, t10 and t40 depict the 
quantification the Ca
2+
 amount upon glycine stimulation. At the x-axis all time-points imaged are plotted in minutes. 
NexCre cDKO cultures were treated for 6 consecutive days with AAV expressing venus and APPsα. Since littermate 
controls treated with AAV expressing only venus were statistically indistinguishable to littermate controls without 
AAV application data were pooled. The same procedure was applied for NexCre cDKO expressing the control 
construct and naïve NexCre cDKOs. (A) Glycine (Gly) application induced in all groups an increase of intracellular 
Ca
2+
 amounts. The comparison of littermate controls (black) and NexCre cDKO expressing APPsα (dark green) 
revealed comparable levels which were found to be lower in naïve NexCre cDKO (blue). (B) A direct evaluation at 
defined imaging time-points clearly indicated a rescue effect of resting Ca
2+
 amount, when APPsα was expressed, 
back to littermate control levels at t-20. However this was only observed by trend at t-10. Upon glycine application 
this pronounced and significant re-storage effect was found for t0 and t40 while t10 again exhibited only a tendency 
for a recue by APPsα expression. Significances were plotted as *p < 0.05, **p < 0.01 and ***p < 0.001. Error bars 
indicate ± SEM. n = number of experiments. Str = strychnine. 
 
Following the same approach, again the frequency was analyzed for NexCre cDKO expressing 
venus alone or additionally APPsα (Figure 3.14). Interestingly, cultures from NexCre cDKOs 
expressing APPsα revealed a stable frequency for resting Ca2+ events of 7 ± 1.5 spikes / min for 
both t-20 and t-10 which significantly decreased to 3 ± 0.6 spikes / min for t0, 4 ± 1.0 spikes / 
min for t10 and 4 ± 0.6 spikes / min for t40 upon glycine treatment. This observation was not 
made for NexCre cDKOs expressing solely the control construct. There only t-20 exhibited a high 
frequency of 8 ± 2.0 spikes / min while at t-10 only 4 ± 1.3 spikes / min occurred. These values 
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were significantly different. When glycine was applied the strong and significant decrease was 
not observed in NexCre cDKO cultures (Figure 3.14 A). This further supports the predicted 
defect in Ca2+ dynamics in NexCre cDKO. Anyhow, when the imaging time-points were 
compared separately, only t0 was highly significant impaired between both NexCre cDKO 
expressing APPsα or only venus (Figure 3.14 B) suggesting a pronounced impaired reaction upon 
stimulation.  
 
Figure 3.14 APPsα expression in NexCre cDKO cultures restored the defect in the frequency of Ca
2+
 spikes 
compared to those receiving the control vector. 
Imaging time-points t-20 and t-10 reflect the frequency in number of spikes / min at resting Ca
2+
 concentration. t0, 
t10 and t40 depict the quantification of spikes / min upon glycine. At the x-axis all time-points imaged are plotted in 
minutes. NexCre cDKO cultures were treated for 6 consecutive days with AAV either expressing venus only (light 
green) or additionally APPsα (dark green). (A) Upon glycine (Gly) stimulation NexCre cDKO expressing APPsα 
exhibited a significant decrease of Ca
2+
 spikes / min while this was not observed in such a strong extent in the 
controls. (B) Plotting the imaging time-points separately only t0 revealed a significant difference between groups. 
Significances were plotted as *p < 0.05, **p < 0.01 and ***p < 0.001. Error bars indicate ± SEM. n = number of 
experiments. Str = strychnine. 
 
Next, the data gained from quantitative Ca2+ imaging of littermate controls (pooled with 
littermate controls expressing control construct as data was statistically indistinguishable), 
NexCre cDKO (pooled with NexCre cDKO expressing control construct as data was statistically 
indistinguishable) and NexCre cDKO expressing APPsα the previously described effect became 
even more obvious (Figure 3.15). Comparably to observations made for the increase of 
cytoplasmatic Ca2+ concentration again an expression of APPsα in NexCre cDKO restored the 
frequency back to littermate control frequency when glycine was applied. This was indicated by 
a significant decrease of spikes / min while this was not observed in NexCre cDKOs (Figure 3.15 
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A). Still, values plotted for each imaging time-point were statistically indistinguishable (Figure 
3.15 B). Results presented for the frequency are difficult to interpret due to high variability.  
 
Figure 3.15 Comparative overview of results obtained for the frequency of Ca
2+
 events from littermate controls, 
NexCre cDKO with and without APPsα expression. 
Imaging time-points t-20 and t-10 reflect the frequency in number of spikes / min at resting Ca
2+
 concentration. t0, 
t10 and t40 depict the quantification of spikes / min upon glycine stimulation. At the x-axis all time-points imaged 
are plotted in minutes. NexCre cDKO cultures were treated for 6 consecutive days with AAV expressing venus and 
APPsα. Since littermate controls treated with AAV expressing only venus were statistically indistinguishable to 
littermate controls without AAV application data were pooled. The same procedure was applied for NexCre cDKOs 
expressing the control construct and naïve NexCre cDKOs. (A) In line with observations made for the Ca
2+
 amount 
again the expression of APPsα in NexCre cDKOs (dark green) rescued the frequency defect of naïve NexCre cDKOs 
(blue) back to littermate control levels (black). Upon glycine (Gly) stimulation a partially significant decrease of Ca
2+
 
spikes / min was observed for littermate controls and NexCre cDKOs expressing APPsα but not for naïve NexCre 
cDKO cultures. Significances were plotted as *p < 0.05, **p < 0.01 and ***p < 0.001. Error bars indicate ± SEM. n = 
number of experiments. Str = strychnine. 
 
3.1.3.6 Gain of Function and Rescue Experiments in the NexCre cDKO: ex vivo Application of 
recAPPsβ 
In the amyloidogenic way of APP processing endogenous APPsβ is formed upon β-secretase 
BACE1 activity and again, like APPsα, secreted extracellular (see 1.3.1). Since APPsβ is slightly 
shorter and was so far not implicated to be crucial for synaptic plasticity I additionally examined 
its ability to rescue the NexCre cDKO LTP defect. Therefore, again electrophysiological 
recordings were applied. Interestingly, LTP induction as well as maintenance was still affected 
upon recAPPsβ application (Figure 3.16 A). The average potentiation for the final 5 min of LTP 
recording was statistically indistinguishable irrespective of whether native (126 ± 4.5 %) or 
boiled recAPPsβ peptide (119 ± 3.9 %, p = 0.281, t-test) was applied to NexCre cDKO slices 
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(Figure 3.16 B). In contrast to recAPPsα treatment no postsynaptic alterations were found in 
boiled and native recAPPsβ treated NexCre cDKOs slices as indicated by overlapping curves 
(Figure 3.16 C and D). Comparable to recAPPsα also native recAPPsβ seemed to restore the PPF 
defect of naïve NexCre cDKO slices although the difference between application of boiled 
(which should reflect the naïve NexCre cDKO state) and native recAPPsβ was not significant at 
any ISI tested. These findings suggest that APPsβ, possibly due to the lack of 17 amino acids 
compared to APPsα, was no longer sufficient to promote activity-dependent synaptic plasticity 
even though it was applied at 5 times higher concentration as recAPPsα.  
 
Figure 3.16 Acute application of recAPPsβ is not sufficient to rescue the LTP defect observed in NexCre cDKOs. 
(A+B) After 20 min of stable baseline recording, while recAPPsβ was present, LTP was induced by TBS (arrow) 
revealing no significant difference between boiled (119 ± 3.9 %, black diamonds) and native (126 ± 4.5 %, orange 
diamonds, p = 0.281, t-test) peptide treated NexCre cDKO slices. These potentiation levels were comparable to those 
obtained from naïve NexCre cDKOs slices (see Figure 3.6 A and B). Neither input-output strength measured at 
defined stimulus intensities (C) nor given fiber volley amplitudes (D) nor presynaptic functions (E) were changed 
upon treatment with recAPPsβ or boiled control. Insets show original traces of representative individual 
experiments. Vertical scale bar = 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± SEM. n.s. = not significant. 
n = number no of slices / number of mice used. 
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3.1.3.7 Gain of Function Experiments in Littermate Controls: ex vivo Application of recAPPsα 
Having established the beneficial effects of recAPPsα I next investigated if an exogenous 
application of recAPPsα additionally to endogenous upon TBS released APPsα, shown by Nitsch 
and colleagues might potentiate the LTP even further (Nitsch et al., 1992). Therefore, littermate 
control mice which still express APP on an APLP2 deficient background were analyzed. Indeed, 
slices treated with recAPPsα revealed a much stronger and significantly increased posttetanic 
potentiation following TBS (t20-43 min: p = 0.023, t-test) compared to the boiled peptide 
treated control group (Figure 3.17 A). Nevertheless, the final 5 min of LTP recording were not 
statistically different although the trend for an increased LTP was still preserved (p = 0.441, t-
test, Figure 3.17 B). Remarkably, the slices treated with recAPPsα showed a prolonged induction 
phase since the formation of a stable plateau took longer than in slices receiving the boiled 
recAPPsα (Figure 3.17 A). These findings point towards its essential role during induction and 
early phase of LTP which was also shown by (Taylor et al., 2008). Results from basal synaptic 
transmission studies revealed an enlarged fEPSP slope size at set stimulus intensities (Figure 
3.17 C). This trend became significant at defined fiber volley amplitudes (0.2 mV: p = 0.026, 0.5 
mV: p = 0.049, t-test, Figure 3.17 D). Strikingly, short-term plasticity and thus presynaptic 
function were enhanced by recAPPsα application as well. This was indicated by a larger ratio of 
slope 2 / slope 1 at smaller ISIs even though this trend was not significant (Figure 3.17 E). All in 
all these findings encourage predicted beneficial characteristics of APPsα. Although this data 
indicate a potentiating effect of APPsα it was shown that high amounts of APPsα (3.3 µM) act 
contrariwise in decreasing synaptic efficacy suggesting dose-dependent relations (Taylor et al., 
2008). 
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Figure 3.17 Acute application of recAPPsα enhanced LTP in littermate control slices. 
(A) LTP induction via TBS (arrow) induced a very robust and significantly stronger PTP in littermate controls upon 
recAPPsα treatment (t20-43 min: p = 0.023, t-test, pink diamonds). Remarkably, plateau formation needed much 
longer compared to littermate slices treated with boiled recAPPsα (black diamonds). Finally, the average 
potentiation of t75-80 min was still higher, although not significant, in native peptide treated NexCre cDKO slice 
(147 ± 10.9 %) than in the control condition (136 ± 7.2 %, p = 0.441, t-test, B). (C) Slices from littermate controls 
treated with recAPPsα exhibited a more pronounced and partially significant input-output strength (0.2 mV: p = 
0.026, 0.5 mV: p = 0.049, t-test, D). (E) The presynaptic compartment was as well positively influenced since ratio 
values tended to be larger upon native peptide application. Insets show original traces of representative individual 
experiments. Vertical scale bar = 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± SEM. n.s. = not significant. 
n = number no of slices / number of mice used. 
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Figure 3.18 summarizes all genotypes, treatments, age relations and results obtained from all 
electrophysiological experiments in this study. 
 
 
Figure 3.18 Overview about results obtained from APP
flox/flox
APLP2
-/-
 crossed to excitatory Cre-deleter lines. 
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3.2 The Role of the APP Protein Family for Synaptic Plasticity in Inhibitory 
Interneurons 
The analysis of NexCre cDKO provided emerging evidence that APP and APLP2 are needed 
during processes of embryonic brain development and acutely at active synapses of excitatory 
neurons. Even though the hippocampus is built up of ~95 % excitatory neurons it is mandatory 
to take also the role of APP and APLP2 in inhibitory neurons into account. Previous 
investigations evidenced that inhibitory input contributes to the phenotype as well. In APPsα-
DM mice an application of GABAA receptor inhibitor picrotoxin 10 min before TBS and during 
the entire recording restored the LTP defect, observed before, back to littermate control levels 
(Weyer et al., 2011). Moreover, the constitutive APP-KO revealed a paired pulse depression of 
GABA mediated inhibitory postsynaptic currents and a high susceptibility for kainate-induced 
seizures which was again rescued by Picrotoxin (Steinbach et al., 1998; Seabrook et al., 1999; 
Fitzjohn et al., 2000). It might be reasonable that the excitation-inhibition balance (E-I balance) 
is affected when both proteins are knocked out in one neuronal subtype. E-I balance is known to 
be a form of homeostatic plasticity necessary to maintain and regulate activity in a neuronal 
circuitry. Since this balance is usually established during brain development it might be 
conceivable that the cDKO of both proteins in either excitatory or inhibitory neurons disrupts 
this balance. This led me to investigate transgenic mice being deficient of both APP and APLP2 
or lacking solely APP in inhibitory neurons.  
 
3.2.1 Conditional APP Knock-out on an APLP2 Expressing Background 
This experimental series was designed to uncover potential age-dependent effects. This idea 
based on findings that constitutive APP-KO mice showed no overt LTP defect at 3-4 months but 
surprisingly at 12-13 months of age (Dawson et al., 1999; Seabrook et al., 1999). This defect was 
rescued by the constitutive expression of the neurotrophic APPsα fragment (Ring et al., 2007). 
This fragment was additionally shown to have different effects on synaptic protein synthesis at 
different months of age. It was evidenced that 3-4 months old rats revealed a significantly 
stronger APPsα-stimulated up-regulation of synaptic protein synthesis compared to 20-22 
months individuals. This age-related effect was not found in rats treated with APPsβ (Claasen et 
al., 2009). Nevertheless, it should be taken into account that in constitutive APP-KO and in 
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APPsα-KI mice still APLP2 was expressed. It has been shown that APLP2 is highly homological to 
APP and processed similarly although it lacks the Aβ domain (Walsh et al., 2007). Thus it might 
be feasible that APP and APLP2 share partially redundant functions for mechanisms of synaptic 
plasticity. This is supported by the observation that if APPsα is expressed solely on an APLP2 
deficient background (APPsα-DM) the LTP defect is then already seen in adult mice (Weyer et 
al., 2011). Predicted compensatory function of APLP2 were strengthened by morphological 
alterations found in OHC cultures of constitutive APP / APLP2 DKO but not in APLP2-KO mice 
(Weyer et al., 2014). 
 
3.2.1.1 DlxCre Conditional Knock-out 
According to the hypothesis proposed before adult 3-4 months old DlxCre cKO mice exhibited 
no gross alterations in activity-dependent synaptic plasticity depicted in Figure 3.19. Both 
genotypes revealed an overall and statistically indistinguishable increase in synaptic strength for 
LTP (littermate control: 139 ± 4.8 %, n = 18 / 6, DlxCre cKO: 135 ± 4.2 %, n = 16 / 5, p = 0.568, t-
test, Figure 3.19 A and B) and L-LTP (littermate control: 138 ± 5.8 %, n = 7 / 6, DlxCre cKO: 137 ± 
11.3 %, n = 8 / 5, p = 0.953, t-test, Figure 3.19 C and D). Consistently, the input-output strength 
was unaffected likewise when the fEPSP slope size was correlated to defined stimulus intensities 
(Figure 3.19 E) or fiber volley amplitudes (Figure 3.19 F). Although the analysis of short-term 
plasticity by the PPF paradigm was not significantly compromised, adult DlxCre cKO mice 
displayed a trend towards decreased presynaptic activity compared to littermate control (Figure 
3.19 G). Overall, these results provide further evidence that APLP2 may be able to compensate 
the loss of APP in adult DlxCre cKO mice. Nevertheless, it cannot be ruled out that the absence 
of a LTP defect was additionally based on diffusion processes of APP cleavage products as the 
majority of neighboring neurons were excitatory and thus still expressed APP. 
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Figure 3.19 LTP experiments in adult DlxCre cKO mice. 
(A+C) Adult DlxCre cKO mice revealed no overt LTP or L-LTP defect indicated by almost overlapping curves with 
control group. In both genotypes the induction by TBS (arrow) resulted in a robust and stable potentiation over 
time. Littermate control slices (black circles) exhibited potentiation levels of 139 ± 4.8 % for t75-80 min in LTP (B) 
and 138 ± 5.8 % for t195-200 min in L-LTP recordings (D). DlxCre cKO slices (dark green circles) showed average 
potentiation levels of 135 ± 4.2 % for the final 5 min of LTP (B) as well as 137 ± 11.3 % for L-LTP (D). Statistical 
analysis by t-test led to p = 0.568 (LTP) and p = 0.953 (L-LTP). Input-output strength at given stimulus intensities (E) 
or defined fiber volley amplitudes (F) and PPF (G) were not significantly changed. Insets show original traces of 
representative individual experiments. Vertical scale bar = 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± 
SEM. n.s. = not significant. n = number no of slices / number of mice used. 
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To rule out whether the unaffected LTP and L-LTP of adult DlxCre cKO was due to cleavage 
products of APP from surrounding excitatory neurons or contributed by APLP2 accomplishment 
next aged DlxCre cKO mice (12-13 months) were analyzed (Figure 3.20). In both LTP and L-LTP 
recordings littermate controls revealed a higher LTP magnitude compared to DlxCre cKO. 
Strikingly, the PTP was heavily impaired between genotypes in LTP as well as L-LTP (Figure 3.20 
A and C). This defect became less prominent with time. For LTP the average potentiation of t75-
80 min was 142 ± 6.1 % for littermate control slices (n = 23 / 6) and 125 ± 3.2 % for DlxCre cKO 
slices (n = 26 / 5, p = 0.019, t-test, Figure 3.20 B). The significance was abolished when the final 
5 min of L-LTP recordings were analyzed (littermate control: 132 ± 9.7 %, n = 9 / 5, DlxCre cKO: 
114 ± 3.0 %, n = 10 / 5, p = 0.088, t-test, Figure 3.20 D). Comparably to adult DlxCre cKO mice 
again input-output strength and thus postsynaptic functionality was unaltered at any condition 
tested (Figure 3.20 E and F). Opposing to adult DlxCre cKO individuals aged ones had a severely 
impaired short-term plasticity including a defect of presynaptic function (Figure 3.20 G). Values 
for ratio of slope 2 / slope 1 revealed a strong and partially significant deficit of DlxCre cKO at 
lower ISIs (20 ms: p = 0.048, t-test). All in all, results obtained from adult and aged DlxCre cKO 
mice reflected abnormalities observed in constitutive global APP-KO mice beforehand.  
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Figure 3.20 LTP experiments in aged DlxCre cKO mice. 
(A+B) After 20 min of stable baseline recording TBS (arrow) induced a robust PTP and maintained LTP in littermate 
controls (142 ± 6.1 %, black circles). However, DlxCre cKO slices (light green circles) revealed a strong and significant 
impairment for PTP as well as for the final 5 min of LTP recording (125 ± 3.2 %, p = 0.048, t-test). (C+D) Regarding L-
LTP again a pronounced deficit in PTP and early LTP could be observed which was consistent during the entire 
recording time, but finally not significant any longer for t195-200 min (littermate control: 132 ± 9.7 % and DlxCre 
cKO: 114 ± 3.0 %, p = 0.088, t-test). (E+F) Input-output strength among genotypes was affected neither at given 
stimulus intensities nor at defined fiber volley amplitudes. (G) In contrast, PPF was significantly impaired at lower 
ISIs (20 ms: p = 0.048, t-test). Insets show original traces of representative individual experiments. Vertical scale bar 
= 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± SEM. n.s. = not significant. n = number no of slices / 
number of mice used. 
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3.2.2 Conditional APP Knock-out on APLP2 Deficient Background 
Investigations of DlxCre cKOs revealed an age-related LTP defect. Compared to adult transgenic 
mice aged animals showed a significant deficit for LTP induction and maintenance (see 3.2.1.1.). 
I assumed that APLP2 was able to compensate the loss of APP in adult but not in aged mice. To 
test this hypothesis DlxCre cDKO were generated which additionally lacked APLP2. Therefore, I 
expected to observe the LTP impairment in adult individuals as well. As a second transgenic 
mouse line GADCre cDKO mice were investigated in which the APP knock-out again was 
restricted to only inhibitory neurons on an APLP2 deficient background (see 2.1.3). This 
provided the advantage to make use of another Cre-deleter line to verify the results.  
 
3.2.2.1 DlxCre Conditional Double Knock-out 
Following a stable baseline recording of 20 min, TBS induced LTP showed an overall robust and 
maintained increase in synaptic efficacy in both adult DlxCre cDKO mice and littermate controls 
(3-4 months, Figure 3.21 A). Nevertheless, a clear and highly significant defect of DlxCre cDKO 
with 129 ± 3.8 % (t 75-80 min, n = 25 / 6) compared to littermate controls with 147 ± 4.6 % (n = 
29 / 6, p = 0.005, t-test, Figure 3.21 B) became obvious. Remarkably, this pronounced deficit 
was not reproducible in protein synthesis dependent L-LTP recordings (Figure 3.21 C). This was 
reflected in potentiation values of 132 ± 8.1 % (littermate control, n = 7 / 5) and 115 ± 5.2 % 
(DlxCre cDKO, n = 11 / 6, p = 0.096, t-test, Figure 3.21 D) for the final 5 min of recording. The 
significant LTP defect was partially accompanied by alterations in the post- and presynaptic 
compartment (Figure 3.21 E-G). While the correlation of the fEPSP slope size to various stimulus 
intensities was not impaired among genotypes (Figure 3.21 E) the correlation to defined fiber 
volley amplitudes was significantly altered (0.4 mV: p = 0.037, 0.5 mV: p = 0.042, t-test, Figure 
3.21 F). This observation goes along with a defect of short-term plasticity. At short ISI the ratio 
of slope 2 / 1 was significantly larger in DlxCre cDKO compared to littermate controls (ISI 10 ms: 
p = 0.043, t-test). All together the data obtained from DlxCre cKO and cDKO established a 
compensatory function of APLP2 in adult transgenic mice and a reproduction of age-
dependency already uncovered in constitutive global APP-KO.  
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Figure 3.21 LTP experiments in adult DlxCre cDKO mice. 
(A+B) LTP induction by TBS (arrow) led to an overall increase of synaptic efficacy which was highly significant 
altered between genotypes (littermate controls: 147 ± 4.6 %, black circles, DlxCre cDKO: 129 ± 3.8 %, orange circles, 
p = 0.005, t-test). (C+D) Surprisingly, this defect was not observable in L-LTP recordings (t195-200 min, littermate 
controls: 132 ± 8.1 %, DlxCre cDKO: 115 ± 5.2 %, p = 0.096, t-test). Although a trend to this difference was visible 
towards the end of the recording. (E+F) While a correlation of given stimulus intensities showed no overt deficit, the 
correlation to defined fiber volley amplitudes pointed towards an alteration of input-output strength in DlxCre 
cDKOs (0.4 mV: p = 0.037, 0.5 mV: p = 0.042, t-test). (G) These findings were corroborated by a significant defect of 
short-term plasticity (ISI 10 ms: p = 0.043, t-test). Insets show original traces of representative individual 
experiments. Vertical scale bar = 1 mV, horizontal scale bar = 5 ms. Error bars indicate ± SEM. n.s. = not significant. 
n = number no of slices / number of mice used. 
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3.2.2.2 GADCre Conditional Double Knock-out 
TBS application led to a successful, robust induction and maintained LTP in both genotypes 
(Figure 3.22 A). While recordings were performed, a LTP defect became visible which was 
significant for the final 5 min when littermate control slices (154 ± 6.7 %, n = 12 / 4) were 
compared to GADCre cDKO mice (135 ± 4.2 %, n = 25 / 6, p = 0.022, t-test, Figure 3.22 B). This 
difference became even more pronounced during the entire recording when protein synthesis 
dependent L-LTP was investigated (Figure 3.22 C). Average potentiation of t195-200 min 
revealed a highly significant defect of p = 0.0004 (t-test) in littermate controls of 160 ± 6.3 % (n 
= 4 / 3) versus GADCre cDKO of 126 ± 2.7 % (n = 8 / 6, Figure 3.22 D). Nonetheless, this distinct 
phenotype was not accompanied by alterations of neither short-term plasticity (Figure 3.22 G) 
nor input-output strength when correlated to given stimulus intensities (Figure 3.22 E) or fiber 
volley amplitudes (Figure 3.22 F). Collectively, the results from mice with APP and APLP2 cDKOs 
restricted to inhibitory interneurons were comparable to results obtained from the cDKO in 
excitatory neurons in NexCre cDKO. An exception was the data from the PPF paradigm where a 
clear defect was found in NexCre cDKO but not in GADCre cDKO. However, it is necessary to 
mention that further analysis of GADCre cDKO mice uncovered spontaneous germ-line 
recombination activities in GADCre-deleter lines. This led to a global APP-KO in the entire 
organism and was thus no longer restricted to inhibitory neurons in the brain. Therefore, it is 
questionable whether data obtained for activity dependent synaptic plasticity reflected the 
physiological state or resulted from side effects of global KO. 
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Figure 3.22 LTP experiments in aged GAD67Cre cDKO mice. 
(A+B) TBS (arrow) application induced a strong and stable LTP in littermate controls of 154 ± 6.7 % (black circles) 
and in GADCre cDKO of 135 ± 4.2 % (turquois circles) for t75-80 min, which resulted in a significant difference 
between genotypes (p = 0.022, t-test). (C+D) Strikingly, the defect was even stronger in results obtained for L-LTP. 
Again a robust induction phase was observed in both genotypes which turned into a highly significant difference 
between littermate controls of 160 ± 6.3 % and GADCre cDKO of 126 ± 2.7 % for t195-200 min in the L-LTP plateau 
(p = 0.0004, t-test). (E+F) Recording of fEPSP slope size at given stimulus intensities and fiber volley amplitudes 
revealed no significant differences among genotypes. (G) Presynaptic function and thus short-term plasticity was as 
well not affected. Insets show original traces of representative individual experiments. Vertical scale bar = 1 mV, 
horizontal scale bar = 5 ms. Error bars indicate ± SEM. n.s. = not significant. n = number no of slices / number of 
mice used. 
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Figure 3.23 summarizes all results obtained from investigations of the role of APP and APLP2 in 
activity dependent synaptic transmission in inhibitory neurons. 
 
 
Figure 3.23 Overview about results obtained from APP
flox/flox
APLP2
-/-
 crossed to inhibitory Cre-deleter lines. 
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4 Discussion 
4.1 Considerable Role of the APP Protein Family in Synaptic Plasticity 
The synapse is the site for dynamic modulations such as strengthening and weakening in case of 
LTP and LTD, respectively. Those mechanisms promote functional and structural plasticity at the 
synapse. Thereby, Ca2+ represents a potent second messenger which activates various enzymes 
to trigger further downstream cascades modifying finally the gene expression of plasticity 
related proteins. The modulation of synaptic plasticity depends on the action of a variety of 
proteins. One of these is the Amyloid precursor protein (APP) which belongs to a family 
including the homologues proteins APLP1 and APLP2. In this thesis, I investigated the role of the 
APP protein family and its cleavage products for the modulation of activity-dependent synaptic 
plasticity in the hippocampal CA3-CA1 pathway. Thereby, I differentiated between the 
involvement of these proteins during brain development as well as the acute function at active 
synapses in the adult CNS.  
Main findings from transgenic mice lacking APP and APLP2 in inhibitory or excitatory forebrain 
neurons uncovered an imbalanced excitation-inhibition ratio that might result from impaired 
network formation during brain development. The lethality of constitutive triple and almost all 
double KO mice, a distinct hint for the involvement of the APP protein family in brain 
development processes, so far precluded the analysis. Intriguingly, I confirmed that APP and 
APLP2 have redundant functions which enable APLP2 to compensate for the loss of APP. 
However, this was only observed in adult but not aged transgenic mice. The two approaches 
applied in this thesis, organotypic hippocampal cultures (OHCs) treated with a specific α-
secretase inhibitor and the conditional deletion of APP on an APLP2 deficient background, 
convincingly showed that a deficiency of both proteins during the formation of neuronal 
networks consequently impairs synaptic plasticity in combination with an altered Ca2+ dynamic. 
The acute function of APP, more precisely the α-secretase processing product APPsα, for the 
modulation of activity-dependent synaptic plasticity became obvious when I showed that 
exogenously applied recAPPsα fully restored the impaired LTP of NexCre cDKO. Consistently, 
virally expressed APPsα on a NexCre cDKO background rescued the Ca2+ dynamic defect. Taken 
together, the results further underline the role of APPsα for potential therapeutic strategies on 
a long road towards a treatment of the devastating Alzheimer’s disease. 
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4.1.1 APP Deficiency Leads to a Disturbed Excitation-Inhibition Balance 
For a successful LTP induction a balanced and well-coordinated tonic excitatory and inhibitory 
input is mandatory. This notion is supported by the finding that the inhibition of GABAA 
receptors facilitates LTP and leads to hyperexcitability causing epileptic seizures (Wigstrom and 
Gustafsson, 1983, 1985; Casasola et al., 2004). The GABAergic system is involved during the 
induction and the early maintenance period of LTP for instance through presynaptic GABAB 
autoreceptors on GABAergic neurons providing a disinhibitory mechanism (Davies and 
Collingridge, 1993; Mott et al., 1993). By this means, alterations in the GABAergic system might 
contribute to the impaired synaptic plasticity of APP/APLP2 transgenic mice.  
This is supported by previous reports which showed an increased susceptibility for kainate-
induced seizures in constitutive APP-KO mice pointing towards a decreased inhibitory input 
(Steinbach et al., 1998). However, more evidence is provided for an increased inhibitory input in 
APP deficient mice. The beforehand mentioned GABAB receptor was recently identified to 
interact with APP (Norstrom et al., 2010). Still, the in vivo relevance of this interaction needs to 
be specified but it might be speculated that a lack of APP disturbs presynaptic inhibitory and 
regulatory GABAB dependent mechanisms leading to increased inhibitory currents. This 
hypothesis was further supported by studies showing that the inhibition of GABAA receptors by 
Picrotoxin in either APP-KO or APPsα- double mutant (APPsα-DM: APPsα+/+ APLP2-/-) rescued the 
LTP defect to control levels presumably because the postsynaptic depolarization is facilitated 
(Fitzjohn et al., 2000; Weyer et al., 2011). Moreover, APP was shown to be a regulator of 
GABAergic short term plasticity in dissociated hippocampal and striatal neurons. An study 
hippocampal and striatal APP-KO neurons showed increased L-type voltage gated Ca2+ channel 
(VGCC) levels and function accompanied by elevated GABAergic Ca2+ currents (Yang et al., 
2009). These impairments were rescued if APP was again expressed. The increased inhibition 
might therefore be linked to the LTP defects observed in this study since the threshold for LTP 
induction and maintenance could have been higher. This explanation is supported by the finding 
that APP/APLP2 transgenic mice like the NexCre cDKO (see Figure 3.6) revealed already directly 
after LTP induction significant defects in the Posttetanic Potentiation. Since the inhibitory input 
mainly contributes to the induction and the early maintenance of LTP one might consider that 
the threshold for LTP was higher due to an increased inhibitory input (Davies and Collingridge, 
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1993; Mott et al., 1993). Additionally, the APP-KO might also affect L-type VGCCs in excitatory 
neurons. The importance of APP and L-type VGCCs interaction in excitatory neurons was shown 
by Santos and colleagues. They found that the acute inhibition of endogenous APP in cortical 
neurons affects the Ca2+ homeostasis by decreasing the amplitude but increasing the frequency 
of Ca2+ events (Santos et al., 2009). Thus, a crucial function of APP in regulating excitation-
inhibition balance via this APP – L-type VGCCs interaction might be likely.  
APP and APLP2 could act directly by being part of intracellular signaling cascades or indirectly 
trigger those cascades through a secondary homeostatic effect which are essential for a 
balanced inhibition. A recent study reported that PKC activators are capable to enhance 
GABAergic neurotransmission (Xu et al., 2014). On the other hand PKC mediated 
phosphorylation of APP was shown to increase α-secretase and decrease the β-secretase 
processing (Buxbaum et al., 1993). Thus, one might speculate that fragments of APP processing 
deriving from the non-amyloidogenic pathway are crucial for modulating the excitation-
inhibition balance as a consequence of activity-dependent synaptic plasticity. These ideas are 
even further supported by the results from LTP studies presented here. The knock-out of both 
APP and APLP2 in either excitatory (NexCre cDKO: NexCre+/T APPflox/flox APLP2-/-, see Figure 3.10) 
or inhibitory (DlxCre cDKO: DlxCre+/T APPflox/flox APLP2-/-, see Figure 3.21) neurons resulted in a 
pronounced and significant LTP defect which was rescued by exogenous recAPPsα application at 
least in NexCre cDKO mice (see Figure 3.11) implicating an essential role for this α-secretase 
cleavage product (Hick et al., 2015). In future experiments a neuron specific, prenatal APP / 
APLP2 cDKO by using the CAGCre-deleter line could be applied to study an APP function in both 
inhibitory and excitatory neurons simultaneously.  
 
4.1.2 Age-dependent Compensatory Function of APP and APLP2  
Multiple lines of evidence indicate a LTP defect in aged but not adult conventional APP-KO mice 
(Dawson et al., 1999; Seabrook et al., 1999; Ring et al., 2007). Notably, these transgenic animals 
revealed severe gliosis which at least in part might contribute to the altered synaptic plasticity 
(Zheng et al., 1995; Dawson et al., 1999). Glia cells are known to be essential for a proper 
neuronal function as they are part of the tripartite synapse promoting the reuptake of 
presynaptically released glutamate and maintaining the ion homeostasis (Eroglu and Barres, 
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2010). Surprisingly, an alternative strain of APP-KO mice didn’t show gliosis any longer but still 
revealed the previously observed LTP defect in aged individuals solely (Ring et al., 2007; Tyan et 
al., 2012). Tyan and colleagues, furthermore, found a pronounced reduction of CA1 pyramidal 
neuron complexity and spine density only for aged APP-KO mice whereas adults were 
indistinguishable to controls. Presumably, the decreased spine number in aged APP-KO mice 
might result from increased spine elimination (Tyan et al., 2012). Still, the question remains why 
this defect was not observed in adult APP-KO mice. Since the APLP2 protein displays a high 
degree of sequence homology to APP and both reveal overlapping processing and expression 
patterns a compensatory function during adulthood is likely which seems to diminish with age 
(Wasco et al., 1993; Nicolas and Hassan, 2014). A study investigating conventional APLP2-KO 
mice addressed this question and found no alterations on neuronal morphology and function 
independent of age suggesting that APP contains features that are either distinct from APLP2 or 
dominant to APLP2 (Weyer et al., 2011; Midthune et al., 2012).  
To prevent the potential compensatory mechanism a double knock-out (DKO) of both APP and 
APLP2 is necessary. Unfortunately, these mice die shortly after birth due to neuro-muscular 
deficits (von Koch et al., 1997; Heber et al., 2000). Therefore, transgenic mouse-lines were 
generated in which the APP gene was replaced by either APPsα or APP∆CT15 on an APLP2 
deficient background termed double mutant (APPsα-DM: APPsα+/+ APLP2-/- or APP∆CT15-DM: 
APP∆CT15+/+ APLP2-/-). Interestingly, these two mouse-lines are viable and exhibit a significantly 
impaired LTP already in adult individuals (see Figure 3.2). This supports the idea of a 
compensatory function of APLP2 in adult mice (Weyer et al., 2011; Klevanski et al., in 
preparation). Nevertheless, APPsα or APP∆CT15 expression might mask further effects. The 
application of an alternative genetic technique, however, enabled us to generate a fully viable 
double knock-out via the conditional approach (cDKO). Besides investigating the role of APP and 
APLP2 in inhibitory neurons for the excitation-inhibition balance (see 4.1.1) I addressed the 
question whether in these mice the age dependency and the APLP2 compensatory function 
would be found as well. Therefore, in a first step adult and aged DlxCre cKO mice (DlxCre+/T 
APPflox/flox) were analyzed in which APP is eliminated while APLP2 is still expressed. In line with 
the results from conventional APP-KO mice again no LTP defect and an unaltered basal synaptic 
transmission was found in adult DlxCre cKOs (see Figure 3.19). Solely aged DlxCre cKO mice 
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revealed a significantly lower LTP compared to controls (see Figure 3.20). It could be speculated 
that for example APPsα, released upon electrical stimulation from surrounding excitatory 
neurons, was not appropriate to prevent the LTP defect in aged individuals. Furthermore, it 
could be assumed that like in aged APP-KO mice APLP2 is not sufficient to compensate the 
defect any longer (Dawson et al., 1999; Seabrook et al., 1999; Ring et al., 2007). Thus, I next 
assessed adult DlxCre cDKO mice (DlxCre+/T APPflox/flox APLP2-/-) lacking both APP and APLP2 were 
investigated and showed, indeed, an impaired LTP and basal synaptic transmission further 
underlining the compensatory age-dependent effect of APLP2 (see Figure 3.21). To verify these 
results another inhibitory neuron specific Cre-deleter mouse line was used. Aged GADCre cDKO 
(GAD67Cre+/T APPflox/flox APLP2-/-) mice were analyzed and showed a significantly impaired 
activity-dependent synaptic plasticity for LTP which became even stronger when late-LTP was 
analyzed (see Figure 3.22). However, further analysis of this mouse-line revealed a spontaneous 
germ-line recombination activity in the GADCre-deleter line which led to a global APP-KO in the 
entire organism. Thus, the interpretation of results obtained from GADCre cDKO mice is difficult 
since one could not distinguish whether the defect reflects the physiological state or is caused 
by side effects of the global KO. Generally, both GADCre cDKO and DlxCre cDKOs revealed a 
comparably impaired activity-dependent synaptic plasticity induced by a DKO of both APP and 
APLP2 in solely inhibitory neurons. 
In line with data obtained for the cDKO restricted to the inhibitory system, I could 
complementarily detect a LTP defect restricted to excitatory neurons of adult NexCre cDKO mice 
(NexCre+/T APPflox/flox APLP2-/-, see Figure 3.6) as well confirming a functional complementation 
by APLP2 in adult APP-KO mice (Hick et al., 2015). Nevertheless, the question why the 
compensatory function of APLP2 in conditional or constitutive APP-KO becomes lost with age 
needs to be assessed further. It might be speculated that for instance normal aging processes in 
the brain significantly contribute or the APP or APLP2 protein expression itself is affected. The 
neuronal plasticity related to cognitive impairments in the aged compared to adult wildtype (wt) 
brain has been intensely investigated (Burke and Barnes, 2006). Beside studies on neuronal 
complexity, spine density and synapse numbers in aged compared to adult wt mice which 
revealed no gross overall alterations, in the CA3-CA1 pathway a disruption of Ca2+ homeostasis 
through higher levels of L-type VGCCs was shown (Foster and Norris, 1997; Burke and Barnes, 
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2006). Moreover, this was accompanied by lower cAMP levels in aged wt (Tombaugh et al., 
2005). All together this increases the threshold for excitability compared to adult wt CA1 
neurons. Notably, this could not be confirmed in in vivo recordings. Another theory states that 
hippocampal perforated synapses become silent or non-functional with normal aging 
contributing to the cognitive decline (Nicholson et al., 2004). A large body of evidence is given 
for a defect of activity dependent synaptic plasticity in aged rodents. These deficits are, 
however, of complex nature, region specific and depend for LTP on the induction protocol used. 
Aged wt CA1 pyramidal neurons exhibited a weaker temporal summation of multiple EPSPs 
induced by high frequency stimulation. Thus, these neurons are less depolarized which might 
explain the observed induction defect (Rosenzweig et al., 1997). Paralleled to an altered 
neuronal function age-related changes in gene expression, a process which is crucial for L-LTP 
maintenance, were indicated (Burke and Barnes, 2006). Interestingly, it was shown that 10 nM 
of APPsα, an APP processing product deriving from the non amyloidogenic pathway via α-
secretase cleavage, had less effects on the enhancement of protein synthesis in aged compared 
to adult rats (Claasen et al., 2009). So it might well be that levels of APLP2, the α-secretase 
cleavage product APLP2sα levels or other proteins of downstream signaling cascades are 
decreased leading to the loss of compensation. As a future direction this idea could be assessed 
by protein quantification via western blot from hippocampal lysates of adult versus aged APP-
KO mice. 
Collectively, my results described above provide evidence that both APP and APLP2 are 
synergistically required for activity-dependent processes of learning and memory. A loss of APP 
can be compensated by APLP2, suggestively via APLP2sα secretion, exclusively in adult and not 
in aged mice whereas a loss of APLP2 is compensated by APP, via APPsα release, throughout 
lifetime (Eggert et al., 2004; Endres et al., 2005; Weyer et al., 2011).  
 
4.1.3 APP is Required for Brain Developmental Processes and the Acute Modulation of 
Synaptic Properties 
One aim of this study was to distinguish between developmental and acute functions of the APP 
protein family and its processing fragments in the adult CNS in modulating the synaptic 
strength. It is well feasible that some functional deficits in APP- and / or APLP-deficient mice 
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result from an altered development. Studies showed an increase in APP expression in the brain 
development during peak periods of neurite outgrowth and synaptogenesis implicating that this 
protein is important for a proper neuronal network formation (Kirazov et al., 2001). 
Additionally, APP was shown to be involved in processes of neuronal progenitor proliferation 
and neuronal migration (Young-Pearse et al., 2007; Young-Pearse et al., 2010; Hu et al., 2013). 
This role is furthermore supported by the fact that an APP / APLP2 / APLP1 triple KO is lethal 
due to cortical dysplasia and partial loss of Cajal-Retzius cells (Herms et al., 2004). Furthermore, 
combined double KO (DKO) mice of APP / APLP2 or APLP1 / APLP2 die shortly after birth due to 
severe defects at the neuromuscular junction probably because an interaction of APP and 
acetylcholine receptors is required (Akaaboune et al., 2000). In contrast mice lacking only one 
protein family member are fully viable suggesting redundant functions (von Koch et al., 1997; 
Heber et al., 2000). 
In this thesis the results of two different mouse strains are presented in which APP is knocked 
out exclusively in excitatory neurons via the conditional strategy on an APLP2 deficient 
background. The first strain is the CaMKIIαCre cDKO (CaMKIIαCreERT2 +/T APPflox/flox APLP2-/-) in 
which the KO of APP is tamoxifen inducible. I analyzed 1x (adult) and 2x (P5 and adult) 
tamoxifen treated mice at 3 – 4 and 12 – 13 months of age. Since solely P5 tamoxifen treated 
mice exhibited only a weak Cre activity during postnatal stages consequently just a small subset 
of CA3 and DG neurons was APP negative. In CA1 no APP deletion at all was found (Meike Hick, 
IPMB Heidelberg). Therefore, to achieve a maximal Cre activation and thus APP ablation 
tamoxifen was applied twice at P5 and in the adulthood. The central aim was to investigate the 
acute effects of APP and its processing products at active synapses. However, the early ablation 
of APP at P5 covers also functions of this protein in early postnatal brain development. 
Surprisingly, I could only observe a mild LTP impairment when activity dependent synaptic 
plasticity was analyzed for aged 1x tamoxifen treated CaMKIIαCre cDKO (see Figure 3.3) as well 
as for adult and aged 2x tamoxifen treated CaMKIIαCre cDKOs (see Figure 3.4 and Figure 3.5). 
Beforehand, these mice performed hippocampus-dependent memory tasks (in the lab of Prof. 
Dr. David Wolfer, Zürich). Interestingly, they showed a defect in place navigation when 
performing the Morris Water Maze task while the spatial working memory tested by the Radial 
Arm Maze task was not affected. Although the 2x tamoxifen applications should lead to ablation 
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of APP in most of the excitatory forebrain neurons, it cannot be ruled out that not all cells were 
targeted. This suggestion was supported by immunohistochemical and western blot analysis 
from Meike Hick (IPMB, Heidelberg, AG Müller) showing that the hippocampi from CaMKIIαCre 
cDKO mice still revealed a relatively high amount of ~20 % APP. Additionally, it should be 
considered that in these mice inhibitory neurons which comprise 5 % of hippocampal neurons 
as well as astrocytes still express APP which might contribute to the mild effect observed 
(Rossner, 2004). Moreover, as it was shown that APP and APLP2 are also involved in earlier 
processes during embryonic brain development the DKO via the CaMKIIα promoter which was 
activated postnatally at P5 might be too late (Herms et al., 2004). When interpreting this data it 
should also be taken to account that the induction of APP excision via tamoxifen represents a 
strong hormonal stress event which might cause undesired side effects. Tamoxifen is a synthetic 
estrogen derivate which is characterized as a selective estrogen-receptor modulator. Beside 
neurotransmitters also neurohormones deriving from the endocrine system contribute to an 
intact neuronal function. Thus, tamoxifen treatment might also change the physiological state of 
the brain since endogenous estrogen is shown to modulate the activation of potassium channels 
in the CNS (Kelly et al., 2003). However, since the littermate control mice received the same 
tamoxifen doses like the CaMKIIαCre cDKO this serves as an internal control. 
To investigate an even earlier role of APP and to circumvent potential side effects of tamoxifen 
in a second approach the NexCre-deleter line was used to generate NexCre cDKO mice 
(NexCre+/T APPflox/flox APLP2-/-). In these mice the APP ablation in excitatory forebrain neurons on 
an APLP2 deficient background is initiated conditionally already at E11.5. Strikingly, the analysis 
of NexCre cDKO mice revealed a strong defect in hippocampus-dependent memory when, 
again, Morris Water Maze and Radial Arm Maze task were tested which was accompanied by a 
pronounced impairment in activity-dependent synaptic plasticity (see Figure 3.6) including an 
altered presynaptic function (Hick et al., 2015). Furthermore, this defect was also reflected at 
the neuronal level by a decreased dendritic complexity accompanied by a reduced hippocampal 
volume. A deficit in spine density was associated with a shift towards more immature stubby 
spines characterized by a smaller PSD (Hick et al., 2015).  
As already introduced in 4.1.1 the APP protein family seems to be important for an intact 
excitation-inhibition balance. Therefore, the data obtained from DlxCre cDKO, revealing a 
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pronounced LTP defect (see Figure 3.21), is well in line with results from NexCre cDKO. Both 
genes Dlx and Nex are expressed around E11. Thus, a crucial role of APP and APLP2 for dendritic 
architecture and neuronal network formation already at early developmental stages can be 
suggested. These alterations on the cellular level match with our recent observations from in 
vitro studies in OHCs in which APLP2-KO OHCs were indistinguishable to wt cultures, but APP-KO 
OHCs exhibited a neuronal branching defect which became even more pronounced when 
additionally APLP2 was gene targeted. Moreover, a decreased spine number was observed 
which notably was not further reduced in APP / APLP2 DKO OHCs (Weyer et al., 2014). 
Collectively, these data provide convincing evidence that both APP and APLP2 are crucial for 
normal morphology and function of pyramidal neurons. Furthermore, data obtained from OHC 
analysis hint towards a potential role of the APP protein family during early postnatal phases for 
the establishment and maturation of synaptic contacts since this period comprises the peak of 
APP protein expression (Loffler and Huber, 1992; Wang et al., 2009). 
Next, I studied the functional role of APP and APLP2 α-secretase cleavage products in synaptic 
plasticity during early developmental processes (see Figure 3.1). Since the long-term incubation 
of a specific α-secretase inhibitor did not affect the LTP in acute slices I switched to OHCs to 
prolong the incubation time. Previous studies as well as results obtained in this thesis confirmed 
that APLP2-KO cultures, only treated with DMSO, still reveal potentiation levels comparable to 
wt controls. Interestingly, the specific inhibition of α-secretase ADAM10 for five consecutive 
days starting at DIV 14-19 should include late phases of synaptogenesis. The reduced LTP 
induction and maintenance in inhibitor treated APLP2-KO OHCs underlines the importance for 
APPsα as the α-secretase APP cleavage product (Hoettecke et al., 2010; Weyer et al., 2011). Wt 
OHCs did not show any impairment neither under DMSO nor inhibitor application implicating 
that still a sufficient amount of APPsα and APLP2sα, both being products of α-secretase 
cleavage, is left to promote LTP. Since this inhibitor specifically blocks the α-secretase ADAM10 
but not the other ADAM family members like ADAM9, ADAM17 or ADAM19 which also process 
APP it might be speculated that through the action of the intact α-secretases still enough APPsα 
and APLP2sα for promoting proper synaptic function is generated (Hoettecke et al., 2010). 
Weyer and colleagues showed that OHCs from double mutants which only express the APPsα 
fragment on an APLP2 deficient background (APPsα+/+ APLP2-/-) did not exhibit any LTP already 
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under DMSO conditions. Presumably, the amount of constitutively generated APPsα was too 
low to promote LTP or permanently expressed APPsα cannot be efficiently transported to the 
active synapses (Weyer et al., 2011). Indeed, numerous studies showed that the secretion of 
APPsα is tightly linked to increased neuronal activity by NMDA or muscarinic acetylcholine 
receptor activation (Nitsch et al., 1992; Fazeli et al., 1994; Gakhar-Koppole et al., 2008; Hoey et 
al., 2009). This is furthermore supported by my observation that the LTP from APP∆CT15-DM 
OHCs (APP∆CT15+/+ APLP2-/-), expressing an APP fragment which is in contrast to APPsα 
membrane bound, is normal under DMSO treatment but significantly impaired when ADAM10 is 
inhibited. In summary, these studies in OHCs revealed a combined role of APP and APLP2 for 
dendritic architecture already at early developmental stages and a unique function of APPsα for 
spine density and synaptic plasticity. 
  
4.1.4 The C-terminal Domain of APP is Crucial to Modulate the Expression of Plasticity 
Related Proteins 
The intracellular C-terminal sequences are most highly conserved among the APP family 
members (see 1.3). The AICD is an important interaction site for phosphorylation and de-
phosphorylation events, binding of adapter proteins and was implicated as  transcription factor 
modulating the gene expression directly or indirectly (Muller et al., 2008; Pardossi-Piquard and 
Checler, 2012). It furthermore contains the YENPTY motif which is an internalization signal for 
endocytosis of APP localized at the membrane and this motif stimulates Aβ generation in vitro 
(Trowbridge et al., 1993; Lai et al., 1995; Perez et al., 1999). Moreover, recent evidence 
implicates that TrkA as a receptor for the nerve growth factor (NGF) is involved in the APP 
signaling pathway. It was reported that TrkA phosphorylates APP on Tyr residues within the 
YENPTY motif and directly binds APP which triggers further downstream cascades of NGF / TrkA 
signaling (Matrone et al., 2011; Matrone, 2013). In addition, this sequence suggestively 
regulates APP processing itself since a mutation of this phosphorylation sites shifts the APP 
processing more to the non amyloidogenic pathway. Alternatively, it could be argued that in this 
case the APP internalization is not working properly. Thus, more APP is membrane bound which 
than as a consequence leads to more APPsα secretion (Barbagallo et al., 2010). The same group 
showed opposing functions for two phosphorylation sites within the AICD of APPmut/mut/APLP2-/- 
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mice: a mutation of Tyr682 led to lethality due to severe neuromuscular defects while the 
mutated Tyr668 had no impact (Barbagallo et al., 2011a, b). This is in clear contrast to the 
APP∆CT15 double mutants (DM, APP∆CT15+/+ APLP2-/-) analyzed in this study which are viable 
although they lack the last C-terminal 15 amino acids including Tyr682 and Tyr668 on an APLP2-
deficient background (Klevanski et al., in preparation).  
One important APP adapter protein is Fe65 which binds the de-phosphorylated YENPTY motif 
inducing the shuttling of a multimeric complex of AICD / Fe65 / Tip60 into the nucleus to 
regulate the gene transcription (Cao and Sudhof, 2001). Comparably to APP the Fe65 protein 
family includes the homologues Fe65L1 and Fe65L2 all of which bind the APP protein family 
members (Guenette et al., 1996). Consistent with the APP / APLP2 DKO the double KO of Fe65 / 
Fe65L1 revealed a significant defect in activity-dependent synaptic plasticity implicating that 
APP-Fe65 interaction is crucial for synaptic function (Strecker et al., in preparation). In order to 
disrupt this interaction we generated the beforehand mentioned APP∆CT15-DM (APP∆CT15+/+ 
APLP2-/-). Acute hippocampal slices revealed a strongly impaired activity-dependent synaptic 
plasticity including a defect in early-LTP and postsynaptic properties while late-LTP showed only 
a trend towards a deficit (see Figure 3.2). In parallel these mice were analyzed regarding 
hippocampus dependent behavior which was found to be severely altered when the T- and 
Radial Arm Maze were applied. Notably, no Morris Water Maze task has been performed since 
these mice exhibited neuromuscular deficits shown by motor tasks. This was reasoned by an 
altered morphology of endplates and postsynaptic terminals mechanistically elicited by an 
impaired neuromuscular transmission (Klevanski et al., in preparation). Similar results were 
found when the APPsα-DM (APPsα+/+ APLP2-/-), expressing only the APPsα fragment on an 
APLP2-deficient background, was analyzed. Surprisingly and comparable to the APP∆CT15-DM, 
these morphological defects were only restricted to the PNS at the neuromuscular junction 
while CNS morphology was unaffected. Nevertheless, again at the functional level central 
glutamatergic synapses were affected shown by an impaired LTP accompanied by a 
compromised Radial Arm and T-Maze performance (Weyer et al., 2011). Interestingly, both 
mouse lines, APPsα- or APP∆CT15-DM, are viable whereas APPsβ-DM mice (APPsβ+/+ APLP2-/-) 
die, resembling the phenotype of full APP / APLP2 DM (Wang et al., 2005; Wang et al., 2009). 
APPsβ is only 17 amino acids shorter compared to APPsα which seems to contain a motif crucial 
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for animal survival (see 4.2.1). Nevertheless, an impaired neuromuscular function and 
morphology was observed in both APPsα- or APP∆CT15 DM compared to APLP2-KO controls 
suggesting that interaction sites like the YENPTY motif within the missing C-terminal domain 
contribute to normal neuronal morphology (Weyer et al., 2011; Klevanski et al., in preparation). 
Collectively, this proofs an essential function of the 15 C-terminal amino acids including the 
YENPTY motif in terms of APP-protein interactions like with the Fe65 protein family. In this 
thesis this interaction site was shown to be crucial for an intact activity-dependent synaptic 
plasticity. Additionally, again the redundant function of APP and APLP2 proteins became clear 
since mice that express APPsα or APP∆CT15 with an intact APLP2 background (APPsα+/+ or 
APP∆CT15+/+) exhibit no motor and synaptic plasticity deficits (Ring et al., 2007). 
 
4.2 The Secreted APPsα Ectodomain is Essential for Regulating Synaptic 
Strength  
Upon α-secretase cleavage of full length APP and APLP2 the large APPsα and APLP2sα 
ectodomains are released into the extracellular space (Lammich et al., 1999; Endres et al., 
2005). Numerous studies confirmed that APPsα has an exceeding role in neuroprotection, 
synaptic plasticity and neuronal network function (Ring et al., 2007; Weyer et al., 2011; Kogel et 
al., 2012; Korte et al., 2012; Zhang et al., 2013; Hick et al., 2015). The APP processing by the α-
secretase is activity-dependent and can thus be potentiated by neuronal depolarization, high 
frequency stimulation and activity of mGluR as well as mAChR (Nitsch et al., 1992; Nitsch et al., 
1993; Fazeli et al., 1994; Gakhar-Koppole et al., 2008). Intriguingly, it was shown that 
endogenously produced APPsα is crucial for LTP induction, maintenance and enhancement 
(Ishida et al., 1997). A regulated APP cleavage by the α-secretase under physiological conditions 
is necessary to form APPsα which seems to be essential during synaptic activity to enhance 
NMDAR signaling during LTP (Weyer et al., 2011). Another reason why constitutive APP / APLP2 
DKO mice die after birth was given by studies of embryonic stem cells which, when they were 
differentiated into glutamatergic neurons, showed a decreased expression of the vesicular 
glutamate transporter 2 resulting in a reduced synaptic transmission (Schrenk-Siemens et al., 
2008). Moreover, they exhibited a decreased glutamate release which might be reasonable for 
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the observed impaired activity-dependent synaptic plasticity (see Figure 3.6) of NexCre cDKO 
mice (Hick et al., 2015). Suggestively, APPsα is able to enhance memory and regulate neuronal 
excitability. A recruitment of NMDARs through APP is discussed while contrariwise toxic Aβ 
oligomers decrease the number of AMPARs and NMDARs (Snyder et al., 2005; Hsieh et al., 
2006a; Hoe et al., 2009). Recent studies showed that APP is associated to the NMDAR in the ER 
but also found at the cell surface integrated in the PSD (Hoe et al., 2009; Hoey et al., 2009). 
GluN2B subunit containing NMDARs are associated with APP that enhanced their cell surface 
recruitment shown by APP overexpression leading to increased NMDAR surface levels (Cousins 
et al., 2009; Hoe et al., 2009). Consistently, the activation of NMDARs stimulates the APP 
processing and simultaneously inhibits the Aβ generation (Hoey et al., 2009). Another 
publication suggests that endogenous APPsα specifically regulates NMDARs currents during high 
frequency stimulation which also could explain why the inhibition of GABAergic neurons or the 
application of recombinant APPsα (see Figure 3.11) restores the impaired LTP to control levels 
(Taylor et al., 2008; Hick et al., 2015). Therefore, it was tested whether the LTP defect of NexCre 
cDKO, in which the potential interaction with NMDARs is abolished, is attributed to a disturbed 
NMDAR expression or composition. Surprisingly, the analysis of spontaneous mEPSCs by patch 
clamp recordings showed no defect in amplitudes, kinetics or NMDA component of mixed EPSCs 
(Hick et al., 2015). Thus, a functional relevance for an APP – NMDAR interaction remains 
unclear. Nevertheless, the group of Prof. Dr. W.C. Abraham (University of Otago, New Zealand) 
showed a significant concentration-dependent effect of recombinant APPsα treatment in acute 
wt rat hippocampal slices (data presented at the neuroscience 2014, K.D. Parfitt, poster ID 
405.05/D52). Lower doses decreased GluN1 and GluA1 expression whereas intermediate doses 
increased both respectively suggesting that APPsα has a fundamental role in the regulation of 
NMDAR and AMPAR subunit composition and receptor localization (data presented at the 
neuroscience 2014, K.D. Parfitt, poster ID 405.05/D52). Still, the observed defect in activity-
dependent synaptic plasticity might be reasonable by the missing APPsα acting pre- and / or 
postsynaptically. This suggestion is supported since the knock-out of the α-secretase ADAM10, 
precluding the processing of both APP and APLP2, leads to comparable impairments observed in 
NexCre cDKO mice. Notably, they did not comment on the remaining cleavage activity of other 
ADAM family member (Prox et al., 2013; Hick et al., 2015). 
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4.2.1 recAPPsα, but not recAPPsβ, Restores the Functional LTP Defect of NexCre cDKO 
The beforehand described neurotrophic characteristic of APPsα is also reflected by its LTP 
enhancing properties. These were shown by the infusion of APPsα which further increased LTP 
in wt acute slices compared to PBS treated control. Consistently, in my experiments the 
application of recAPPsα on acute slices of littermate control mice led to a significantly enhanced 
posttetanic potentiation (PTP) and a trend of an increased LTP compared to slices treated with 
the boiled peptide (see Figure 3.17). This is in line with the observation that APPsα acts on early 
stages of LTP induction like PTP (Ishida et al., 1997). Moreover, Taylor and colleagues showed a 
reduced tetanically evoked NMDAR current when an antibody against APPsα or an α-secretase 
inhibitor were applied. In a rescue of function experiment the co-application of an α-secretase 
inhibitor and additional recAPPsα restored the reduced LTP back to control level (Taylor et al., 
2008). To distinguish acute effects of APP / APLP2 double knock-out from developmental 
effects, I implemented a comparable rescue of function experiment. The exogenous application 
of recAPPsα would only restore the previously observed LTP defect in NexCre cDKO mice if 
changes in the expression of APP or APLP2 are acutely necessary for synaptic function and 
modulation. Contrary, if the DKO of both proteins exerts its effects by developmental deficits, 
no rescue should be possible. Indeed, an application of 10 nM recAPPsα 1 h prior and during the 
entire experiment fully restored the LTP and short-term plasticity impairment (see Figure 3.11). 
These findings establish an endogenous role of APPsα for the acute modulation of synaptic 
properties on a fast time scale. This is corroborated by a reduced PSD95 level and a decreased 
mushroom type spine number (Hick et al., 2015). 
Intriguingly, I found that the application of recAPPsα sufficiently restored the LTP defect in 
NexCre cDKO while recAPPsβ did not (see Figure 3.16, (Hick et al., 2015). This strongly 
implicates that the motif which is crucial to promote LTP is localized within the 17 amino acids 
of difference between APPsα and APPβ or that these are responsible for a confirmation that 
makes APPsβ less effective. This is supported by the fact that APPsβ was shown to be 100 x less 
potent in protecting hippocampal neurons against excitotoxicity compared to APPsα (Furukawa 
et al., 1996). Within this sequence difference a heparin-binding domain is localized which was 
suggested to influence the effectiveness (Furukawa et al., 1996). The emerging role of these 17 
amino acids was further supported by an APPsβ-DM mouse line (APPsβ+/+ APLP2-/-) which was 
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not viable still showing severe neuromuscular defects compared to an APPsα-DM (APPsα+/+ 
APLP2-/-) which was fully viable but still as well shows neuromuscular deficits (Li et al., 2010; 
Weyer et al., 2011).  
Furthermore, auto-regulatory mechanisms have been discovered whereby APPsα was capable 
to reduce the β-secretase activity and therefore decrease the APPsβ generation but 
simultaneously stimulate the α-secretase processing of APP (Obregon et al., 2012). However, 
the precise mechanism how APPsα exerts its neurotrophic as well as protective function and 
regulates neuronal excitability is unknown. The literature for the identification of its receptor is 
diffuse and often contradictory. APP itself has been proposed to be the receptor for APPsα since 
it was shown to disrupt APP dimers (Gralle et al., 2009). This needs to be queried with regard to 
the recAPPsα rescue results of NexCre cDKO mice since no APP is available in these individuals 
(Hick et al., 2015). Processes of learning and memory might be modulated by activating an 
unknown cell surface receptor that modulates the activity of potassium channels and also 
activates the transcription factor NF-κB (Barger and Mattson, 1996; Guo et al., 1998; Ryan et al., 
2013). Furthermore, p75 receptor and APPsα as well as APPsβ were co-immunoprecipitated but 
only APPsα revealed neurotrophic properties in promoting neurite outgrowth (Hasebe et al., 
2013). A recent study proposed the existence of a high-affinity receptor which binds APPsα by 
an interaction with its E1 domain promoting the function as a heparin-binding growth factor 
(Reinhard et al., 2013). However, the molecular link between the observed rescue ability of 
APPsα in case of activity-dependent synaptic plasticity in the NexCre cDKOs still remains elusive 
and thus precludes a definitive mechanistic explanation how it promotes this effect. 
Nevertheless, although the receptor in that case is unidentified one might speculate that via this 
unknown receptor the intracellular Ca2+ dynamics and release from internal stores is controlled 
and triggered. This is supported by my finding that a viral expression of APPsα in NexCre cDKO 
dissociated hippocampal cultures restored the observed defect in Ca2+ dynamics before and 
upon chemically induced LTP by glycine administration (see Figure 3.8 and Figure 3.10). 
Numerous studies, including my results, implicated that APP exerts its physiological functions 
rather by the secreted APPsα than the APPsβ fragment. Tyan and colleagues recently showed 
that APPsα but not APPsβ partially rescued defects in dendritic spine number and morphology 
of primary hippocampal neurons from APP-KO mice (Tyan et al., 2012). Additionally, this 
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peptide restored an in vivo LTP defect, induced by inhibiting the α-secretase, back to control 
values. Notably, Taylor and colleagues showed a dose-dependency for the function of APPsα. 
The concentration applied to the hippocampus for LTP facilitation was 11 nM, comparable to 
such I used for the NexCre cDKO LTP rescue, while a much higher dose of 3300 nM acted 
contrariwise in decreasing the LTP compared to controls (Taylor et al., 2008). However, these 
high concentrations might cause side effects by peptide aggregation or the amount of peptides 
is toxic due to unphysiological levels. A comparable concentration of 10 nM APPsα was shown 
to upregulate the de novo protein synthesis of synaptic proteins implicating that this might 
contribute to long-lasting effects in synaptic plasticity (Claasen et al., 2009). In line with my 
observations that contrary to APPsα the application of APPsβ failed to restore the LTP defect of 
NexCre cDKOs, no significant increase in synaptic protein expression was observed when 10 nM 
APPsβ were applied (Claasen et al., 2009). Whereas, APPsα was shown to modulate the gene 
expression via activation of plasticity related transcription factors CREB and NF-κB (Claasen et 
al., 2009; Ryan et al., 2013). Notably, I decided to use a concentration of 50 nM recAPPsβ to 
consider the fact that this peptide was shown to be less potent than recAPPsα (Furukawa et al., 
1996). Another approach to, indirectly increase the APPsα level was carried out by an 
overexpression of its producing α-secretase which finally led to a LTP rescue of the defect in 
these AD mouse mutant as well (Postina et al., 2004). Interestingly, a recent publication 
reported that LTP decreases ADAM10 surface levels by clathrin mediated endocytosis leading to 
a reduced overall ADAM10 activity whereas contrariwise the opposite was observed during LTD 
(Musardo et al., 2013). This is in clear contrast to findings from Postina and colleagues. 
Nevertheless, an overexpression does not represent the physiological state by which opposing 
results might be explained. 
The beforehand described setup for LTP rescue experiments require large amounts of recAPPsα 
and β whose generation is relatively time consuming. Therefore, currently NexCre cDKO mice 
are established which express APPsα that is virally applied into the hippocampus. This enables 
to directly establish stable levels of APPsα in vivo. Furthermore, this allows testing whether a 
potential rescue is also observed at morphological and functional level like learning behavior or 
synaptic plasticity. This is promising since APPsα has been shown to increases synaptic density 
and improve memory retention when recAPPsα was infused into the brain (Roch et al., 1994; 
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Meziane et al., 1998; Taylor et al., 2008). A further support is given by the finding that the 
expression of APPsα in APP-KO mice restores the defect in spine density as well as spine subtype 
distribution (Weyer et al., 2014). 
 
4.2.2 The Application of recAPPsα Further Increases Synaptic Strength: a Therapeutic Benefit 
The intriguing observation that recAPPsα but not recAPPsβ is capable to restore the impaired 
LTP in NexCre cDKO mice provides an emerging potential in consideration of therapeutic 
strategies in Alzheimer’s disease (AD). Therefore, the secretases which are involved in full length 
APP processing are of particular interest. The formation of toxic Aβ oligomers and plaques has 
been established to highly contribute to the cognitive decline in AD (Schaeffer et al., 2011). 
Additionally, the reduction of α-secretase cleavage might foster AD pathogenesis, potentially by 
increasing Aβ levels and decreasing the neuroprotective APPsα.  
Loss-of-function mutations in the pro-domain of the α-secretase ADAM10 were discovered in 
families with late onset forms of AD leading to an APPsα reduction and Aβ raise (Kim et al., 
2009). Consistently, the mutation within the ADAM10 gene led to an attenuated ADAM10 
activity and as a result less APPsα was secreted but more β-secretase cleavage occurred (Suh et 
al., 2013). Furthermore, an impaired ADAM10 delivery to cell membranes in AD patients was 
shown (Musardo et al., 2013). In line, some, but not all studies analyzing APPsα levels in 
cerebrospinal fluid reported a reduction in AD versus control patients (Sennvik et al., 2000; 
Olsson et al., 2003; Fellgiebel et al., 2009). Low APPsα levels were also correlated with poor 
spatial memory performance in rats and humans (Almkvist et al., 1997; Anderson et al., 1999). 
Strikingly, the overexpression of APPsα in the hippocampus of old AD model mice restored the 
beforehand established LTP defect. This implicates that an APPsα expression in mice which 
already reveal an Aβ deposition still has the potential to ameliorate neurotoxic effects (Postina 
et al., 2004), data presented at the neuroscience 2014, M. F. Yahaya, University of Otago, New 
Zealand, poster ID 405.06/D53).  
With respect to AD, the alterations of plasticity in APP deficient and APPsα-DM mice suggest 
that increasing α-secretase activity or the infusion of APPsα could be a promising therapeutic 
strategy (Kojro et al., 2001; Fahrenholz and Postina, 2006; McConlogue et al., 2007; 
Lichtenthaler, 2012). Vice versa a reduction of β-secretase BACE1 activity would be a further 
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potential target for an effective therapy or even prevention of AD since this enzyme selectively 
cleaves APP in the initial step of the amyloidogenic pathway (McConlogue et al., 2007; De 
Strooper et al., 2010). However, the establishment of suitable drugs that can be applied in 
humans remains challenging because besides the processing of APP those secretases are shown 
to be involved in various other biological processes. Their inhibition might cause undesired toxic 
side effects. Furthermore, the full length APP is processed by different α-secretases whose exact 
role in that process is still debated. Therefore, a direct and specific activation might be difficult. 
However, the inhibitor applied in this study to selectively inhibit the ADAM10 α-secretase 
activity was shown to be highly specific (Andrews et al., 2000; Hoettecke et al., 2010; Weyer et 
al., 2011). Another issue is the application of the compound since it needs to cross the blood-
brain-barrier. Moreover, it needs to be considered that in the healthy brain APP processing 
follows a tight balance in which also low amounts of Aβ are crucial for a proper neuronal 
functionality and memory formation (Puzzo et al., 2008; Abramov et al., 2009; Puzzo et al., 
2011). Alternatively, downstream targets like PKC, MAPK, tyrosine kinases or Ca2+ mediated 
pathways could be modulated by selective drugs (De Strooper et al., 2010). Collectively, the 
development of specific compounds for the beforehand described targets provides a high 
potential as a promising therapeutic strategy for this devastating disease. 
 
4.2.3  An APP and APLP2 Deficiency Leads to an Impaired Ca2+ Dynamic Before and Upon 
Chemically Induced LTP 
The pathological shift from the non amyloidogenic to more amyloidogenic processing of the full 
length APP also affects the neuronal Ca2+ homeostasis which is a prerequisite for a regulated 
neuronal excitability and synaptic plasticity. Many publications report an elevated intracellular 
Ca2+ concentration when, in case of Alzheimer’s disease, Aβ accumulates extracellularly (LaFerla, 
2002; Bezprozvanny and Mattson, 2008; Kuchibhotla et al., 2008; Lopez et al., 2008). This 
elevation arises from pores within the cell membrane formed by Aβ and an increased 
conductance of specific Ca2+ channels. Additionally, Aβ oligomers stimulate the release of Ca2+ 
from the ER through mGluR activation or increased IP3 production (Arispe et al., 1993; Renner 
et al., 2010; Demuro and Parker, 2013). This unphysiological Ca2+ amount has several functional 
consequences such as the modification of the cytoskeleton, induction of apoptosis and 
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disruption of spine-dendritic Ca2+ compartmentalization (Mattson et al., 1991; Kuchibhotla et 
al., 2008). The latter was shown to be crucial for neuronal signaling and synaptic communication 
(Yuste et al., 2000; Araya et al., 2006). All of these observations open the possibility of an 
important role of APP for a physiological Ca2+ homeostasis.  
The relationship between APP, its cleavage products and Ca2+ is multifaceted and can be 
analyzed in a bidirectional manner. First, the question is raised in which way APP is involved in 
Ca2+ signaling and vice versa how Ca2+ dependent pathways influence APP processing. The 
analysis of NexCre cDKO primary hippocampal cultures revealed an impaired Ca2+ dynamic 
before and upon chemically induced LTP by glycine which might at least in part contribute to the 
impaired synaptic plasticity assessed by electrophysiological techniques (see Figure 3.8 A and B). 
These results point towards an important function of the APP-protein family in terms of Ca2+ 
dynamics. Consistently, APP-KO fibroblasts revealed a decreased Ca2+ release from internal 
stores. Comparable results were obtained when wt fibroblasts were treated with γ-secretase 
inhibitor indicating a crucial function of the intracellular AICD fragment and γ-secretase activity 
for Ca2+ dynamics. This was corroborated by the finding that an expression of the AICD fragment 
in APP-KO fibroblasts restored this defect (Leissring et al., 2002). Since the AICD fragment acts 
as a direct or indirect transcription factor (see 4.1.4) it modulates the gene expression (Jacobsen 
et al., 2006; Pardossi-Piquard and Checler, 2012). The importance of the internal APP C-terminal 
region, more precisely the final 15 amino acids, was also shown in this thesis by the analysis of 
APP∆CT15 DM mice (see Figure 3.2) which revealed an impaired activity dependent synaptic 
plasticity (Klevanski et al., in preparation). Thus, a disturbed Ca2+ dynamic is conceivable leading 
to the observed defect (Hamid et al., 2007). Interestingly, studies on a mouse model of murine 
trisomy revealed higher intracellular Ca2+ concentrations (Cardenas et al., 2002). This mouse line 
carries the APP gene on chromosome 16. As three of them exist, a specific gene dosage effect is 
observed. In line with the finding that hippocampal cultures from NexCre cDKO mice exhibited a 
significantly decreased Ca2+ response already before cLTP induction (see Figure 3.8 A and B), 
cells from mice with trisomy in which the APP expression was knocked down to 40 % showed a 
comparable defect (Rojas et al., 2008).  
The question how elevated Ca2+ levels itself affect the APP processing is far less intensely 
studied than the opposing situation described beforehand. It was suggested that a high cytosolic 
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Ca2+ level further enhances amyloidogenic APP cleavage resulting in more Aβ generation 
(Querfurth and Selkoe, 1994). Mechanistically, high cytosolic Ca2+ amounts lead to a transient 
phosphorylation of APP which shifts to more Aβ production (Pierrot et al., 2006). However, 
these findings are debated. Buxbaum and colleagues showed that the inhibition of the sarco / 
endoplasmic reticulum calcium-ATPase (SERCA) decreased Aβ generation (Buxbaum et al., 
1994). 
To chemically induce LTP glycine stimulation was used which is in many aspects comparable to 
TBS induced LTP (Shahi et al., 1993). High concentrations of glycine induced long-lasting changes 
in synaptic efficacy in rat hippocampal slices (Shahi et al., 1993). Since in the present study 
hippocampal dissociated neuronal cultures which display a different network were used, a 
stable Ca2+ increase especially for later time points analyzed was unlikely. Indeed, in every result 
presented, t40 always revealed much lower Ca2+ concentrations irrespective of the genotype 
(see Figure 3.8). An explanation might be that hippocampal cultures lack the modulatory 
dopaminergic and cholinergic input. Furthermore, not all synapses are innervated which might 
as well clarify why these cultures could not be potentiated as strong and stable as expected. 
Moreover, these cultures do not represent the neuronal network which is found in vivo. 
Alternatively, OHCs could overcome this issue. 
Maybe, the cultures used could not react with an enlargement of PSD upon stimulation because 
the induction was not strong enough to stimulate the required processes. At resting conditions 
cytosolic Ca2+ concentrations usually range between 50-300 nM which increases to several mM 
when neurons are activated (LaFerla, 2002). For the unstimulated condition the littermate 
control cultures reached 50 nM (see Figure 3.8). Also the increase upon cLTP induction was not 
as strong as expected. Therefore, it might be necessary to apply an optimized protocol. A pre-
conditioning of the cultures with APV was shown to activate more NMDAR and thus increase 
the synchronous network activity (Molnar, 2011). Maybe without APV exposure the induction 
was not sufficient enough to trigger changes in protein expression which are crucial for long-
lasting changes.  
In conclusion, the lower Ca2+ response in NexCre cDKO cultures may indicate a lower bursting 
activity which might originate from an immature network (see Figure 3.8). As already shown by 
Hick and colleagues NexCre cDKO neurons exhibited a decreased spine number including a shift 
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from mature mushroom towards more immature stubby spines which was accompanied by a 
reduced PSD95 level (Hick et al., 2015). Fewer spine numbers which are less mature are 
correlated to a decreased synaptic activity accompanied by a reduced Ca2+ response. 
Nevertheless, in relation to the resting activity also NexCre cDKO cultures respond equally in 
comparison to littermate control cultures (see Figure 3.9) showing that although they have 
fewer spines those which are activated can be comparably potentiated. However, in addition to 
these morphological defects the impaired Ca2+ dynamics might be caused by affected internal 
stores or Ca2+ channels. 
 
4.2.4 The Defect in Ca2+ Dynamics of NexCre cDKO Mice is Partially Based on an Impaired ER 
Function 
To gain a mechanistic insight into the defect of Ca2+ dynamics in NexCre cDKO I co-applied 
glycine and specific inhibitors for distinct Ca2+ resources (see Figure 3.8 and Figure 3.10). 
Endogenous glycine receptors were always blocked by strychnine. First, I inhibited ionotropic 
NMDA receptors by a 2-amino-5-phosphonopentanoic acid (APV) application (see (see Figure 
3.8 C and D, Figure 3.10 C and D). This way a cLTP induction was completely abolished similarly 
in both littermate control and NexCre cDKO cultures suggesting that NMDARs are the crucial 
and main component for Ca2+ increase permitting the potentiation via glycine stimulation. 
Second, I co-applied glycine and cyclopiazoic acid (CPA) which selectively blocked the sarco / 
endoplasmic reticulum calcium-ATPase (SERCA) which promotes the reuptake of Ca2+ back into 
the ER (see Figure 3.8 E and F, Figure 3.10 E and F). The cLTP induction led to no significant 
increase in littermate control cultures showing that the reuptake is essential for Ca2+ oscillations 
in the intact CNS. Interestingly, the lack of APP in NexCre cDKO cultures seems to influence this 
process since a highly significant Ca2+ increase was found upon glycine application although the 
SERCA was inhibited by CPA. The values obtained for NexCre cDKO cultures directly after cLTP 
induction were much higher under glycine and CPA compared to only glycine treatment (see 
Figure 3.8 A,B,E,F). Furthermore, the analysis of the relative Ca2+ amount was exclusively 
significantly increased under glycine and CPA conditions (see Figure 3.9 C). The application of 
CPA resulted in no significant decrease in the frequency upon co-treatment with glycine in both 
genotypes irrespective if separately littermate controls and NexCre cDKOs (see Figure 3.10 E) or 
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imaging time-points were analyzed (see Figure 3.10 F). However, it is conspicuous that the 
comparison of data obtained from NexCre cDKO by measuring the Ca2+ concentration (see 
Figure 3.8 E) and the frequency (see Figure 3.10 E) uncovered an inverse correlation. Upon co-
application of glycine and CPA, the amount of cytoplasmatic Ca2+ increased for t0, but then 
decreased continuously at t10 and t40 (seeFigure 3.8 E). The opposite was observed in terms of 
the frequency. Here upon glycine and CPA treatment an initial decrease of spikes / min was 
detected which then constantly increased during imaging 10 and 30 min later (see Figure 3.10 
E). Reasons for this could be multifaceted: It may be speculated that in glycine treatment alone 
the SERCA might be very efficient in transporting the Ca2+ back to the ER, reflected by lower 
cytoplasmatic Ca2+. Another suggestion might be that Ca2+ buffer proteins are affected e.g. by 
less functional or lower amounts. Since less Ca2+ may be bound to buffer proteins, more is taken 
up into the ER. If this hypothesis holds true specific buffer proteins could be tested regarding 
their expression levels by western blot analysis in future experiments. These ideas were further 
supported by the results for later time-points in NexCre cDKO cultures as due to the blockade of 
SERCA no longer Ca2+ could be transported back into the ER. Reflected by apparently decreasing 
values no stable increase of Ca2+ upon co-application of glycine and CPA was possible in NexCre 
cDKOs (see Figure 3.8 E).  
Third, I inhibited L-type voltage gated calcium channels (VGCCs) via Nifedipine application (see 
Figure 3.8 G and H, Figure 3.10 G and H). The blockade prevented a significant cLTP induction in 
both littermate controls and NexCre cDKO, respectively. However, although no difference was 
observed when Nifedipine and glycine were co-applied the cLTP impairment in NexCre cDKO 
cultures under only glycine conditions could be explained by a relation of APP and L-type VGCCs 
in excitatory and inhibitory neurons. The acute expression of human APP in cortical neurons was 
reported to increase the L-type VGCC mediated Ca2+ currents which is consistent with my 
observation that a lack of APP and APLP2 decreased the Ca2+ response upon glycine application 
(Santos et al., 2009). Cortical neurons form networks in which oscillation processes are required 
for long-term consolidation of memory (Buzsaki and Draguhn, 2004). Primary cortical cultures 
also form such networks in which glutamatergic input leads to spontaneous synchronous Ca2+ 
oscillations. Interestingly, an overexpression of APP prevented these oscillations. 
Mechanistically, it is proposed that APP overexpression enhanced the L-type VGCC activity. The 
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following Ca2+ influx stimulates K+ channels which are responsible for the medium 
afterhyperpolarization which in turn decreases the excitability of APP overexpressing cells and 
finally leads to the inhibition of Ca2+ oscillations. Vice versa the knock-down of endogenous APP 
increased the frequency but simultaneously decreased the amplitude of these oscillations which 
was in line with my findings because NexCre cDKO cultures exhibited decreased Ca2+ amplitudes 
before and upon cLTP induction (Santos et al., 2009; Octave et al., 2013). Consistently, an 
upregulation of presynaptic L-type VGCC in GABAeric neurons was found which was 
accompanied by an impaired short-term plasticity in APP-KO striatal neurons (Yang et al., 2009).  
Collectively and in line with observation from Santos and colleagues a crucial function of APP for 
maintenance of neuronal Ca2+ dynamics can be stated. Furthermore, a loss of APP and APLP2 
affects the ER function. Consequently, this might also be an explanation for the observed 
defects in activity-dependent synaptic plasticity since such Ca2+ homeostasis is important for 
synaptic transmission (Zucker, 1999; Rochefort and Konnerth, 2012; Octave et al., 2013; Brini et 
al., 2014). Nevertheless, to clarify the exact mechanisms how a loss of APP and APLP2 is 
connected to disturbed Ca2+ dynamics needs to be applied. 
  
4.2.5 APPsα is Capable to Restore the Impaired Ca2+ Dynamics of NexCre cDKO Mice 
Another APP processing product, APPsα, exhibits its neuroprotective properties in case of 
excitotoxicity by attenuating the Ca2+ response (Mattson et al., 1992; Mattson et al., 1993). In 
line with this APPsα was shown to stabilize the Ca2+ homeostasis via a mechanism which 
includes NF-κB activation in PC12 cells with a mutated Presenilin-1 gene thereby preventing 
apoptosis (Guo et al., 1998; Ryan et al., 2013). Interestingly, a modulation of NF-κB through TNF 
signaling was shown to regulate neuronal excitability and hippocampal synaptic plasticity 
(Albensi and Mattson, 2000). These observations might at least in part contribute to the rescue I 
showed for dissociated hippocampal cultures from NexCre cDKO embryos in which a viral 
expression of APPsα restored the observed defect in Ca2+ amounts before as well as upon cLTP 
induction by glycine application (see Figure 3.12 and Figure 3.14). The action of APPsα on the 
amount of intracellular Ca2+ is discussed controversially. On the one hand it was shown to lower 
the resting Ca2+ concentration and inhibit the Ca2+ increase induced by glutamate application in 
hippocampal cultures (Mattson, 1994; Furukawa et al., 1996). However, it was also reported 
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that besides this inhibitory function APPsα also was found to increase the intracellular Ca2+ 
amount via IP3-dependent mechanisms. Notably, this effect was only observed in 1-2 days 
cultured neurons. It successively disappeared with days in vitro indicating a functional role of 
APPsα during development (Koizumi et al., 1998). It might be speculated that the impaired LTP 
in NexCre cDKO and DlxCre cDKO (see Figure 3.6 and Figure 3.21) as well as the impaired Ca2+ 
dynamics in NexCre cDKO hippocampal cultures (see Figure 3.8 A and B) might arise from the 
lack of APPsα during synaptogenesis. This is consistent with the finding that a viral expression of 
APPsα restores the defect in the Ca2+ dynamics. However, the observation that an application of 
recAPPsα is sufficient to restore the LTP points towards two separate functions one during 
development the other as an acute mediator for activity-dependent synaptic plasticity. 
 
 
 
C o n c l u s i o n s  a n d  O u t l o o k  |  1 2 9  
 
4.3 Conclusions and Outlook 
In this thesis, I could show an emerging physiological role of APP and APLP2. This role was 
further specified for brain development presumably during synapse and neuronal network 
formation as well as acutely at active synapses during LTP in the mature brain. For an intact 
neuronal function an excitation-inhibition balance is required. Since I could show a defect in 
activity-dependent synaptic plasticity when APP and APLP2 are knocked out in either excitatory 
or inhibitory neurons this balance likely is impaired. In these mice APP and APLP2 were still 
expressed in astrocytes and the respective neuronal subtype which was not targeted. In future 
experiments a ubiquitous postnatal ablation of both proteins throughout all neurons would be 
feasible by using the CAG-deleter line. This provides the possibility to investigate a full DKO 
situation which might increase the defect observed before.  
I could again successfully reproduce the previously described age-related loss of compensatory 
functions of APLP2 in aged APP-KO mice while APP was still capable to restore the loss in aged 
APLP2-KO individuals. A possible explanation for this might be a reduction of APLP2 expression 
in aged individuals. This should be tested by Western Blot.  
One important finding during my investigations was that recombinant APPsα fully restored the 
previously observed impaired activity-dependent synaptic plasticity in NexCre cDKO acute slices 
back to control levels. This emphasizes its necessity for a proper neuronal function and memory 
formation. However, to obtain stable levels a viral delivery of APPsα in vivo via hippocampal 
stereotactic injection could be performed. This ensures a re-introduction of APPsα into the 
NexCre cDKO mice and thus enables the experimenter to perform gain of function and rescue 
experiments. This would then be not only restricted to electrophysiological recording but these 
mice could also be analyzed regarding neuronal morphology and learning behavior which was 
shown to be significantly impaired in NexCre cDKO mice. Furthermore, this viral approach could 
be a useful tool to accomplish acute loss of function studies in adult mice by a delivery of the 
Cre-recombinase in floxed individuals.  
The LTP defect observed in NexCre cDKO mice is tightly linked to a perturbed Ca2+ dynamic as 
implicated by my observations. One of the beforehand mentioned hypothesis stated that the 
Ca2+ buffer protein expression is lower compared to controls and the surplus of unbound Ca2+ is 
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transported into the endoplasmatic reticulum. This could be proven by Western Blot analysis for 
concentrations of candidate proteins like calbindin, calretinin, parvalbumin and calmodulin. 
I could furthermore demonstrate that in contrast to recAPPsα the application of recAPPsβ was 
not capable to restore the LTP defect of NexCre cDKOs emphasizing the importance of the 17 
amino acids of difference. To investigate whether comparable to this electrophysiology study 
also APPsβ is ineffective to restore the Ca2+ concentration before and upon cLTP induction 
APPsβ could be applied by AAV.  
Since a viral delivery of APPsα was sufficient to restore the impaired Ca2+ dynamics it might be 
interesting to see whether this also restores the impaired spine morphology. Therefore, mApple 
or mCherry transfected cultures enable to perform Ca2+ imaging at the spine level paralleled by 
analyzing morphological changes. 
As already noted in the discussion the imaging time point t40 always revealed decreased Ca2+ 
amount irrespective of genotype. One explanation is that the missing modulatory input might 
be responsible but also an insufficient NMDAR activation might be accountable for that. 
Therefore, the modification of the protocol for instance by preconditioning of cultures with APV 
might be an option. Alternatively to hippocampal dissociated cultures the quantitative Ca2+ 
imaging might be established in organotypic hippocampal cultures which have the advantage of 
an intact neuronal network comparable to the in vivo situation. 
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ISI    Inter-stimulus interval 
KI    Knock-in 
KO     Knock-out 
LFS    Low-frequency stimulation 
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LTD     Long-term depression 
LTP     Long-term potentiation 
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TBS     Theta-burst stimulation 
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